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ABSTRACT 
 
The aerobic respiratory chain of mycobacteria consists of at least two branches, a 
cytochrome c branch terminating in an aa3-type cytochrome c oxidase, and a quinol 
branch terminating in cytochrome bd oxidase. The structure and function of the former 
branch, leading from the menaquinone-menaquinol pool to the cytochrome bc1 complex 
and terminating in the aa3-type cytochrome c oxidase, was characterized in 
Mycobacterium smegmatis. Allelic exchange mutants of M. smegmatis in the bc1 
complex (ΔqcrCAB::hyg) and in subunit II of the aa3-type cytochome c oxidase 
(ΔctaC::hyg) were constructed and analyzed for growth, and gene expression using lacZ 
reporter assays and genome expression profiling by DNA microarray. Both mutants were 
found to be profoundly growth impaired. Disruption of this pathway resulted in an 
adaptation of the respiratory network that is characterized by a marked up-regulation of 
cydAB, which encodes the bioenergetically less-efficient and microaerobically induced 
cytochrome bd-type menaquinol oxidase that is required for the growth of M. smegmatis 
under O2-limiting conditions. Other adaptations to re-routing of the electron flux through 
the branch terminating in the bd-type oxidase were revealed by comparative expression 
profiling of the bc1-deficient mutant and its parental wild type strain using a partial-
genome microarray of M. smegmatis that is enriched in essential genes. The majority of 
the genes up-regulated in the mutant are involved in intermediary metabolism and 
respiration. Also induced were several genes including, uspL and a homologue of 
Rv1592c, which were previously shown to be up-regulated by hypoxia in M. smegmatis 
(uspL) and M. tuberculosis (uspL and Rv1592). The cytochrome bc1-aa3 branch is 
required for growth of M. smegmatis under aerobic conditions and its disruption results in 
growth attenuation and up-regulation of cytochrome bd oxidase. 
 
 
 
 
 
 
 iii 
DEDICATION 
 
 
 
 
 
 
I am proud to dedicate this thesis to the memory of my father 
Mpiti B. Matsoso (1922-1989) 
Father, I always wish you were here to share in my achievements,  
but I do know that you have always been watching over me from Heaven. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv 
ACKNOWLEDGEMENTS 
 
I would like to express my gratitude to my supervisor, Professor Valerie Mizrahi, 
whose invaluable guidance, and support led me through this study. Val, I learnt a lot from 
you, and I appreciate everything. Thanks for the opportunities to travel abroad and 
present my work internationally. I am also grateful to Dr Bavesh Kana, for his input in 
various aspects of this study. None of these went unnoticed or unappreciated, thank you. 
 I would like to thank all my colleagues, in the Molecular Mycobacteriology 
Research Unit, names mentioned or not, for their various contributions to my learning 
during this study. Edith thanks for repeatedly showing me that computers are not the 
monsters that I sometimes thought they were. To Julia, thanks for always finding a way 
to put a smile on my face at times when I would otherwise be frowning. You are more 
than just a colleague.  
 I wish to thank Dr. Ross Coppel and his colleagues for their collaboration on the 
microarray experiments, especially Dr. David Powell (Victorian Bioinformatics 
Consortium, Monash University, Australia) for his assistance with the analysis of some of 
the DNA microarray data. I would also like to thank Dr. Harvey Rubin, Dr. Martin 
Voskuil and Dr. David Sherman for their helpful discussions. 
 I appreciate the financial support provided by the Howard Hughes Medical 
Institute (International Research Scholar’s grant to Prof. Mizrahi), the Medical Research 
Council of South Africa and the National Research Foundation of South Africa (grants to 
Prof. Mizrahi). 
 To my family- mother (‘Mapontso M. Matsoso), my brothers, sisters and their 
families, thank you all for your love, support and encouragement, and thanks for always 
believing in me. Special thanks to you mother: I don’t have enough words to express my 
gratitude to you– for being a mother, a “father” and a friend all in one. You have always 
been the source of love, dignity, courage, strength, and perseverance to me, and I thank 
God for keeping you.  
 Above all, I thank God for everything. 
 
 
 v 
PUBLICATIONS FROM THIS THESIS 
 
Matsoso, L. G., B. D. Kana, P. K. Crellin, D. J. Lea-Smith, A. Pelosi, D. Powell, S. S. 
Dawes, H. Rubin, R. L. Coppel, and V. Mizrahi. 2005. Function of the cytochrome 
bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation 
occurring in response to its disruption. J. Bacteriol. 187:6300-6308. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vi 
TABLE OF CONTENTS 
 
DECLARATION........................................................................................................... i 
ABSTRACT................................................................................................................... ii 
DEDICATION............................................................................................................... iii 
ACKNOWLEDGEMENTS........................................................................................... iv 
PUBLICATIONS FROM THIS THESIS...................................................................... v 
TABLE OF CONTENTS............................................................................................... vi 
LIST OF FIGURES....................................................................................................... xiii 
LIST OF TABLES......................................................................................................... xv 
1. INTRODUCTION.................................................................................................... 1 
1.1 Mycobacteria and diseases........................................................................ 1 
1.2 Tuberculosis: a global burden.................................................................. 1 
1.2.1 Tuberculosis prevention and treatment ................................... 2 
The BCG vaccine and challenges facing it.............................. 2 
Antitubercular chemotherapy and drug resistance................. 4 
1.2.2 Latency.........................................................................................  5 
Containment of latent M. tuberculosis infection in 
granulomas................................................................................ 
 
6 
Environmental conditions faced by M. tuberculosis in 
           latent infections.......................................................................... 
 
7 
1.3 Respiration.................................................................................................. 7 
1.3.1 Aerobic respiration..................................................................... 8 
1.3.2 Respiration in eukaryotes........................................................... 9 
NADH:ubiquinone oxidoreductase (complex I)............. 9 
Succinate:ubiquinone oxidoreductase (complex II)....... 10 
The ubiquinone/ubiquinol pool and other 
dehydrogenases.............................................................. 
 
10 
Ubiquinol-cytochrome c oxidoreductase or 
cytochrome bc1 complex (complex III)........................... 
 
11 
Cytochrome c oxidase (complex IV).............................. 11 
 vii 
The ATPsynthase (F0F1-ATPase; complex V................. 12 
1.4 Respiration in bacteria.............................................................................. 12 
1.4.1 The multiplicity of respiratory pathways.................................  12 
The respiratory chain of Escherichia coli................................ 13 
The respiratory chain of Corynebacterium glutamicum....... 14 
NADH:menaquinone oxidoreductase............................ 15 
Succinate:menaquinone oxidoreductase........................ 15 
Other dehydrogenases that can reduce menaquinone... 15 
Menaquinol:cytochrome c oxidoreductase or 
cytochrome bc1 complex.................................................  
 
16 
Cytochrome c oxidase (cytochrome aa3)........................ 18 
Cytochrome bd oxidase..................................................    18 
ATP synthase and bioenergetics in C. glutamicum....... 19 
1.4.2 Respiratory inhibitors................................................................. 20 
Inhibitors of NADH dehydrogenase......................................... 20 
Inhibitors of the cytochrome bc1 complex................................ 20 
Inhibitors of terminal oxidases................................................. 21 
1.4.3 Regulation of expression of the bacterial respiratory chain 
components............................................................................... 
 
21 
Direct oxygen sensors............................................................... 22 
The FixLJ system........................................................... 22 
The Fnr system............................................................... 23 
Redox sensors............................................................................ 23 
The ArcAB system..........................................................  23 
The RegB-RegA and PrrB-PrrA systems....................... 25 
The DosR-DosS/DosT (DevR-DevS/DevT) system........ 25 
The SenX3-Reg3 system................................................. 29 
1.5 Respiration in mycobacteria..................................................................... 29 
1.5.1 Respiration in M. smegmatis...................................................... 30 
1.5.2 Respiration in M. tuberculosis.................................................... 30 
1.6 Aims and objectives of this study.............................................................. 31 
 viii 
2. MATERIALS AND METHODS............................................................................ 33 
2.1 General recombinant DNA methods and reagents................................. 33 
2.1.1 Bacterial strains and plasmids................................................... 33 
2.1.2 Bacterial culture conditions and selective agents..................... 33 
2.1.3 DNA extraction............................................................................ 35 
Plasmid preparation from E. coli.............................................. 35 
Chromosomal DNA extraction from mycobacteria................... 36 
DNA purification from agarose gels or enzymatic reactions.... 37 
2.1.4 DNA manipulations..................................................................... 37 
Restriction enzyme digests.........................................................  37 
Dephosphorylation of 5’ ends.................................................... 37 
Modification of 5’ and 3’ overhangs.......................................... 38 
Ligations..................................................................................... 38 
2.1.5 Polymerase Chain Reactions (PCR).......................................... 38 
2.1.6 Sequencing................................................................................... 39 
2.1.7 Agarose gel electrophoresis........................................................ 39 
2.1.8 Southern blot analysis................................................................. 39 
Preparation of probe.................................................................. 39 
Electroblotting........................................................................... 40 
Hybridization............................................................................. 40 
2.1.9 Transformations.......................................................................... 41 
Rubidium chloride transformation of E. coli............................. 41 
Electroporation of mycobacteria............................................... 41 
2.2 Cloning and characterization of cytochrome bc1 and aa3 mutants  
      of M. smegmatis and M. tuberculosis........................................................ 
 
42 
2.2.1 Construction of knockout vectors for qcrCAB, ctaC, ctaDI   
         and ctaDII genes of M. smegmatis.............................................. 
 
42 
PCR amplification and cloning of deletion allele substrates…. 42 
Cloning of marker cassettes....................................................... 43 
2.2.2 Allelic replacement of the qcrCAB, ctaC, ctaDI and ctaDII    
         genes of M. smegmatis................................................................. 
 
44 
 ix
Delivery of knockout constructs into M. smegmatis.................. 44 
Selection and genotypic analysis of mutants............................. 44 
2.2.3 Phenotypic characterization of M. smegmatis mutants........... 47 
Preparation of M. smegmatis seed stocks…………………...... 47 
Growth in shaking flasks............................................................ 47 
Growth in a bioreactor under oxystatic conditions................... 47 
2.2.4 cyd expression analysis in a ΔqcrCAB::hyg mutant using  
         a lacZ reporter............................................................................. 
 
48 
Construction of cyd reporter strain .......................................... 48 
Oxystatic growth of the reporter strains.................................... 49 
β-galactosidase assay................................................................ 49 
Bradford assay........................................................................... 50 
2.2.5 Genome expression profiling of the M. smegmatis bc1  
         and aa3 mutants using DNA microarray................................... 
 
50 
Sources of DNA microarrays .................................................... 50 
RNA extraction........................................................................... 51 
Preparation of labelled cDNA probes....................................... 52 
Microarray hybridization........................................................... 53 
Data analysis.............................................................................. 54 
2.2.6 Effects of chlorpromazine on the transcriptome of a bc1  
         mutant of M. smegmatis.............................................................. 
 
55 
DNA microarray........................................................................ 55 
Semi-quantitative RT-PCR......................................................... 55 
2.2.7 Complementation of the M. smegmatis ctaC mutant............... 56 
2.2.8 Attempts to construct a cytochrome bc1 - bd double mutant.. 57 
2.2.9 Attempts to construct a ctaC mutant of M. tuberculosis.......... 57 
Cloning and delivery of the knockout substrate......................... 57 
Selection of recombinants.......................................................... 57 
3. RESULTS................................................................................................................. 59 
Function of the cytochrome bc1-aa3 branch of the respiratory network 
 in mycobacteria............................................................................................... 
 
59 
 x
3.1 Identification of the aerobic respiratory genes in the genome of  
      M. smegmatis............................................................................................... 
 
59 
3.1.1 Occurrence of multiple ctaD homologues in M. smegmatis..... 61 
Analysis of the M. smegmatis CtaD homologues reveals a 
possible frame-shift in ctaDI...................................................... 
 
63 
The occurrence of multiple ctaD alleles is not uncommon in 
actinomycetes............................................................................. 
 
63 
3.1.2 Genetic composition and organization of the aerobic  
         respiratory chain of M. smegmatis.............................................  
 
65 
Genetic structure of the M. smegmatis cytochrome bc1-aa3 
pathway...................................................................................... 
 
67 
3.2 Targeted knockout of genes in the cytochrome bc1-aa3 pathway in  
       M. smegmatis.............................................................................................. 
 
67 
3.2.1 Construction of a cytochrome bc1 mutant of M. smegmatis.... 68 
Genotypic analysis of the DCO mutants....................................  70 
3.2.2 Targeted knockout of cytochrome aa3 oxidase subunit I of   
          M. smegmatis............................................................................... 
 
70 
Targeted knockout of ctaDI in M. smegmatis mc2155............... 72 
Attempts to create a null ctaDI mutant in M. smegmatis ΔDR . 74 
Construction of a ctaDII mutant of M. smegmatis mc2155........ 75 
3.2.3 Construction of a M. smegmatis cytochrome aa3 knockout   
         mutant lacking subunit II (CtaC)..............................................  
 
76 
3.2.4 Targeted knockout of genes in the cytochrome bc1-aa3  
          respiratory pathway in M. tuberculosis.................................... 
 
77 
3.3 Phenotypic analysis of M. smegmatis cytochrome bc1 and aa3 mutants 79 
3.3.1 ΔqcrCAB::hyg and ΔctaC::hyg mutants are attenuated for  
         growth.......................................................................................... 
 
79 
3.3.2 Complementation of the M. smegmatis ctaC mutant with  
         M. tuberculosis ctaC..................................................................... 
 
81 
3.3.3 Over-expression of cytochrome bd oxidase compensates for   
         loss of the bc1 complex................................................................ 
 
81 
 xi
3.3.4 Attempts to construct a cytochrome bc1/ cyotochrome bd  
         double mutant of M. smegmatis.................................................  
 
85 
3.3.5 Genome expression profiling of the cytochrome bc1  
         (ΔqcrCAB::hyg) and cytochrome aa3 (ΔctaC::hyg) mutants... 
 
85 
Differential gene expression profiling of the ΔqcrCAB::hyg 
mutant of M. smegmatis using a partial-genome amplicon 
microarray................................................................................. 
 
 
86 
Differential gene expression profiling of the ΔqcrCAB::hyg 
mutant using a whole- genome oligo array of M. smegmatis.... 
 
89 
Transcriptome analysis of the cytochrome aa3 mutant using 
the amplicon array..................................................................... 
 
92 
3.3.6 Effects of chlorpromazine on the transcriptomes of the bc1  
         and aa3 mutants........................................................................... 
 
92 
Analysis by DNA microarray.....................................................  92 
Analysis of effects of CPZ on the bc1 mutant using RT-PCR.....  100 
4. DISCUSSION........................................................................................................... 102 
Genomic organization of the cytochrome bc1................................................ 102 
Cytochrome bc1 complex........................................................................  102 
Cytochrome c oxidase............................................................................ 103 
The apparent essentiality of the M. smegmatis ctaDI gene........................... 103 
Are there isoenzymes of aa3-type cytochrome c oxidase in M. smegmatis? 104 
Growth attenuation of the cytochrome bc1 (ΔqcrCAB::hyg) and aa3-type 
cytochrome c oxidase (ΔctaC::hyg) mutants of M. smegmatis...................... 
 
105 
Over-expression of cytochrome bd oxidase compensates for loss of the 
bc1 complex or aa3-type cytochrome c oxidase.............................................. 
 
106 
Cytochrome bd’ oxidase (YthAB) is not differentially expressed in the 
mutants.............................................................................................................. 
 
107 
Induction of hypoxia-responsive genes in the cytochrome bc1-aa3 
pathway mutants of M. smegmatis.................................................................. 
 
107 
Proposed changes in the redox states of electron carriers in the 
cytochrome bc1-aa3 pathway mutants............................................................ 
 
108 
 xii
Effects of chlorpromazine on the transcriptome of the cytochrome bc1 
mutant............................................................................................................... 
 
109 
The regulation of cytochrome bd oxidase in M. smegmatis.......................... 112 
A possible role for SenX3-RegX3 in the regulation of cytochrome bd 
oxidase................................................................................................... 
 
112 
The proposed signal for SenX3-RegX3.................................................. 113 
Other adaptations to re-routing the electron flux through cytochrome bd 
oxidase............................................................................................................... 
 
114 
Evidence for reduced metabolic activity in the cytochrome bc1-aa3 
pathway mutants....................................................................................  
 
116 
Differences in the transcriptomes of the cytochrome bc1 and aa3 mutants 116 
What can be learnt about mycobacterial respiration from this study?...... 116 
The role of the respiratory chain in the pathogenesis of M. tuberculosis....  118 
Future studies................................................................................................... 119 
5. APPENDICES.......................................................................................................... 120 
APPENDIX A: Abbreviations........................................................................... 120 
APPENDIX B: Media and solutions.................................................................. 122 
APPENDIX C: Plasmid Maps........................................................................... 124 
APPENDIX D: DNA microarray supplementary information.......................... 132 
6. REFERENCES......................................................................................................... 137 
 
 
 
 
 
 
 
 
 
 
 
 xiii 
LIST OF FIGURES 
 
Figure 1. The respiratory chain of C. glutamicum...............................................  16 
Figure 2. Knockout constructs used for inactivation of the M. smegmatis 
aerobic respiratory genes......................................................................  
 
45 
Figure 3. M. tuberculosis ctaC constructs...........................................................  58 
Figure 4. Comparison of subunit I of cytochrome c oxidase (CtaD) from M. 
tuberculosis and M. smegmatis............................................................  
 
62 
Figure 5. Phylogenetic relationship of CtaD proteins from sequenced 
actinomycetes bearing multiple ctaD alleles........................................  
 
64 
Figure 6. Genetic composition and organization of the aerobic respiratory 
chain of M. smegmatis..........................................................................  
 
66 
Figure 7. Site-specific integration of the M. smegmatis qcrCAB knockout 
vector, pQCRSMKO, in the chromosome............................................ 
 
69 
Figure 8. Allelic replacement of M. smegmatis qcrCAB with the mutant 
ΔqcrCAB::hyg....................................................................................... 
 
71 
Figure 9. Genotypic analysis of ctaDI mutants of M. smegmatis mc2155 and 
ΔDR...................................................................................................... 
 
73 
Figure 10.   Allelic exchange mutagenesis of ctaDII in M. smegmatis mc2155...... 76 
Figure 11. Construction of a ctaC deletion mutant of M. smegmatis.................... 77 
Figure 12. Targeted knockout of cytochrome c oxidase subunit II (encoded by 
ctaC) in M. tuberculosis H37Rv........................................................... 
 
78 
Figure 13. Growth of cytochrome bc1 and aa3 mutants of M. smegmatis under 
aerobic conditions.................................................................................  
 
80 
Figure 14. Complementation of M. smegmatis ctaC mutant with M. 
tuberculosis ctaC gene carried on pMVCTAC....................................  
 
82 
Figure 15. Effect of cytochrome bc1 disruption on expression of the cyd operon 
in M. smegmatis.................................................................................... 
 
84 
Figure 16. Expression analysis, as assessed by semi-quantitative RT-PCR, of 
sentinel genes differentially expressed in response to CPZ................. 
 
101 
Figure 17. Aerobic respiration through the cytochrome bc1-aa3 pathway in M.  
 xiv
smegmatis, and effects of its disruption on the redox states................ 110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xv
LIST OF TABLES 
 
Table 1. Bacterial strains used in this study....................................................... 34 
Table 2. Plasmids used in this study.................................................................. 34 
Table 3. Oligonucleotides used for construction of knockout vectors...............  46 
Table 4. M. smegmatis respiratory genes present on the partial-genome 
amplicon array...................................................................................... 
 
52 
Table 5. Oligonucleotides used in RT-PCR....................................................... 56 
Table 6. Genes encoding components of the aerobic respiratory chain of M. 
smegmatis............................................................................................. 
 
60 
Table 7. Sequence distances between various actinomycete CtaD 
polypeptides......................................................................................... 
 
64 
Table 8. Genes differentially expressed in aerobically grown ΔqcrCAB::hyg  
mutant of M. smegmatis.......................................................................  
 
88 
Table 9. Genes induced in aerobically grown ΔqcrCAB::hyg mutant of M. 
smegmatis (whole-genome microarray)...............................................  
 
90 
Table 10. Genes induced in aerobically grown ΔctaC::hyg mutant of M. 
smegmatis (partial-genome array)........................................................ 
 
91 
Table 11. Genes up-regulated in response to CPZ in the ΔqcrCAB::hyg  
mutant (partial- genome array)............................................................. 
 
94 
Table 12. Genes down-regulated in response to CPZ in the ΔqcrCAB::hyg 
mutant (partial-genome array).............................................................. 
 
96 
Table 13. Genes down-regulated in response to CPZ in the ΔqcrCAB::hyg 
mutant (TIGR arrays)........................................................................... 
 
98 
Table D1. M. smegmatis ΔqcrCAB::hyg genes induced during growth at 21%  
oxygen (partial-genome amplicon array).............................................  
 
132 
Table D2. M. smegmatis ΔqcrCAB::hyg genes repressed during growth at 21% 
oxygen (partial-genome array).............................................................  
 
133 
Table D3. Genes up-regulated in response to CPZ in the ΔqcrCAB::hyg mutant  
(full-genome oligonucleotide array).................................................... 
 
135 
 
 1 
1. INTRODUCTION 
 
1.1 Mycobacteria and diseases 
Mycobacteria are Gram-positive bacteria belonging to the family Actinomycetales, 
members of which include other clinically and industrially important genera such as 
Corynebacterium, Nocardia, Rhodococcus and Streptomyces (Ishikawa et al., 2004). 
Members of this family are characterized by GC-rich DNA and a cell wall that contains 
mycolic acids (Brennan and Nikaido, 1995; Bott and Niebisch, 2003; Ishikawa et al., 
2004). The genus Mycobacterium comprises more than seventy species of human and 
animal pathogens as well as non-pathogenic saprophytes (Krzywinska et al., 2004). 
Among the world’s most important human pathogens are Mycobacterium tuberculosis 
and Mycobacterium leprae, the causative agents of tuberculosis and leprosy, respectively. 
The naturally non-pathogenic members of the Mycobacterium avium complex are 
increasingly emerging as opportunistic pathogens in immuno-compromised individuals 
such as AIDS patients (Hou et al., 2002). Although the availability of multi-drug therapy 
and the BCG vaccine helped to reduce the incidence of leprosy, the annual emergence of 
690 000 new cases clearly indicates that this disease remains a health concern (Cole et 
al., 2001). However, the scale of infection by M. tuberculosis poses an even higher threat 
world-wide. 
 
1.2 Tuberculosis: a global burden 
Tuberculosis (TB) incidences have escalated at an alarming rate over the past two 
decades, prompting the World Health Organisation (WHO) to declare TB as a global 
emergency (Ortalo-Magne et al., 1996). Approximately one third of the world’s 
population is estimated to be latently infected with M. tuberculosis and 2-3 million 
people die from TB every year, while an estimated 8.2 million new cases were reported 
per year by 2002 (Raviglione, 2003; Rook et al., 2005). The impact of TB is mostly 
suffered in developing countries, with the highest prevalence in Southeast Asia and sub-
Saharan Africa, where the currently available BCG vaccine is failing to control the 
disease (Rook et al., 2005). However, TB is a threat to the whole world as there is no 
population that is immune to the disease risk (van Helden, 2003).  
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 The battle to bring TB under control is hampered by, among other factors, the 
overwhelming increase in the spread of human immunodeficiency virus (HIV) infection, 
with a significant fraction of the TB deaths being attributable to co-infection with HIV 
(Williams and Dye, 2003; Corbett et al., 2003; Andries et al., 2004; Ballel et al., 2005). 
The problem is further compounded by the emergence of drug-resistant strains of M. 
tuberculosis, demonstrating the urgent need to develop new anti-tubercular drugs (Cohen 
et al., 2003; Andries et al., 2004; Ballel et al., 2005). Nevertheless, there is an even more 
compelling need to develop drugs that can act against latent M. tuberculosis as most 
cases of active TB result from reactivation of latent infections (D. R. Sherman, 6th 
International Conference on the Pathogenesis of Mycobacterial Infections, Stockholm, 
2005). 
  
1.2.1 Tuberculosis prevention and treatment  
The BCG vaccine and challenges facing it 
An ideal way to control a disease such as TB would be to have a protective vaccine that 
would prevent infection and progression of disease. The only currently available vaccine 
for TB, Mycobacterium bovis bacille Calmette-Guérin (BCG) – an attenuated deletion 
mutant of M. bovis – (Horwitz et al., 2005), is the world’s most widely used (Andersen 
and Doherty, 2005; Horwitz et al., 2005) and one of the safest vaccines known (Rook et 
al., 2005). However, this vaccine is failing to control TB. Whereas BCG successfully 
protects against disseminated forms of TB such as miliary TB in children (Brennan, 
2005; Rook et al., 2005) and tuberculous meningitis (Andersen and Doherty, 2005; Rook 
et al., 2005), it provides little or no efficacy against adult pulmonary TB (Brennan, 2005; 
Andersen and Doherty, 2005; Rook et al., 2005; Grode et al., 2005), with the BCG 
failure being highest in developing countries where it is most needed (Andersen and 
Doherty, 2005; Rook et al., 2005). Adult pulmonary TB is both the main source of new 
infections and the main cause of morbidity and mortality (Andersen and Doherty, 2005). 
This therefore underscores the need for development of new vaccines or improvement of 
BCG. An example of an improved BCG vaccine has recently been reported, which 
consists of a urease C-deficient recombinant BCG mutant that expresses listeriolysin, and 
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it has been shown to display a superior protection against tuberculosis, compared to its 
parental wild type, in a mouse model (Grode et al., 2005).   
 The question of whether BCG should be improved or replaced remains a subject 
of debate as some studies have suggested that the low efficacy against adult pulmonary 
TB may be due to the limited life-span of BCG protection, which is estimated to be 10-20 
years (Andersen and Doherty, 2005). This waning BCG protection in adolescence 
corresponds to the increase in the levels of adult pulmonary TB (Brennan, 2005; 
Andersen and Doherty, 2005). If correct, this then argues against development of a better 
vaccine to replace BCG in infant vaccination but instead, favours development of a 
booster for BCG or a combination of both (Brennan, 2005; Andersen and Doherty, 2005). 
However, this would require an understanding of why the efficacy of BCG varies so 
much in human hosts as opposed to animal models. While still a subject of debate, two 
hypothetical reasons have been proposed to account for the failure of BCG in tropical 
regions, both of which are linked to exposure of individuals to environmental 
mycobacteria (Andersen and Doherty, 2005). Firstly, the masking hypothesis suggests 
that the immunity provided by environmental mycobacteria masks that derived from a 
subsequent BCG vaccination as the two are superimposed (Andersen and Doherty, 2005). 
Alternatively, the blocking hypothesis proposes that the pre-existing immune responses 
derived from exposure to environmental mycobacteria block BCG replication and 
therefore render the vaccine ineffective. Nonetheless, the two hypotheses are not 
mutually exclusive (Andersen and Doherty, 2005). 
 Although a number of vaccines have recently been developed, which have entered 
or are on their way to clinical trials (Andersen and Doherty, 2005; Rook et al., 2005), the 
main challenge that remains is to determine whether they will also be safe and effective 
against bacilli in latent TB infections, as these represent the reservoir for the disease 
(Andersen and Doherty, 2005; Rook et al., 2005). It has been suggested that such a 
vaccine be designed to reduce immunopathology (Andersen and Doherty, 2005). 
However, the lack of knowledge on the biology of M. tuberculosis in latent infections 
hinders progress towards development of such vaccines (Brennan, 2005). 
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Antitubercular chemotherapy and drug resistance 
TB incidences have continued to rise in spite of the availability, for more than half a 
century, of chemotherapeutic drugs to treat the disease (Ballell et al., 2005). Due to the 
high drug tolerance exhibited by M. tuberculosis, a multidrug regimen has long been 
introduced for treatment of TB (Morris et al., 2005). The regimen involves a daily 
treatment with the four front-line drugs, isoniazid (INH), rifampin (RIF), pyrazinamide 
(PZA) and ethambutol (EMB) for 2 months, followed by daily doses of RIF and INH for 
4 months (Ballell et al., 2005). The escalating figures have been attributed to a number of 
reasons including coinfection with HIV, and the emergence of multidrug resistance 
resulting from lack of compliance (Ballell et al., 2005; Morris et al., 2005) and/or 
suboptimal drug dosage (Morris et al., 2005). To address the problem of non-compliance, 
the WHO introduced the directly observed therapy, short course (DOTS) strategy (Cohen 
and Murray, 2004; Ballell et al., 2005) a decade ago. This strategy involves supervised 
administration of the four front-line drugs to sputum-positive TB patients to ensure their 
compliance, and it has been shown to have cure rates as high as 95%. However, the 
implementation of DOTS requires substantial infrastructure and is labour-intensive, and 
therefore has not been fully implemented in all WHO regions, making it difficult to 
prevent development of multidrug resistant (MDR) M. tuberculosis (Ballell et al., 2005). 
This problem is exacerbated by the delay in detecting drug resistance (Cohen and 
Murray, 2004; Ballell et al., 2005). 
 Although the impact of MDR M. tuberculosis emergence on the global TB control 
remains unknown (Cohen and Murray, 2004), recent mathematical models have 
paradoxically suggested that successful reduction of wild type drug-sensitive strains of 
M. tuberculosis, where effective treatment programs are in place, paves the way for new 
infection with the circulating MDR strains (Blower and Chou, 2004; Cohen and Murray, 
2004). Therefore, there is a need for development of strategies that will combine high-
quality DOTS programs with therapy for MDR TB infections (Cohen and Murray, 2004; 
Ballell et al., 2005). Equally important to the treatment of MDR infections is the 
eradication of bacilli in latent infections or prevention of such infections to develop into 
active disease (Lenaerts et al., 2005). An approach to address both of these problems 
calls for development of new drugs that can shorten the length of treatment as pointed out 
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by the Global Alliance for TB Drug Development (Andries et al., 2004; Lenaerts et al., 
2005). One such drug, a diarylquinoline active against ATP synthase of M. tuberculosis, 
is currently undergoing clinical trials (Andries et al., 2004). Another example of a drug 
that has shown the required properties in preclinical tests is the nitroimidazopyran PA-
824 (Lenaerts et al., 2005). Development of more potent drugs that will be active against 
various strains of M. tuberculosis in different stages/forms of infection requires an 
understanding of the biology of these bacilli. However, little is known about the biology 
of bacilli in latent infections.  
 
1.2.2 Latency  
There is growing awareness regarding the way in which the terms latency and persistence 
were loosely used interchangeably in the past, and the importance of what they mean in 
the current era of growing insight into the possible physiological differences exhibited by 
bacilli in latent compared to persistent infections. However, in the context of this study, 
the term latency is used to refer to the state(s) in which tubercle bacilli exist in the host 
for an extended period of time without causing clinical disease symptoms, following an 
infection. This excludes bacilli that may remain in the host following chemotherapeutic 
treatment. Following a primary infection with M. tuberculosis, one of a number of 
outcomes can ensue. The host’s innate immune mechanisms may destroy the bacilli 
(Flynn and Chan, 2001), although the organism is almost never eliminated (Glickman et 
al., 2001; Stewart et al., 2003; Monack et al., 2004). Alternatively, failure of the innate 
immunity to control the infection can lead to progression to active disease (Dannenberg 
and Rook 1994), within 1 to 3 years of infection (Flynn and Chan, 2001; Stewart et al., 
2003), and this proportion constitutes 5-10% of individuals who are infected with M. 
tuberculosis (Stewart et al., 2003; Rook et al., 2005).  
 Individuals who harbour the bacilli but do not develop clinical disease are said to 
be latently infected (Flynn and Chan, 2001; Flynn and Chan, 2005), and these constitute 
approximately 90% of the people who are infected with M. tuberculosis (Rook et al., 
2005). The bacilli in such cases can persist undetected in the host for decades before 
causing active disease (Cosma et al., 2004). By mechanisms yet to be elucidated, it is 
estimated that 5-10% of latent TB infections will reactivate to cause active disease (Flynn 
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and Chan, 2001; Flynn and Chan, 2005; Boshoff et al., 2005). The only clinical evidence 
in latently infected individuals is the delayed-type hypersensitivity (DTH) reaction as 
determined by the skin test with the purified protein derivative (PPD) used in screening 
for TB infection (Dannenberg and Rook 1994; Flynn and Chan, 2001; Glickman et al., 
2001). The presence of a healing granulomatous structure in the lungs of latently infected 
individuals has also been noted (Boshoff et al., 2005).  
 Bacilli in a latent infection are thought to be in a “dormant’ state, another term 
that requires contextual definition. In this work dormancy refers to the state in which the 
bacteria exhibit highly reduced or no metabolism, are not (or very slowly) replicating and 
do not increase in numbers (Wayne and Sohaskey, 2001). Very little is known about the 
exact location of these dormant bacteria during latent infection (Monack et al., 2004), but 
they are thought to reside mainly in the granulomas where their metabolism and 
replication remain under the immune surveillance of the host (Cosma et al., 2004; 
Monack et al., 2004; Boshoff et al., 2005). However, some models hypothesize that the 
bacilli reside in the caseum, while others propose that they can escape from the 
granuloma to new sites (Cosma et al., 2004).  
 
Containment of latent M. tuberculosis infection in granulomas 
Although the mechanisms by which latent infection is established and maintained remain 
largely unknown, there is consensus that an interplay of the M. tuberculosis virulence 
determinants and the host’s immune response contribute towards this (Shen et al., 2004; 
Volkman et al., 2004; Flynn and Chan, 2005; Wallis, 2005). Formation of granulomas 
represents an effort by the host’s immune system to contain the infection that otherwise 
cannot be eradicated (Volkman et al., 2004; Flynn and Chan, 2005; Salgame, 2005; 
Wallis, 2005). Granulomas are complex structures composed of tight aggregates of 
mononuclear phagocytes that form around macrophages infected with M. tuberculosis in 
both latent and active infection (Volkman et al., 2004; Salgame, 2005; Wallis, 2005). 
From the host’s side, the tuberculous granuloma is a physical barrier that helps to limit 
bacterial replication and probably dissemination, while, to the pathogen’s advantage, it 
provides a niche for evading eradication by the immune system (Flynn and Chan, 2005).  
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Environmental conditions faced by M. tuberculosis in latent infections 
The granuloma is thought to create a hostile environment for M. tuberculosis, in which 
pH, nutrient availability, oxidative and nitrosative stress are likely to restrict the growth 
of this organism (Wayne and Sohaskey, 2001; Dahl et al., 2003; Timm et al., 2003; 
Wallis, 2005). Of these conditions, the mechanism of physiological adaptation of M. 
tuberculosis to oxygen (O2) depletion has been most intensively investigated. Whereas a 
rapid shift from an O2-rich environment to an O2-deficient one has been shown to result 
in death (Wayne and Sohaskey, 2001), the widely accepted Wayne model has 
demonstrated that a gradual depletion of O2 from M. tuberculosis cultures leads to 
progression of this organism through two stages of non-replicating persistence (Wayne 
and Sohaskey, 2001). This model demonstrates that M. tuberculosis replication requires 
O2. A number of studies that have utilized transcriptional profiling to investigate the 
metabolic response of M. tuberculosis to inhibition of aerobic electron flow by O2 
restriction (Sherman et al., 2001; Schnappinger et al., 2003; Voskuil et al., 2003; Voskuil 
et al., 2004; Boshoff et al., 2004) or by other means (Boshoff et al., 2004; Voskuil et al., 
2003) have revealed the importance of the respiratory network in adaptation of M. 
tuberculosis. In order to investigate some of the hypotheses derived from these studies, a 
more in-depth understanding of the function and regulation of the respiratory network of 
M. tuberculosis is required.  
 
1.3 Respiration 
In broad terms, respiration at the level of the organism refers to the exchange of gases 
between the organism and its environment. However, of relevance to this study is 
respiration at the cellular level, which generally refers to the process by which cells 
extract energy from nutrients and conserve it in the biologically useful forms, such as 
ATP. Respiration comprises a chain of enzyme-mediated reductive-oxidative (redox) 
reactions in which electrons are transferred in a stepwise fashion from the nutrient 
(donor) to a terminal oxidant (acceptor). At certain points along the chain, electron 
transfer is coupled to energy-conserving proton translocation, which drives production of 
ATP (Payne, 2001). This energy can subsequently be used to support other metabolic 
activities of the cell. Depending on its environment and the type of biological machinery 
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it is equipped with, an organism can use one or both of two types of respiration, aerobic 
or anaerobic respiration. In aerobic respiration, O2 is used as the terminal oxidant, 
whereas other organic and inorganic substances such as nitrate are used as terminal 
oxidants in anaerobic respiration (Poole and Cook, 2000). These two types of respiration 
differ greatly in terms of energy yield, with more energy produced by aerobic than by 
anaerobic respiration.  
 
1.3.1 Aerobic respiration 
Aerobic respiration is characterized by a stepwise four-electron reduction of O2 to water 
(Hansford, 2001; Wikstöm, 2001). In this multi-step redox process, hydrogen atoms (or 
their electrons) are transferred from the substrate such as glucose, pyruvate, and fatty 
acids, to O2 through a chain of electron carriers (Hansford, 2001). Electron carriers 
consist of a diverse group of compounds ranging from cytochromes, quinones, NADH 
(NAD+ + H+ + 2e-), flavins, to iron-sulfur proteins and others (Roehm, 2001). Some of 
these electron carriers act as prosthetic groups for the membrane-bound respiratory 
proteins while others act as intermediate mobile carriers between such proteins (Roehm, 
2001). For electron transfer to proceed spontaneously (without requiring external energy), 
the reduction potential of the acceptor must be higher than that of the donor, suggesting 
that electron carriers have to be arranged in order of increasing redox potential (Roehm, 
2001). This array of electron carriers forms what is referred to as the electron transport 
(or respiratory) chain. However, it is important to note that the respiratory proteins may 
not necessarily be physically arranged in the order of their roles in the membrane.  
 The passage of hydrogen atoms (or electrons) along the respiratory chain in the 
series of redox reactions is coupled to ATP formation by a process called oxidative 
phosphorylation (Hansford, 2001; Solomon et al., 1993). This process, which only occurs 
in membrane-bound structures, and is commonly explained by the chemiosmotic model 
of energy conservation, was initially proposed by Peter Mitchell in 1961 (Solomon et al., 
1993; Hansford, 2001). According to this model, the stepwise oxidation of NADH or 
FADH2 by oxygen, catalysed by components of the respiratory chain, results in the 
release of energy that is used to pump protons across the membrane, forming a proton 
gradient (protonmotive force). This force then draws protons back into the matrix (in the 
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case of mitochondria) through special channels that occur in the ATP synthase complex, 
releasing free energy that is used by this enzyme to synthesize ATP from ADP and 
inorganic phosphate (Pi) (Hansford, 2001; Solomon et al., 1993).  
 
1.3.2 Respiration in eukaryotes 
In eukaryotes, respiration occurs in specialized organelles known as mitochondria, whose 
structure is adapted for its function. Each mitochondrion consists of an inner 
compartment (the matrix) that is bounded by two membranes – an inner and an outer 
membrane– (Solomon et al., 1993). The space between the membranes (the 
intermembrane space) forms another compartment. The mitochondrial respiratory chain 
consists of four complexes, NADH:ubiquinone oxidoreductase (NADH dehydrogenase, 
complex I), succinate:ubiquinone oxidoreductase (succinate dehydrogenase, complex II), 
ubiquinol:cytochrome c oxidoreductase or cytochrome bc1 complex (complex III), and an 
aa3-type cytochrome c oxidase (complex IV) (Solomon et al., 1993; Cruciat et al., 2000). 
These protein complexes are embedded in the inner mitochondrial membrane (Cruciat et 
al., 2000). The smaller respiratory molecules, ubiquinone and cytochrome c act as mobile 
electron carriers between these complexes (Hansford et al., 2001). The fifth complex, 
ATP synthase (complex V) does not transport electrons but plays a very important role in 
oxidative phosphorylation.  
 
NADH:ubiquinone oxidoreductase (complex I) 
NADH dehydrogenase is the largest enzyme complex of the mitochondrial respiratory 
chain, consisting of more than 40 protein subunits encoded by the nuo operon, one non-
covalently bound flavin mononucleotide (FMN) and at least 5 iron-sulfur clusters 
(Schuler et al., 1999; Tsang et al., 2001). Whereas the mammalian mitochondria contain 
only type I NADH dehydrogenase (NDH-I), some eukaryotes have been shown to have a 
single subunit type II alternative NADH dehydrogenase (NDH-II) (Nantapong et al., 
2005). This complex catalyses the oxidation of NADH into NAD+, and links this to 
reduction of ubiquinone into ubiquinol. At the same time the enzyme translocates protons 
from the matrix into the intermembrane space. NADH is bound on the module of the 
protein that protrudes into the matrix, and electrons from it are transferred in a yet 
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undefined series of steps via the flavin cofactor and iron-sulfur clusters to ubiquinone 
(Hansford, 2001). The overall reaction can be summarized as follows: 
NADH + H+ + ubiquinone + 4H+ (in) → NAD+ + ubiquinol + 4H+ (out) 
where “in” and “out” indicate movement of protons into and out of the matrix, 
respectively. NDH-I pumps four protons across the mitochondrial inner membrane for 
every pair of electrons transferred (Hansford, 2001). 
 
Succinate:ubiquinone oxidoreductase (complex II) 
This enzyme complex forms an integral part of the mitochondrial membrane, and is 
composed of 4 protein subunits, a flavin adenine dinucleotide (FAD) and several iron-
sulfur clusters (Roehm, 2001; Yankovskaya et al., 2003; Hederstedt, 2003). Though part 
of the Krebs cycle, succinate dehydrogenase also forms part of the respiratory chain 
(Solomon et al., 1993). It catalyzes oxidation of succinate into fumarate in the matrix and 
simultaneously reduces ubiquinone. Unlike NDH-I, succinate dehydrogenase does not 
pump protons, as there is not enough free energy released during electron transfer by this 
complex to drive translocation of protons (Hansford, 2001).  
 
The ubiquinone/ubiquinol pool and other dehydrogenases 
Quinones are derivatives of benzoquinone that bear long hydrophobic isoprenoid side 
chains that render them soluble in the hydrophobic interior of membranes (Roehm, 2001). 
They can freely move laterally within the membrane, a property that makes them suitable 
for transfer of electrons between complexes of the respiratory chain (Roehm, 2001). 
Quinones can carry hydrogen atoms (Solomon et al., 1993). In addition to complexes I 
and II, the ubiquinone pool can also be reduced by electrons coming from oxidation of 
other metabolites such as acyl-coenzyme A (acyl-CoA; produced by β-oxidation of fatty 
acids) and α-glycerophosphate by their respective dehydrogenases in the matrix. Reduced 
ubiquinone transfers the electrons to ubiquinol:cytochrome c oxidoreductase (Solomon et 
al., 1993). 
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Ubiquinol-cytochrome c oxidoreductase or cytochrome bc1 complex (complex III) 
Cytochrome bc1 complex plays a crucial role in both photosynthetic and respiratory 
electron transport chains (Zhang et al., 1998; Darrouzet and Daldal, 2002). The 
mammalian mitochondrial complex III consists of 11 subunits, 2 of which form the 
catalytic core of the enzyme. This complex contains 4 redox centres: 2 heme groups, bH 
(high-spin heme b) and bL (low-spin heme b) of cytochrome b (subunit III), 1 heme group 
in cytochrome c1 (subunit IV), and 1 iron-sulfur cluster of Rieske protein (subunit V) 
(Zhang et al., 1998). The enzyme complex transfers electrons from ubiquinol to a water-
soluble cytochrome c. It is believed that for each pair of electrons transferred, the 
complex draws 2 protons from the matrix and pumps 4 out into the cytosolic side 
(Hansford, 2001). The overall redox reaction catalysed by this enzyme complex is as 
follows: 
ubiquinol + 2 cytochrome c3+ + 2H+ → ubiquinone + 2 cytochrome c2+ + 4H+ 
 
Cytochrome c oxidase (complex IV) 
Cytochrome c oxidase is the key enzyme of cellular respiration (Wikström, 2001) and 
together with other respiratory oxidases is estimated to be responsible for at least 90% of 
the total consumption of O2 in the biosphere (Garcia-Horsman et al., 1994; Hansford, 
2001). The mammalian cytochrome c oxidase consists of 2 units each of 13 polypeptides, 
the 3 largest and most hydrophobic (subunits I, II and III) of which are encoded in the 
mitochondria, whereas the remaining 10 are encoded in the nucleus (Garcia-Horsman et 
al., 1994; Hansford, 2001). It belongs to the heme-copper oxidase super-family, members 
of which are characterized by presence of a subunit homologous to the largest subunit I 
of mammalian enzyme, and have in common a low-spin heme and a binuclear centre 
composed of a high-spin heme and CuB (Garcia-Horsman et al., 1998).  
 This enzyme catalyses the four-electron reduction of O2 to water, and also couples 
that to proton translocation. It has four redox-active metal sites, namely, heme a, heme 
a3, CuA and CuB (Gennis, 1998; Bränden et al., 2001). Subunits I and II contain all the 
redox cofactors required for catalysis, with subunit I containing the heme a3- CuB 
binuclear centre where O2 is bound until it has been fully reduced to H2O, as well as the 
low-spin heme a (Wikström, 2001). Subunit II contains the unique bimetallic copper 
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center (two CuA atoms) that serves as the primary electron acceptor of the enzyme 
(Wikström, 2001). CuA receives electrons from cytochrome c and each electron is 
transferred via heme a to the heme a-CuB binuclear centre. The sequestration of O2 in the 
binuclear centre ensures that release of partially reduced and toxic O2 intermediates is 
prevented (Hansford, 2001). Although it is known that cytochrome c oxidase can pump 
protons, the mechanism by which this happens remains unknown in spite of years of 
study (Wikström, 2004). However, the general consensus is that the enzyme takes up 8 
protons from the medium (matrix) and pumps 4 into the intermembrane space per O2 
molecule that is reduced (Gennis, 1998; Wikström, 2001). The overall reaction for O2 
reduction can be presented as follows, 
4e-1 + 8Hi+ + O2 → 2H2O + 4Ho+  
where “i” and “o” refer to the protons input and output, respectively. 
 
The ATPsynthase (F0F1-ATPase; complex V) 
Although it does not transport electrons, ATP synthase is responsible for generation of 
ATP via oxidative phosphorylation. This is a large multi-subunit transmembrane protein 
comprising peptides encoded in the mitochondrial and nuclear genomes (Hansford, 
2001). It uses energy stored in the pH and potential gradients, created by pumping of 
protons across the membrane by enzymes of the respiratory chain, to synthesize ATP. It 
is believed that electrons flow back into the mitochondrial matrix down the gradient via a 
special channel accompanied by conformational changes in the ATP synthase, releasing 
energy that is used to drive ATP synthesis from ADP and inorganic phosphate (Hansford, 
2001; Tran and Cook, 2005).   
 
1.4 Respiration in bacteria 
1.4.1 The multiplicity of respiratory pathways  
The remarkable ability of bacteria to survive in a wide variety of environments is 
attributable to their complex respiratory pathways (Poole and Cook, 2000). These 
systems are believed to have evolved over time, in bacterial progenitors, in response to 
the changing environmental conditions they were subjected to. Unlike the mitochondrial 
respiratory chain which is branched at the dehydrogenase end but terminates in only one 
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oxidase (cytochrome c oxidase), the bacterial respiratory chains are equipped with 
multiple terminal oxidases which can be modulated depending on the prevailing 
environmental conditions (Poole and Cook, 2000; Winstedt and von Wachenfeldt, 2000). 
These branched bacterial respiratory pathways enable the organisms to use O2 as the 
terminal oxidant (aerobic respiration), or other, alternative terminal acceptors in the 
absence of oxygen (anaerobic respiration). Bacterial respiratory chains share a number of 
characteristics, namely (i) branching at both the dehydrogenase and reductase ends, (ii) 
use of O2 and other alternative electron acceptors, (iii) presence of numerous 
cytochromes and quinones, (iv) the possibility of pairing one reductant with several 
oxidants, and (v) coupled proton translocation and energy transduction (Poole and Cook, 
2000).    
 
The respiratory chain of Escherichia coli 
The E. coli respiratory chain is the best characterized of all bacterial respiratory chains 
that have been studied to date (Garcia-Horsman, 1994; Poole and Cook, 2000). It consists 
of a number of dehydrogenases that can oxidize various substrates (e.g. NADH, 
succinate, malate, lactate and hydrogen) and contribute their reducing equivalents into the 
quinone pool (Poole and Cook, 2000). At least two types of quinones, ubiquinone and 
menaquinone, are involved in the respiratory chain of E. coli, and they are used 
selectively depending on the terminal oxidant to which the electrons are destined. It has 
been proposed that electrons destined to O2 are transferred through ubiquinone (Poole 
and Cook, 2000). From ubiquinol, the electrons can be transferred directly to either one 
of three oxidases, cytochrome bo3 (encoded by cyoABCDE), cytochrome bd (encoded by 
cydAB) or possibly to cytochrome bd II (encoded by cbdAB) (Poole and Cook, 2000; 
Bebbington and Williams, 2001). This is notably different from the mitochondrial 
respiratory chain where electrons are transferred from ubiquinol to the terminal oxidase 
via a cytochrome bc1 complex and cytochrome c. Since they oxidize the ubiquinol pool 
directly, these E. coli terminal oxidases are referred to as quinol oxidases as opposed to 
the mitochondrial cytochrome c oxidase. While the E. coli cytochromes bo3 and bd 
oxidases have been extensively characterized, the function of the third oxidase, 
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cytochrome bd II, has not yet been discerned (Sturr et al., 1996; Poole and Cook, 2000; 
Bebbington and Williams, 2001). 
 The two quinol oxidases, cytochrome bo3 and cytochrome bd, differ in their 
structural and functional properties, including affinity for O2 (Sturr et al., 1996; Poole 
and Cook, 2000; Bebbington and Williams, 2001). Cytochrome bo3 belongs to the heme-
copper oxidase superfamily and can pump protons across the plasma membrane, whereas 
cytochrome bd does not. The former oxidase has a low affinity for O2 and has been 
shown to be required for growth under O2-rich conditions. Its ability to pump protons 
makes it energetically more efficient than cytochrome bd oxidase, which has a higher 
affinity for O2, and is highly expressed under microaerobic conditions, but cannot pump 
protons (Sturr et al., 1996; Poole and Cook, 2000; Bebbington and Williams, 2001; 
Alexeeva et al., 2002). It is noteworthy that though cytochrome bd does not pump 
protons, it does contribute towards generation of a transmembrane electrical potential 
difference (Zhang et al., 2004; Belevich et al., 2005).  
 
The respiratory chain of Corynebacterium glutamicum 
C. glutamicum is gaining increasing recognition as a model organism for studying the 
certain aspects of the biology of high G+C content Gram-positive bacteria, including 
pathogens such as C. diphtheria and M. tuberculosis (Nolden et al., 2002; Niebisch and 
Bott, 2003). The aerobic respiratory chain of C. glutamicum is by far the best-
characterized among the nocardioform actinobacteria. It comprises several branches of 
dehydrogenases that transfer electrons into the menaquinone pool, from where they can 
be transferred to the terminal electron acceptor O2 via one of at least two pathways – the 
cytochrome c branch or quinol branch (Bott and Niebisch, 2003). The respiratory chain 
of C. glutamicum is schematically illustrated in Figure 1. The cytochrome c branch 
consists of a cytochrome bc1 complex that oxidizes menaquinol and passes electrons to 
the terminal aa3-type cytochrome c oxidase, whereas the quinol branch terminates in a 
cytochrome bd-type menaquinol oxidase. The former branch was shown to be of primary 
importance for aerobic growth as mutants lacking either cytochrome bc1 complex or 
cytochrome aa3 had severe growth defects (Niebisch and Bott, 2001). The presence of a 
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third putative terminal oxidase that is cyanide-resistant has been proposed, but its 
existence has yet to be proven (Bott and Niebisch, 2003; Nantapong et al., 2005).  
 
NADH:menaquinone oxidoreductase 
Interestingly, C. glutamicum synthesizes only one type of NADH dehydrogenase, NDH-
II encoded by ndh, and its genome does not encode any other NADH dehydrogenase 
(Bott and Niebisch, 2003; Nantapong et al., 2005). In contrast to the mitochondrial NDH-
I and the E.coli NDH-I, both of which are multi-subunit proton-pumping enzymes 
specified by the nuo operon, C. glutamicum NDH-II is a single-subunit enzyme, which 
does not translocate protons (Bott and Niebisch, 2003; Nantapong et al., 2005). In 
addition to NADH dehydrogenase activity, this enzyme was found to exhibit NADPH 
oxidase activity, and has been proposed to couple oxidation of NADPH to reduction of 
O2 (Nantapong et al., 2005). The same study demonstrated that C. glutamicum NDH-II 
was a source of reactive O2 species such as superoxide and hydrogen peroxide, associated 
more with oxidation of NADPH than NADH (Nantapong et al., 2005).  
 
Succinate:menaquinone oxidoreductase 
The genome of C. glutamicum contains genes (sdhCAB) that encode a three-subunit 
succinate dehydrogenase. The subunits include a flavoprotein (SdhA), an iron-sulfur 
protein (SdhB) and a membrane anchor protein (SdhC) (Bott and Niebisch, 2003). This 
enzyme has not yet been characterized in C. glutamicum, but genome comparisons 
suggest that it belongs to the same class as those of B. subtilis and Wolinella succinogens 
(Bott and Niebisch, 2003).   
 
Other dehydrogenases that can reduce menaquinone 
In addition to NADH and succinate dehydrogenases, C. glutamicum possesses genes 
encoding at least six other dehydrogenases, malate:menaquinone oxidoreductase (mqo), 
pyruvate oxidase (poxB), D-lactate dehydrogenase (dld), L-lactate dehydrogenase (lldD), 
glycerol-3-phosphate dehydrogenase (glpD) and L-proline dehydrogenase (putA) (Bott 
and Niebisch, 2003). These enzymes allow C. glutamicum to utilize various substrates to 
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generate energy. Electrons from these substrates are used to reduce the menaquinone pool 
(Bott and Niebisch, 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The respiratory chain of C. glutamicum (Adapted from Bott and Niebisch, 2003). 
Boxes represent the various dehydrogenases (DH) (left) or the terminal oxidases (right). The 
gene(s) encoding each dehydrogenase is shown in brackets. The solid arrows denote electron 
transfer, and the broken arrow denotes a putative path for electron flow.  
 
Menaquinol:cytochrome c oxidoreductase or cytochrome bc1 complex  
The quinol-cytochrome c oxidoreductases comprise a large superfamily of enzymes 
found in mitochondrial and bacterial respiratory and photosynthetic electron transfer 
chains, and which couple electron transfer to proton translocation (Sone et al., 2001). 
These enzymes accept electrons from quinol and transfer them to a small cytochrome c 
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located in the mitochondrial intermembrane space of eukaryotes or in the periplasmic 
space of bacteria, from where they are transferred to a cytochrome c oxidase (Sakamoto 
et al., 2001).  
 The cytochrome bc1 complex of C. glutamicum is encoded by the qcrCAB genes 
which specify cytochrome c1, Rieske iron-sulfur protein, and cytochrome b, respectively 
(Sone et al., 2001; Niebisch and Bott, 2001). Bioinformatic analysis of the deduced 
protein sequences and subsequent genetic and biochemical characterization of the 
proteins revealed a number of features that distinguish the bc1 complex of C. glutamicum 
from the classical examples of these enzymes (Bott and Niebisch, 2003). The most 
peculiar of these features is presence of two heme-binding motifs (CXXCH) instead of 
one, in cytochrome c1 (QcrC), which is indicative of a diheme c1-type cytochrome (Sone 
et al., 2001; Niebisch and Bott, 2001). This was found to be the sole c-type cytochrome 
in aerobically grown cells of C. glutamicum (Sone et al., 2001; Niebisch and Bott, 2001), 
leading to the proposal that the second heme domain of cytochrome c1 performs the 
function of a separate cytochrome c in the transfer of electrons form the bc1 complex to 
the aa3-type cytochrome c oxidase (Niebisch and Bott, 2001). The other differences 
include a 120 amino acid (aa) extension at the C-terminus of cytochrome b (QcrB), and 
presence of three instead of one transmembrane helices in the Rieske iron-sulfur protein 
(QcrA) (Bott and Niebisch, 2003). Genome comparisons of the C. glutamicum qcrCAB 
operon and deduced protein sequences with those of other bacteria showed a high 
similarity with those from Mycobacterium, Streptomyces (Sone et al., 2001; Niebisch and 
Bott, 2001), and Rhodococcus rhodochrous (Sone et al., 2003).  
 A qcrCAB deletion mutant of C. glutamicum was severely attenuated when grown 
aerobically in glucose minimal medium, indicating that the cytochrome bc1 complex was 
important for aerobic growth of this organism (Niebisch and Bott, 2001). Spectral 
analysis of membranes from this mutant demonstrated that cytochrome c1 was absent 
from this strain. In contrast, a peak characteristic of cytochrome aa3 was not diminished 
in the mutant, indicating that this mutant could still synthesize the aa3-type cytochrome c 
oxidase (Niebisch and Bott, 2001).   
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Cytochrome c oxidase (cytochrome aa3) 
The aa3-type cytochrome c oxidase of C. glutamicum is encoded by ctaD (subunit I), 
ctaC (subunit II), ctaE (subunit III) and ctaF (subunit IV). Whereas subunit I (CtaD) 
showed all features typical of heme-copper terminal oxidases, subunits II and III 
displayed some differences from those of other organisms, while subunit IV was found to 
be unique to actinomycetes (Bott and Niebisch, 2003). Subunit II has an insertion of an 
extra 30 aa in the substrate-binding domain, which is absent from the mitochondrial and 
proteobacterial counterparts, and is proposed to play a role in the interaction of this 
oxidase with the di-heme cytochrome c of the bc1 complex (Sakamoto et al., 2001). 
Subunits I and II form the catalytic core of the enzyme, while the functions of subunits III 
and IV remain to be elucidated.  
 Analysis of mutants in the different subunits of aa3-type cytochrome c oxidase 
(ΔctaD and ΔctaF) showed severe growth defects, demonstrating that like the bc1 
complex, this oxidase is important for aerobic growth of C. glutamicum (Niebisch and 
Bott, 2001; Niebsch and Bott, 2003). Spectral analysis of both ΔctaD and ΔctaF mutants 
revealed the absence of cytochrome a, proving that both ctaD and ctaF encode subunits 
of the aa3-type cytochrome c oxidase. In addition, both mutants exhibited a drastically 
reduced cytochrome c1 peak (at 550 nm) than the wild type strain, suggesting that 
cytochrome aa3 oxidase was important for the stability of cytochrome c1. Based on these 
data and the primary structures of cytochromes bc1 and aa3, it was postulated that the two 
complexes associate to form a supercomplex (Niebisch and Bott, 2001). This hypothesis 
was later confirmed by the co-purification of bc1- and aa3-subunits using either 
streptavidin-tagged QcrB or CtaD (Niebisch and Bott, 2003). 
 
Cytochrome bd oxidase     
The bd-type menaquinol oxidase of C. glutamicum is encoded by cydA and cydB for 
subunits I and II, respectively (Kusumoto et al., 2000; Bott and Niebisch, 2003). These 
genes form a cluster with the cydD and cydC genes which are proposed to encode an 
ABC-type transporter. Based on sequence analysis, subunit I (CydA) of C. glutamicum 
and other high G+C Gram-positive bacteria lack a significant portion of the Q-loop found 
in E. coli, low G+C Gram-positive bacteria, proteobacteria and others (Bott and Niebisch, 
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2003). The cytochrome bd oxidase of C. glutamicum contains two heme types, a heme d 
and two heme b (high- and low-spin), and it exhibits menaquinol oxidase acivity 
(Kusumoto et al., 2000). This oxidase was found to be dominant in the stationary phase 
of cells grown aerobically in copper-deficient medium (Kusumoto et al., 2000). 
However, its general induction during stationary phase remains to be investigated (Bott 
and Niebisch, 2003). 
 
ATP synthase and bioenergetics in C. glutamicum 
The genome of C. glutamicum encodes an F1F0-ATP synthase (atpI-BEFHAGDC operon) 
(Bott and Niebisch, 2003). Whereas the function of the atpI gene is not known, atpB, 
atpE and atpF encode components of the F0 part, a-, c- and b-subunit, respectively. 
Components of the F1 part, δ-, α-, γ-, β- and ε-subunit, are encoded by atpH, atpA, atpG, 
atpD and atpC, respectively (Bott and Niebisch, 2003). An ATP synthase mutant with a 
point mutation in the γ-subunit had a decreased ATP synthase activity. Interestingly, this 
mutant exhibited an increased glucose consumption and respiration rate. This phenotype 
was assumed to be due to a shortage of ATP resulting from a defect in oxidative 
phosphorylation. Low ATP was proposed to increase the glucose catabolism and hence 
production of NADH, which consequently led to an increase in the rate of respiration by 
O2 consumption (Bott and Niebisch, 2003). 
 The efficiency of oxidative phosphorylation has been shown to be dependent on 
the electron transfer pathway utilized. In C. glutamicum aerobic respiration, electron 
transfer to O2 involves three enzymes that contribute towards the generation of an 
electrochemical proton gradient across the cytoplasmic membrane, namely, cytochrome 
bc1 complex, aa3-type cytochrome c oxidase and cytochrome bd oxidase (Bott and 
Niebisch, 2003). It is assumed that one molecule of ATP is synthesized by ATP synthase 
from every three or four protons transported from the outside to the inside. The 
cytochrome bc1-aa3 supercomplex is estimated to transport a net of six protons per two 
electrons, whereas the net value for cytochrome bd oxidase is two protons per two 
electrons. Therefore the transfer of electrons from NADH via the cytochrome bc1-aa3 
branch is estimated to generate approximately three times more ATP than that generated 
when electrons flow to cytochrome bd oxidase. It is expected that transfer of electrons to 
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the menaquinone pool by lactate dehydrogenase, glycerol-3-phosphate dehydrogenase, 
proline dehydrogenase and malate:menaquinone reductase would yield similar energy 
proportions as for NADH dehydrogenase above. In all these enzymes, the protons used 
for the reduction of menaquinone come from the cytoplasm. In contrast the reduction of 
menaquinone by succinate dehydrogenase uses protons from the periplasmic side of the 
membrane and results in a net extrusion of four protons for every two electrons 
transferred. This translates to formation of approximately 1.3 ATP when electrons are 
transferred from succinate to O2 via the cytochrome bc1-aa3 branch as opposed to 2 ATP 
formed when electrons come from NADH dehydrogenase through the same branch. 
Transfer of electrons from succinate to O2 via the cytochrome bd oxidase results in no net 
proton extrusion and therefore no ATP synthesis by oxidative phosphorylation (Bott and 
Niebisch, 2003).     
 
1.4.2 Respiratory inhibitors 
Inhibitors of NADH dehydrogenase 
In various organisms respiration has been shown to be inhibited by a wide spectrum of 
chemicals which target different components of the respiratory chain. The availability of 
such compounds has contributed towards understanding of the roles of the individual 
respiratory components. Phenothiazines such as chlorpromazine have long been known to 
inhibit respiration though their precise mode of action was not known. Recent studies 
have shown that these chemicals  inhibit NADH dehydrogenase in M. tuberculosis 
(Boshoff et al., 2004; Weinstein et al., 2005) and M. smegmatis (Boshoff et al., 2004), 
whereas azoles were shown to inhibit succinate dehydrogenase activity (Boshoff et al., 
2004). Inhibition of NADH dehygrogenase was accompanied by a decrease in the redox 
potential leading to a decrease in the intracellular ATP levels (Boshoff et al., 2004).  
 
Inhibitors of the cytochrome bc1 complex 
A number of chemicals have been shown to block electron transfer through the 
respiratory chain by inhibiting the cytochrome bc1 complex, and these include 
myxothiazol, stigmatellin and antimycin (Zhang et al., 1998; Ouchane et al., 2002). 
Whereas antimycin binds at the site (Qi) where the reduction of quinone is postulated to 
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take place, stigmatellin and myxothiazol inhibit the complex by binding to the Qo site of 
quinol oxidation (Zhang et al., 1998; Ouchane et al., 2002). Recently a novel inhibition at 
the cytochrome c1 subunit of the complex by cyanide was reported for Rhodobacter 
capsulatus (Osyczka et al., 2004). Since cytochrome bc1 complex is one of the proton 
coupling sites along the electron transport chain, its inhibition is expected to result in a 
change in the transmembrane proton gradient and thus lower the production of ATP by 
oxidative phosphorylation. 
 
Inhibitors of terminal oxidases 
The known inhibitors of aerobic respiratory terminal oxidases include nitric oxide (NO), 
cyanide and azides. NO has long been known to inhibit cytochrome c oxidase [reviewed 
by Cooper (2002)]. At high concentrations, it competes with O2 by reversibly binding to 
the reduced iron of the heme a3/CuB binuclear centre, and it binds to the oxidized copper 
under low concentrations. NO can also reversibly inhibit cytochrome bd oxidase, which 
unlike heme-copper oxidases does not contain CuB (Borisov et al., 2004). On the other 
hand, the respiratory inhibitors such as cyanide and azides specifically inhibit cytochrome 
c oxidase, but not cytochrome bd oxidase in M. tuberculosis (Boshoff et al., 2004).  
 
1.4.3 Regulation of expression of the bacterial respiratory chain components 
Bacteria respond to changes in the environment by altering the level of expression of 
genes required for growth or survival under such conditions (Poole and Cook, 2000). 
Adaptation to the changing conditions often requires coordinated regulation of a set(s) of 
genes, which often, may be controlled by a single transcriptional regulator (Boshoff et 
al., 2004; Green and Paget, 2004). Bacteria are equipped with a variety of two-
component signal transduction regulatory systems, which can sense environmental 
changes and subsequently regulate a network of target genes. A two-component 
regulatory system consists of a membrane-bound sensor kinase that can activate a 
cognate transcriptional regulator by phosphorylation. The activated regulator can then 
turn a set(s) of genes (regulon) on or off (Himpens et al., 2000; Georgellis et al., 2001a; 
Parish et al., 2003).  
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 For respiratory metabolism, availability of O2 or other electron acceptors 
determines the switch from aerobic to anaerobic respiration (Poole and Cook, 2000). 
Alternatively, disruption of one or more of the pathways by chemical or genetic means 
can also lead to the switch. In the presence of adequate O2, genes required for aerobic 
respiration may be switched on and those required for anaerobic respiration may be 
repressed. The converse is true under anoxic conditions (Zientz et al., 1998; Green and 
Paget, 2004). A number of bacterial two-component regulatory systems have been 
described that are responsible for regulation of respiratory metabolism, and they have 
been shown to respond to a range of signals, including environmental O2, the redox states 
of electron carriers (quinone, NAD+) and nitrite/nitrate levels. A few examples of these 
systems will be discussed below (Green and Paget, 2004). 
 
Direct oxygen sensors 
The FixLJ system 
FixLJ is an oxygen-responsive two-component system that regulates genes involved in 
nitrogen fixation in bacteria such as Rhizobium meliloti (Miyatake et al., 2000; Green and 
Paget, 2004). Bacteria that are equipped with machinery necessary for fixing atmospheric 
nitrogen to ammonia are able to survive in habitats where fixed nitrogen is limiting. 
However, nitrogen-fixation is an energy-demanding process and therefore it has to be 
controlled tightly to avoid unnecessary energy consumption (Grabbe and Schmitz, 2003; 
Green and Paget, 2004). The sensor kinase FixL contains a kinase domain and a heme 
domain, and the latter acts as a sensor by binding O2 (Green and Paget, 2004). 
 The FixLJ is the only system for which the mechanism for O2 sensing has been 
elucidated in detail (Swem et al., 2003; Baruah et al., 2004). Under aerobic conditions, 
oxygen binds to the heme domain of FixL and converts its iron to a low-spin state. This 
causes a conformational change which inhibits the activity of the kinase domain, thus 
preventing FixL autophosphorylation and promoting the dephosphorylation of the 
response regulator, FixJ. Conversely, when O2 is limiting, no O2 is bound to the sensor 
(heme) domain and the heme iron changes to a high-spin state, which allows 
autophosphorylation of FixL and subsequent phosphorylation of FixJ. The activated FixJ 
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induces expression of FixK and NifA, which control expression of nitrogen-fixation 
genes (Miyatake et al., 2000; Green and Paget, 2004).  
 
The Fnr system 
Fnr (fumarate nitrate reduction) system is another example of an O2 sensor and 
transcription factor which regulates expression of respiratory genes in response to 
hypoxia (Geadle and Ratcliffe, 2001). This system functions in close co-operation with 
the ArcAB system discussed below. In E. coli the system is expressed under both aerobic 
and anaerobic conditions. Under microaerobic conditions, Fnr activates the expression of 
cytochrome bd oxidase and represses that of cytochrome bo3 oxidase. Whereas Fnr has 
no effect on the expression of cytochrome bo3 oxidase anaerobically, it represses the 
expression of cytochrome bd oxidase and activates the nitrate reductase (Swem and 
Bauer, 2002; Brekasis and Paget, 2003; Green and Paget, 2004).  
 Fnr contains two domains, an amino terminal sensory domain and a carboxyl 
DNA-binding domain. The sensory domain contains a cysteine coordinated [4Fe-4S]2+ 
cluster that is essential for dimerization. Under anaerobic conditions, Fnr is a 
homodimeric protein containing one [4Fe-4S]2+ per subunit, and in this form it can bind 
to target promoters and regulate their expression. In the presence of O2, this cluster is 
disassembled to a [2Fe-2S]2+ that, probably through conformational changes, causes a 
switch from the dimeric form to the monomeric form that is unable to bind DNA 
(Brekasis and Paget, 2003; Green and Paget, 2004).  
   
Redox sensors 
The ArcAB system  
The E. coli Arc (anoxic redox control) system is the best-studied of the bacterial two-
component regulatory systems. ArcB is a transmembrane sensor kinase that can 
autophosphorylate in response to a signal, and then transphosphorylate the cytosolic 
response regulator, ArcA (Georgellis et al., 2001a; Alexeeva et al., 2003; Green and 
Paget, 2004). This system is a global regulator of gene expression under microaerobic 
and anaerobic conditions (Green and Paget, 2004). Under O2-limiting conditions, ArcB 
autophosphorylates at the conserved His292 of the primary transmitter domain, and the 
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phosphate is relayed to Asp576 in the receiver domain and then to His717 situated in the 
secondary transmitter domain and subsequently transphosphorylates the response 
regulator, ArcA, at the conserved Asp54 residue. The phosphorylated ArcA (ArcA~P) 
activates or represses expression of genes involved in respiratory metabolism (Georgellis 
et al., 2001a; Green and Paget, 2004). Among the genes regulated by ArcA~P are those 
encoding the terminal oxidases, cytochrome bo3 and cytochrome bd. The major aerobic 
terminal oxidase cytochrome bo3 is repressed while the microaerobic cytochrome bd 
oxidase is activated. Similarly, ArcA~P inversely regulates the two quinone reductases, 
NADH dehydrogenase and succinate dehydrogenase, with the former being activated 
while the latter is repressed (Liu and de Wulf, 2004; Green and Paget, 2004).  
 Georgellis et al (2001a) used different quinone analogs to demonstrate that ArcB 
autophosphorylation was inhibited by oxidized forms of quinone during aerobiosis, 
indicating that ArcB senses the redox state of the quinone pool. Based on these data it 
was proposed that accumulation of reduced quinol during microaerobic growth would 
stimulate autophosphorylation of ArcB. This proposal was later supported by data, from 
the same group, showing that formation of disulphide bonds between ArcB monomers 
was necessary for inhibition of ArcB autophosphorylation, with quinones probably acting 
as oxidants of the cysteines involved in bond formation (Malpica et al., 2004). 
 The Arc system is not confined to E. coli, but is present in other bacteria. In 
Haemophilus influenzae the ArcB sensor kinase has been demonstrated to 
autophosphorylate in response to redox conditions despite lacking a PAS domain. 
Northern blot analysis of the H. influenzae lctD gene, a homologue of the E. coli L-lactate 
dehydrogenase gene (lldD), demonstrated anaerobic repression of this gene by ArcB,  
suggesting that the Arc system of H. influenzae plays a similar role as that of E. coli in 
response to redox conditions (Georgellis et al., 2001b). Another two-component system, 
BvgAS that responds to the redox status of the quinol pool has been reported in 
Bordetella pertussis. The BvgAS system is involved in the regulation of virulence genes 
in this organism, including the gene encoding the pertussis toxin (Bock and Gross, 2002).  
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The RegB-RegA and PrrB-PrrA systems 
The RegB-RegA two-component regulatory system of Rhodobacter capsulatus regulates 
photosystem and respiratory gene expression under anaerobic conditions. Under these 
conditions the sensor kinase RegB autophosphorylates and then transphosphorylates its 
cognate response regulator, RegA (Swem et al., 2003; Green and Paget, 2004). The 
activated RegA~P then regulates target genes including those that encode the terminal 
oxidases cytochrome cbb3 and ubiquinol oxidase (Swem ad Bauer, 2002; Swem et al., 
2003; Green and Paget, 2004). However, regulation of these oxidases involves other 
regulatory systems in addition to RegB-RegA. Both are also regulated by FnrL and 
HvrA, as well as CrtJ and Aer for the ubiquinol oxidase (Swem ad Bauer, 2002). 
 RegB uses a redox-active cysteine as a mechanism for regulation of gene 
expression in response to changing oxygen conditions. Under oxidizing conditions, 
formation of intermolecular disulphide bonds in RegB results in accumulation of the 
tetrameric form of the protein, which inhibits its autophosphorylation. The disulphide 
bond formation is mediated by a redox-sensitive Cys265, mutation of which resulted in 
derepression of photosynthetic genes under aerobic conditions (Swem et al., 2003). 
 Another global regulator of anaerobic and photosynthetic gene expression is the 
PrrBA two-component system of Rhodobacter sphaeroides (Oh and Kaplan, 2000; Oh 
and Kaplan, 2002). This system has been shown to sense O2 levels indirectly by 
monitoring electron flow through the cytochrome cbb3 oxidase, generating an inhibitory 
signal for the PrrBA. The magnitude of electron flow through the cbb3 oxidase 
determines the strength of the inhibitory signal generated by the oxidase to alter the PrrB 
activity from the kinase mode to a phosphatase mode, which would inhibit activation of 
the photosynthesis genes (Oh and Kaplan, 2002). The ability of the cbb3 terminal oxidase 
to directly stimulate the dephosphorylation of PrrB, thereby resulting in inactivation of 
PrrA, has recently been shown (Green and Paget, 2004).   
 
The DosR-DosS/DosT (DevR-DevS/DevT) system 
The alarming increase in the incidence of TB world-wide has prompted an urgent need 
for development of new drugs and vaccines, but the success in winning this battle hinges 
on an understanding of the physiology of M. tuberculosis and how it adapts to its 
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intracellular environment. In an attempt to understand the way M. tuberculosis responds 
to changing conditions as well as to identify potential drug targets, considerable effort has 
been placed on investigating its various regulatory systems. The genome of M. 
tuberculosis encodes 11 two-component regulatory systems (Cole et al., 1998; Zahrt and 
Deretic, 2001), of which the DosR-DosS/DosT (dormancy survival) system is the best 
studied, This system consists of two histidine sensor kinases, DosS (Rv3132c) and DosT 
(Rv2027c), and a response regulator, DosR (Rv3133c) (Dasgupta et al., 2000; Roberts et 
al., 2004). The genes encoding this system were first isolated by subtractive hybridization 
as differentially expressed in virulent (dev) vs. avirulent strains of M. tuberculosis 
(Dasgupta et al., 2000). The Dos system belongs to the LuxR family of two-component 
regulatory systems, members of which include NarL, FixJ, BvgA, and UhpA (Dasgupta 
et al., 2000). The functionality of the DosR-DosS as a two-component system was 
analyzed by in vitro phosphorylation assays, which demonstrated the ability of DosS to 
autophosphorylate and to phosphorylate DosR, thus proving that DosS is a functional 
kinase for this system (Roberts et al., 2004; Saini et al., 2004). Similarly, the alternative 
kinase, DosT was demonstrated to be a bona fide sensor kinase for the Dos system 
(Roberts et al., 2004). Based on its constitutive expression under hypoxia, DosT was 
suggested to respond initially leading to amplification of DosS expression and hence, the 
hypoxic response (Roberts et al., 2004). 
 DNA microrarray analysis of hypoxically-grown cultures of M. tuberculosis 
revealed a 47-gene set that was induced under these conditions, among which were dosR 
(Rv3133c) and dosS (Rv3132c), and the hypoxia-responsive α-crystallin homologue, 
hspX (Rv2031) (Sherman et al., 2001). HspX is one of the proteins that had previously 
been demonstrated to be required for low-O2-induced stationary survival of M. 
tuberculosis (Yuan et al., 1996; Cunningham and Spreadbury, 1998; Purkayastha et al., 
2002; Rosenkrands et al., 2002). It is responsible for the cell wall thickening that has long 
been shown to characterize Wayne’s model of non-replicating persistence (Wayne and 
Hayes, 1996; Wayne and Sohaskey, 2001). Mutational studies of dosS, dosR and the gene 
immediately upstream of dosR, Rv3134c, confirmed that the Dos system was required for 
hypoxic induction of hspX, suggesting that this two-component regulatory system was 
involved in mycobacterial latency (Sherman et al., 2001). Further extensive studies on 
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the DosR-DosS/DosT system demonstrated that it is required for induction of an 
approximately 48-gene regulon by hypoxia (Voskuil et al., 2003; Park et al., 2003; Bacon 
et al., 2004; Karakousis et al., 2004; Kendall et al., 2004; Muttucumaru et al., 2004; 
Saini et al., 2004; Voskuil et al., 2004) and low concentrations of NO (Voskuil et al., 
2003; Schnappinger et al., 2003). Computational analyses revealed a conserved 
palindromic sequence1 upstream of nearly all hypoxically-induced DosR-regulated genes 
(Florczyk et al., 2003; Park et al., 2003), and DosR binding to this promoter region was 
demonstrated using hspX (Park et al., 2003).  
 The DosR-DosS/DosT system has attracted considerable interest owing to its 
involvement in the regulation of genes required for adaptation to hypoxia and NO, the 
conditions to which M. tuberculosis is proposed to be subjected in the granuloma 
(Voskuil et al., 2003; Park et al., 2003; Schnappinger et al., 2003). Some members of the 
DosR regulon encode universal stress proteins (USPs), suggesting that this class of 
proteins may be involved in the development and survival of dormancy during latent TB 
infections (O’Toole and Williams, 2003b). By analogy to their E. coli counterparts, it has 
also been speculated that the mycobacterial USPs may protect the organism from NO, 
oxidative and acid stress during its survival in the macrophage (O’Toole and Williams, 
2003b). The virulence of M. tuberculosis DosR mutants was found to be attenuated in 
vivo in guinea pig (Maholtra et al., 2004) and rabbit models (D. R. Sherman, 6th 
International Conference on the Pathogenesis of Mycobacterial Infections, Stockholm, 
2005). 
 Despite extensive studies, the mechanisms of signal sensing and transduction by 
the DosR-DosS/DosT system are still not known. Induction of the DosR regulon by 
signals arising from either O2 depletion or the presence of low amounts of NO led 
Voskuil et al (2003) to propose that the major aerobic terminal oxidase, aa3-type 
cytochrome c oxidase, or alternatively another heme-containing enzyme, might be the 
sensor of O2 and NO. This proposal was based on the previous reports showing that: (i) 
the mitochondrial counterpart of this oxidase could reversibly be inhibited by low 
concentrations of NO; and (ii) the yeast cytochrome c oxidase (Kwast et al., 1999) and 
the R. sphaeroides cytochrome cbb3 (Oh and Kaplan, 2000) act as O2 sensors. Unless the 
                                                 
1 Some genes have two copies of this palindromic sequence recognized by DosR. 
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specificity of interactions of the mycobacterial cytochrome c oxidase with NO or other 
inhibitors determines the type of signal generated, it would be tempting to propose that 
other inhibitors of cytochrome c oxidase would result in the induction of the DosR 
regulon. However, treatment of the M. tuberculosis oxidase with inhibitors such as 
cyanide and azide did not induce such a response, arguing against the notion that 
cytochrome c oxidase might be the sensor of O2 (Boshoff et al., 2004). Boshoff et al. 
(2004) also reported that there was no correlation between the induction of the dormancy 
regulon and the menaquinone/menaquinol or NADH/NAD+ ratios in M. tuberculosis, but 
could not rule out the possibility that the redox state of another electron carrier signaled 
this response (Boshoff et al., 2004).  
 Although proposed to play an important role in the pathogenesis of M. 
tuberculosis, the DosR-DosS/DosT system is also present in the non-pathogenic M. 
smegmatis (Mayuri et al., 2002; O’Toole et al., 2003a). This is consistent with its role in 
the establishment and/or maintenance of oxygen-depletion induced dormancy, a 
phenomenon that has been demonstrated for both pathogenic (reviewed in Wayne and 
Sohaskey, 2001) and non-pathogenic mycobacteria (Dick et al., 1998). However, the 
dormancy regulon of M. smegmatis has not yet been fully defined. Analysis of the then 
unfinished genome sequence of M. smegmatis revealed the presence of homologues of 
the genes encoding hspX and the DosR-DosS/DosT system, and their hypoxia-
responsiveness was demonstrated by RNA and protein analysis (Mayuri et al., 2002; 
O’Toole et al., 2003a). In addition, analysis of a dosR mutant of M. smegmatis revealed 
that DosR was required for hypoxia induction of hspX (MSMEG3937)2, uspL 
(MSMEG3944), uspM (MSMEG3945), uspN (MSMEG4368), and acg (MSMEG5231) 
(O’Toole et al., 2003). Together, these data suggest that the transcriptional and/or 
physiological response to hypoxia is broadly conserved in M. tuberculosis and M. 
smegmatis. In support of this proposal, hypoxia-induced expression of the M. 
tuberculosis dosR and Rv3133c promoters was successfully achieved in M. smegmatis, 
suggesting that M. smegmatis can be used as a model for studying the dormancy response 
of M. tuberculosis (Bagchi et al., 2003).   
                                                 
2 This gene annotation is obtained from the complete genome sequence of M. smegmatis mc2155 site at 
TIGR (http://www.tigr.org/tigr-scipts/CMR2/CMRHomePage.spl). 
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The SenX3-Reg3 system 
Despite being the first reported example of a M. tuberculosis two-component regulatory 
system (Wren et al., 1992), and contrary to the better-studied DosR system discussed 
above, the mycobacterial SenX3-RegX3 system has only been partially characterized. 
Based on homology searches, this system is proposed to be an orthologue of the E. coli 
ArcB-ArcA system, which regulates expression of aerobic genes (Rickman et al., 2004). 
Independent studies that used M. tuberculosis mutants in the senX3 and/or regX3 
demonstrated that these mutants were attenuated for virulence in mouse models (Parish et 
al., 2003; Rickman et al., 2004). Moreover, microarray analysis of a senX3-regX3 mutant 
revealed that cydB, encoding subunit II of cytochrome bd oxidase was among the genes 
possibly regulated by this two-component system (Parish et al., 2003).  
 The SenX3-RegX3 system is not restricted to M. tuberculosis, but is found in 
other mycobacteria including M. leprae, which has retained only four of the 11 two-
component regulatory present in M. tuberculosis, suggesting that this system may be 
necessary for survival in the harsh environment of the host (Rickman et al., 2004). The 
ability of SenX3 to autoregulate and transphophorylate RegX3 was demonstrated using a 
recombinant SenX3 from Mycobacterium bovis BCG overexpressed in E. coli (Himpens 
et al., 2000). The authors further showed that RegX3 can bind to the senX3-regX3 
promoter and positively regulate the operon. 
 
1.5 Respiration in mycobacteria 
Although respiration in mycobacteria has long been proposed to play an important role in 
the success of some mycobacterial species as pathogens, very little is known about the 
respiratory chains of these organisms. Bioinformatic analyses of those mycobacteria for 
which the complete or partial sequence information is available have revealed that as in 
many other bacteria, mycobacteria possess a branched aerobic respiratory chain, 
terminating in at least two oxidases. Electrons flow from NADH dehydrogenase and 
succinate dehydrogenase, and possibly other dehydrogenases, into the menaquinone-
menaquinol pool, from where they can be transferred to the terminal electron acceptor, 
O2, through either of two branches, the cytochrome bd-type menaquinol oxidase branch 
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or the cytochrome c oxidase branch. In the former branch, electrons flow directly for 
menaquinol to the terminal cytochrome bd oxidase, whereas in the latter, electrons are 
transferred from menaquinol to the aa3-type cytochrome c oxidase via a cytochrome bc1 
complex (Kana et al., 2001; Weinstein et al., 2005; Boshoff et al., 2005). Genome 
comparisons have revealed a high resemblance of the mycobacterial respiratory chain to 
that of C. glutamicum shown in Figure 1 though some of the dehydrogenases seem to be  
absent in mycobacteria.   
 
1.5.1 Respiration in M. smegmatis 
 In a pioneering genetic study on the mycobacterial respiratory chain, the branch 
terminating in cytochrome bd oxidase in M. smegmatis was previously shown to be 
important for microaerobic respiration in this organism (Kana et al., 2001). Spectral 
analysis of cydA::aph and cydB::aph mutants in comparison to their parental wild type 
strain revealed loss of a heme-d signature, confirming the presence, in M. smegmatis, of a 
γ-proteobacterial type cytochrome bd-type oxidases as well as providing evidence that 
this oxidase is encoded by the cydAB genes (Kana et al., 2001). Although the cydA::aph 
mutant did not show any growth defects under aerobic conditions, it displayed significant 
growth impairment when air saturation was dropped below 1%, suggesting that this 
oxidase was required for microaerobic growth. This observation was further confirmed 
by expression analysis of the M. smegmatis cyd promoter under oxystatic growth 
conditions, which revealed a more than two-fold increase in cyd expression between 5 
and 0.5% air saturation (Kana et al., 2001). The mutant also displayed cyanide sensitivity 
when co-cultured with the wild type, suggesting that the alternative oxidase(s) functional 
in this mutant was inhibited by cyanide (Kana et al., 2001). Together, these data 
suggested that the alternative branch terminating in the aa3-type cytochrome c oxidase 
was the major respiratory route under aerobic conditions. However, this remains to be 
proven experimentally. 
 
1.5.2 Respiration in M. tuberculosis 
Evidence is accumulating that the success of M. tuberculosis as a pathogen depends 
largely, if not entirely, on its ability to switch its metabolism to adapt to the prevailing 
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conditions within its host (Boshoff et al., 2005). A large amount of data emerging from 
transcriptome analyses of M. tuberculosis have generated promising hypotheses that can 
guide towards a better understanding of the incredibly flexible adaptation exhibited by 
this bacterium (Boshoff et al., 2005). At the centre of metabolic adaptation of M. 
tuberculosis is its ability to generate cellular energy, by oxidative phosphorylation, to 
maintain basic cellular processes (Weinstein et al., 2005). While the respiratory chain has 
partially been characterized in M. smegmatis, very little is known  about the respiratory 
chain of M. tuberculosis. The information currently available came from studies that have 
utilized inhibitors of respiratory metabolism as well as biochemical analyses, highlighting 
the functionality of some components of the respiratory chain (Boshoff et al., 2004; 
Weinstein et al., 2005), and suggesting possible roles for them in the pathogenesis of M. 
tuberculosis (Boshoff et al., 2005). Based on their data on inhibition of NADH 
dehydrogenase activity by phenothiazines, and previous studies that have shown the 
dispensability of the type I NADH dehydrogenase (NDH-I), Weinstein et al (2005) 
suggested that the type II NADH dehydrogenase (NDH-II) is the sole NADH 
dehydrogenase in the aerobically grown M. tuberculosis. Spectral analysis of M. 
tuberculosis membrane preparations confirmed presence of the cytochrome components 
of the cytochrome bc1 complex and aa3-type cytochrome c oxidase (Weinstein et al., 
2005). Boshoff et al. (2004) used inhibitors of aa3-type cytochrome c oxidase to show 
that disruption of electron flow to this terminal oxidase resulted in up-regulation of the 
alternative bd-type menaquinol oxidase encoded by cydABDC, which was also 
responsive to hypoxia and changes in the transmembrane proton gradient. 
  
1.6 Aims and objectives of this study  
The long-term goal of this study was to understand how M. tuberculosis uses its 
respiratory chain to modulate its metabolic activities under various environmental 
conditions during an infection. The aim was to use a genetic approach to elucidate the 
composition and functionality of the aerobic respiratory chains of mycobacteria. To 
achieve this goal, an understanding of the conserved genetic, biochemical and 
physiological aspects of the mycobacterial respiratory chain was initially explored in the 
fast-growing non-pathogenic species, M. smegmatis. Although concerns have previously 
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been expressed regarding the suitability of M. smegmatis for studying the physiology of 
M. tuberculosis (Barry, 2001), M. smegmatis has proved useful in studying the conserved 
areas of mycobacterial physiology (Reyrat and Kahn, 2001; Tyagi and Sharma, 2002; 
Murray and Rubin, 2005). In support of this, the recently completed genome sequence of 
this organism has revealed that it contains a high repertoire of genes found in pathogenic 
cousins, particularly M. tuberculosis. The respiratory chains of these two organisms are 
highly conserved, and therefore provide ground for using M. smegmatis to guide 
investigations in M. tuberculosis.  
 Following a previous characterization of the respiratory branch terminating in 
cytochrome bd oxidase by Kana et al (2001), the focus of this study was to investigate 
the cytochrome bc1-cytochrome aa3 branch of the respiratory chain, terminating in 
cytochrome aa3 oxidase in M. smegmatis. The ultimate goal was to use the findings of 
this study to guide a more in-depth investigation of the respiratory chain of M. 
tuberculosis.  
 
Against this background, the specific aims and objectives of this study were as follows: 
 
1. To generate M. smegmatis and M. tuberculosis mutant strains deficient in the 
cytochrome bc1 complex and aa3-type cytochrome c oxidase.  
2. To determine the effects of such mutations on the growth of the organisms.  
3. To investigate the effects of loss of the cytochrome bc1 complex and aa3-type 
cytochrome c oxidase on the expression of the alternative oxidase, cytochrome bd in 
M. smegmatis under conditions of varying O2 tension. 
4. To determine the general adaptive responses, at the transcriptional level, of M. 
smegmatis as a result of loss of functionality in the cytochrome bc1-cytochrome aa3 
branch. 
5. To determine the effects of known respiratory inhibitors on the expression profile of 
the M. smegmatis cytochrome bc1 complex and aa3-type cytochrome c oxidase 
mutants. 
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2. MATERIALS AND METHODS 
 
2.1 General recombinant DNA methods and reagents 
Standard molecular biology techniques were performed as previously described by 
Sambrook and Russell (2001). The suppliers of all reagents used in this work are listed in 
parentheses within the text. Unless otherwise stated, all enzymes were obtained from 
Roche Biochemicals. Solutions and media are detailed in Appendix B. 
 
2.1.1 Bacterial strains and plasmids  
The bacterial strains and plasmids used in this study are detailed in Tables 1 and 2, 
respectively. Restriction maps of the plasmids are shown in Appendix C. E. coli strains 
were stored at -70°C in LB plus 50% glycerol. M. smegmatis and M. tuberculosis strains 
were stored at -70°C in 50% DUBOS (Difco, Becton Dickinson, USA).  
 
2.1.2 Bacterial culture conditions and selective agents 
E. coli DH5α used for cloning procedures was grown in Luria broth (LB) or agar (LA) 
containing 100 µg/ml ampicillin (Ap), 50 µg/ml kanamycin (Km) or 200 µg/ml 
hygromycin (Hyg) where necessary. Liquid cultures were grown at 37°C with shaking 
(350 rpm). To avoid plasmid rearrangements, E. coli strains carrying large constructs 
(≥8000 bp) were incubated at 30°C with slow shaking (100 rpm). M. smegmatis strains 
were grown in LB or MADC-Tw [Middlebrook 7H9 broth (Difco, Becton Dickinson, 
USA) supplemented with 0.085% NaCl, 0.2% glucose, 0.2% glycerol, and 0.05% Tween 
80 (Jacobs et al., 1991)] or on LA for solid medium. Where necessary, antibiotic 
supplements were added to the following concentrations: Km - 10 µg/ml (solid medium) 
or 25 µg/ml (liquid medium) and Hyg - 50 µg/ml. Unless otherwise stated, cultures were 
grown in Erlenmeyer conical flasks at 37°C with shaking (350 rpm). Specific growth 
conditions for analyses of M. smegmatis mutant strains are described in section 2.2.3. For 
M. tuberculosis culturing was carried out in a Biosafety Level 3 (BSL 3) laboratory and 
bacilli manipulations were performed under negative pressure (180 kPa) in a Class II 
flow cabinet. Strains were grown at 37°C in Middlebrook 7H9 medium supplemented 
with 10% v/v ADC (Difco, Becton Dickinson, USA), 0.2% glycerol and 0.05% Tween 80 
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in roller bottles or as stirred cultures. For solid medium, Middlebrook 7H10 agar 
supplemented with 10% v/v OADC (Difco, Becton Dickinson, USA) and 0.5% glycerol 
was used. Antibiotic supplements were as defined for M. smegmatis above. For DNA 
extraction, M. tuberculosis strains were grown on LJ slants supplemented with the 
relevant antibiotics. Other selective agents used were sucrose (Suc) at 5% for E. coli and 
2% for mycobacteria, and X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoide), at 
a concentration of ca. 40 μg/ml for all strains. 
 
Table 1. Bacterial strains used in this study 
Strain Characteristics Source / Reference 
E. coli 
   DH5α 
 
supE44 ΔlacU169 (Φ80lacZΔM15) 
hsdR17 recA1 endA1 gyrA96 thi-1 relA1 
 
Hanahan, 1983 
   
M. tuberculosis 
   H37Rv 
 
Laboratory strain (ATCC 27294) 
 
Laboratory collection 
   
M. smegmatis   
   mc2155 High frequency transformation mutant of ATCC 
607 
Snapper et al., 1990 
   ΔqcrCAB::hyg qcrCAB deletion-insertion mutant of mc2155; HygR   This work 
   ΔctaC::hyg ctaC deletion-replacement mutant of mc2155; HygR This work 
   ctaD+/- Derivative of mc2155 with one wild type ctaDI and 
one ctaDI::hyg allele; HygR 
This work 
   ΔctaDII::hyg ctaDII deletion-replacement mutant of mc2155; 
HygR 
This work 
   ΔctaC::hyg attB::ctaC ΔctaC::hyg complemented with M. tuberculosis 
ctaC integrated at the attB locus; HygR, KmR 
This work 
   ΔqcrCAB::hyg::pBK4 ΔqcrCAB::hyg carrying pBK4 integrated at cyd 
locus; HygR, KmR  
This work 
   mc2155::pBK4 mc2155 carrying pBK4 integrated at cyd locus; KmR Kana et al., 2001 
   ΔDR Derivative of mc2155 that has lost the entire 
chromosomal duplication 
D. F. Warner, PhD 
thesis 
HygR, hygromycin resistant; KmR, kanamycin resistant 
 
Table 2. Plasmids used in this study 
Plasmida Characteristics Source or reference 
pGEM3Z(+)f E. coli cloning vector; ApR Promega 
pGEMTeasy
  
E. coli vector for cloning PCR products; ApR Promega 
pCR2.1-TOPO E. coli vector for cloning PCR products; KmR, ApR Invitrogen 
p2NIL E. coli vector for cloning homologous recombination 
substrates; KmR 
Parish & Stoker, 2000 
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Plasmida Characteristics Source or reference 
pGOAL17 Vector carrying PAg85-lacZ Phsp60-sacB as a PacI 
marker cassette; ApR 
Parish & Stoker, 2000 
pOLYG E. coli-Mycobacterium replicating shuttle vector; 
HygR 
O’Gaora et al., 1997 
pIJ963 E. coli vector carrying hyg cassette Blondelet-Roualt et al., 
1997 
pY6002 E. coli vector carrying aph cassette from transposon 
Tn903; ApR, KmR 
Husson et al., 1990 
pBK4 p2NIL containing the M. smegmatis cydA’::lacZ 
fusion cassette; HygR 
Kana et al., 2001 
pMV306K E. coli-Mycobacterium integrating shuttle vector; 
KmR 
Stover et al., 1991 
pCYDAKO Knockout vector carrying M. smegmatis cydA::aph 
allele; KmR 
Kana et al., 2001 
pQCRTBKO Knockout vector carrying M. tuberculosis DqcrCAB 
allele; HygR, KmR 
This work 
pCTACTBKO Knockout vector carrying M. tuberculosis DctaC::hyg 
allele; HygR, KmR 
This work 
pQCRSMKO Knockout vector carrying M. smegmatis 
DqcrCAB::hyg allele;  Hygr, Kmr 
This work 
pCTADISMKO Knockout vector carrying M. smegmatis DctaDI::hyg 
allele;  HygR, KmR 
This work 
pGEMCTADIKO Knockout vector carrying M. smegmatis DctaC::aph 
allele in pGEM3Z; KmR, AmpR 
This work 
pCTADIISMKO Knockout vector carrying M. smegmatis DctaDII::hyg 
allele;  HygR, KmR 
This work 
pCTACSMKO Knockout vector carrying M. smegmatis DctaC::hyg 
allele;  HygR, KmR 
This work 
pMVCTAC Complementing vector carrying M. tuberculosis 
ctaCF genes on a 2892 bp KpnI fragment, cloned into 
pMV306K; KmR 
This work 
a The intermediary plasmids constructed in this study are not shown in this Table, but are listed 
instead in Appendix C. 
 
2.1.3 DNA extraction 
Plasmid preparation from E. coli  
For small scale plasmid preparations, single colonies harbouring plasmids of interest 
were inoculated into 2 ml LB containing an appropriate antibiotic and grown to stationary 
phase at 37°C with shaking (350 rpm).  Cells were harvested in microcentrifuge tubes by 
centrifuging for 1 min at 10 000 × g and then resuspended in 100 µl of solution I (50 mM 
Tris-HCl, pH 8.0; 10 mM EDTA) by vortexing. To lyse the cells, 200 µl of solution II 
(0.2 M NaOH; 1% SDS) was added and the mixture was incubated at room temperature 
for 5 min, before neutralizing with 150 µl of solution III (3 M potassium acetate, pH 5.5; 
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11.5% glacial acetic acid). Following 10 min incubation on ice, the mixture was 
centrifuged at 9 000 × g for 5 min (4°C) and the supernatant decanted into a clean 
Eppendorf tube. To remove contaminating RNA, ribonuclease A was added to a final 
concentration of 10µg/ml and the mixture was incubated at 42°C for 10 min. DNA was 
precipitated with 260 µl of isopropanol and collected by a 10 min centrifugation at room 
temperature (10 000 × g).  The pellet was washed with an equal volume of ethanol and 
then dried under vacuum. DNA was resuspended in an appropriate volume of sterile 
distilled water. For large scale preparations, bacterial cultures were grown overnight in 
100 ml LB as previously described. Cells were collected by centrifugation at 1100 × g for 
5 min in a Beckman J2-21 rotor. DNA extraction was carried out using a 
Nucleobond®AX kit (Macherey-Nagel, Germany) according to the manufacturer’s 
instructions. 
 
Chromosomal DNA extraction from mycobacteria 
CTAB method. Cultures were grown to stationary phase in liquid media for M. smegmatis 
or on LJ slants for M. tuberculosis and then heat-killed at 100°C for 10 min. [For M. 
tuberculosis, all the steps up to chloroform/isoamyl alcohol extraction were done in a 
Class II flow cabinet at negative pressure (180 kPa) in the BSL 3 laboratory]. The cells 
were harvested by centrifugation (10 000 × g for 1 min) and then resuspended in 500 µl 
of TE (10 mM Tris; 1 mM EDTA, pH 7.6) containing 1 μg/μl of lysozyme. The mixture 
was incubated at 37°C for 1 h and then 70 µl of 10% SDS and 6 µl of proteinase K (10 
mg/ml) were added, followed by incubation at 37°C for 2 h. To this, 100 µl of 5 M NaCl 
and 80 µl CTAB/NaCl solution (10% CTAB [N-cetyl-N,N,N-trimethylammonium 
bromide] in 0.7 M NaCl) were added and the mixture was incubated at 65°C for 10 min.  
To separate DNA from protein, 750 µl CHCl3/IAA was mixed in and centrifuged for 5 
min at 10 000 × g. The aqueous phase was transferred to a clean Eppendorf tube and 
DNA was extracted with an equal volume of isopropanol. The DNA pellet was washed 
with 70% ethanol, dried and then resuspended in an appropriate volume of sterile distilled 
water.  
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Phenol-chloroform method. Cells were harvested by centrifugation (10 000 × g for 1 min) 
and then resuspended in 500 μl TES buffer (10 mM Tris-HCl, pH 8; 1 mM EDTA; 150 
mM NaCl). Seven hundred μl of phenol were added and cells were shaken for at least 1 h 
at 37°C (100 rpm). The phenol and DNA layers were separated by centrifuging for 10 
min at 10 000 × g. The top (DNA) layer was aspirated and an equal volume of 
CHCl3/IAA was added and centrifuged at room temperature for 1 min. The top layer was 
aspirated again and the DNA was precipitated with 2.5 volumes of ethanol and 0.1 
volume of 3 M NaOAc. The DNA pellet was collected by centrifugation at 10 000 × g, 
washed with 70% ethanol, dried and resuspended in an appropriate volume of sterile 
distilled water. 
 
DNA purification from agarose gels or enzymatic reactions 
DNA from excised gel slices or enzymatic reactions was purified using GeneClean®III kit 
(BIO 101, CA, USA) or Nucleospin® kit (Macherey-Nagel, Germany), according to the 
manufacturer’s instructions.  
 
2.1.4 DNA manipulations 
Restriction enzyme digests  
Plasmid or chromosomal DNA was digested with the appropriate enzyme as specified by 
the manufacturer. Reactions were incubated at appropriate temperatures for a period of 1 
to 16 h. When double digests could not be performed in a common buffer, DNA was cut 
with one enzyme, ethanol precipitated and then digested with the second enzyme. DNA 
fragments were fractionated on agarose gels by electrophoresis. 
 
Dephosphorylation of 5’ ends  
Linearised plasmid DNA was treated with calf intestine alkaline phosphatase (CIP; 
Roche Biochemicals, Germany) or shrimp alkaline phosphatse (SAP; Roche 
Biochemicals, Germany) to remove the 5’-phosphate. One unit of enzyme was added to 
the DNA in the presence of 1/10 v/v reaction buffer and incubated at 37°C for 2 h (CIP) 
or 30 min (SAP). The phosphatase was heat-inactivated and DNA was recovered by 
ethanol precipitation for use in ligation reactions. 
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Modification of 5’ and 3’ overhangs  
Enzyme-restricted DNA fragments with 5’ overhangs were filled in using Klenow 
enzyme (Roche Biochemicals, Germany) to produce blunt ends. The reaction mixture 
consisted of 1/10 vol. reaction buffer, 0.8 mM each of dATP, dCTP, dGTP and dTTP, 
and 1 U klenow enzyme. Samples were incubated at 37°C for 20-40 min. To remove 3’ 
overhangs, the linearized DNA fragments were treated with 1 U of T4 DNA polymerase.  
 
Ligation reactions  
DNA ligations were carried out using the Fast Link ligation kit (Epicenter Technologies, 
Madison, USA) according to the manufacturer’s instructions with incubation times 
ranging from 15 min to 3 h. Ligation reactions (or aliquots thereof) were used directly in 
E. coli transformation reactions. 
 
2.1.5 Polymerase Chain Reaction (PCR) 
Thermocycling was carried out in a MasterCycler gradient 5331 (Eppendorf, Hamburg, 
Germany) or a PCR Express (Hybaid, Middlesex, UK) machine. For preliminary PCR 
analysis, a Faststart Taq polymerase (Roche Biochemicals, Germany) was used, whereas 
the high-fidelity Expand PCR system (Roche Biochemicals, Germany) was used for the 
generation of PCR products to be used for cloning purposes. Fifty ml reactions containing 
2 μl of genomic DNA template, 1/10 volume reaction buffer, 2 mM MgCl2, 0.2 mM 
dNTPs, 5% DMSO, 1 μM of forward and reverse primers, and 2.5 U of polymerase were 
set up on ice. With modifications suited to the various templates, the thermal cycling 
program generally included an initial denaturation step at 94°C for 5 min, followed by 
elongation in 30 cycles of 60 s at 94°C, 60 s at 60°C (or other primer-specific annealing 
temperatures, T°, as calculated in Appendix B; in the range of 52-65°C), and 60 s at 
72°C, terminating in 1 cycle of 5 min at 72°C. For PCR reactions using Expand PCR 
system, the elongation step was extended by 5 s per cycle. Following thermal cycling, the 
samples were kept at 4°C, frozen at -20°C or used immediately. PCR following reverse 
transcription is described in section 2.2.6. 
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2.1.6 DNA sequencing 
Automated DNA sequencing was performed by the Inqaba Biotec sequencing facility 
(Pretoria, South Africa), on a Spectrumedix 2410 Capillary Electrophoresis automated 
DNA sequencer. For this purpose a Big Dye DNA sequencing kit was used and results 
were analysed on the Big Dye Terminator v3.1 software from ABI. Plasmids, PCR 
products or linear DNA fragments were purified with a Nucleospin kit (Macherey-Nagel, 
Germany), resupended in sterile distilled water and then provided to Inqaba Biotec 
together with the relevant DNA sequencing primers. The sequences obtained were then 
analysed using EditSeq and SeqMan™ II modules of the Lasergene suite of programs 
(DNASTAR, Madison, WI). Each sequence was aligned with the original sequence 
downloaded from the relevant site (http://genolist.pasteur.fr/TubercuList/ or 
http://www.tigr.org/tigr-scripts/CMR2/CMRHomePage.spl), and then scanned for 
mutations. 
 
2.1.7 Agarose gel electrophoresis 
Agarose gels were prepared in 1 × TAE buffer (40 mM Tris; 1 mM EDTA, pH 8.0; 0.1% 
glacial acetic acid). For large DNA fragments (≥ 1 kb), 1% gels were prepared from high-
melting agarose powder (SeaKem), while smaller fragments (≤ 1 kb ) were analysed on 2 
- 3 % low-melting agarose (Nusieve® GTG) gels. Thirty ml of molten agarose containing 
1.5 µl of 10 mg/ml ethidium bromide for DNA visualization was poured into a gel 
casting tray (Hoeffer, Amersham Pharmacia, USA) and gels were allowed to set at room 
temperature or at 4oC (low-gelling agarose). Once the gels had set, samples containing a 
tracking dye (0.025% bromophenol blue in 30% glycerol) were loaded and the gels were 
run in cold 1 × TAE buffer at 80-120 volts. Gels were viewed and scanned on a Gel Doc 
2000 system (BIO-RAD, Johannesburg, South Africa). 
 
2.1.8 Southern blot analysis 
Preparation of probes  
DNA probes were labelled with [α-32P]dCTP using the Random Primed Labelling kit 
(Roche Biochemicals, Germany). Nine ml of probe DNA was denatured at 95°C for 10 
min and then snap-cooled on ice before adding the labelling reagents as recommended by 
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the manufacturer. To terminate the reaction, 80 μl of TE buffer was added and 
unincorporated nucleotides were removed by fractionation through a Sephadex G-25 spin 
column equilibrated with TE buffer. The probe was either used immediately or frozen at -
20°C for later use within a period of up to 7 days. 
 
Electroblotting  
Enzyme-restricted DNA of interest was separated on a 1% agarose gel by electrophoresis 
at 80 volts. DNA was depurinated by soaking the gel in 0.25 M HCl for 15 min followed 
by a 15 min denaturation in 0.5 M NaOH/1.5 M NaCl solution, with a brief rinse in 
distilled water in between the two steps. The gel was equilibrated in 1 ´ TBE buffer 
(0.178 mM Tris; 17.8 mM boric acid; 2 mM EDTA, pH 8.0) before a nylon membrane 
(HybondTM-N) was placed on top of the gel. The gel overlaid with membrane was placed 
between two double sheets of 3MM Whatman blotting paper and TBE-soaked sponges, 
and then placed in a blotting cassette. DNA transfer was carried out in a Mini Transfer 
(Hoeffer scientific) system for 2 h at 0.5 A. The DNA was then cross-linked to the 
membrane by UV-irradiation in a UV Stratalinker 1800 (Stratagene), using the autocross-
link program. 
 
Hybridization  
Membranes were pre-hybridized, for 2 h at 42°C, with 10 μg/ml heat-denatured salmon 
sperm DNA in a pre-hybridization buffer (0.5% SDS; 6× SSC; 5× Denhardts; 50% 
deionised formamide) in Techne Hybridiser HB-1 roller bottles. The probe was heat-
denatured, added to the pre-hybridization buffer and then incubated at 42°C for 16-18 h. 
The hybridization buffer was discarded and the membranes were washed twice in wash 
solution I (2 × SSC; 0.1% SDS) for 15 min at 42°C, once in wash solution II (0.5 × SSC; 
0.1% SDS) for 15 min at 42°C, once in wash solution III (0.1 × SSC; 0.1% SDS) for 15 
min at 42°C and finally in solution IV (0.1 × SSC; 1.0% SDS) for 30 min at 65°C. The 
membranes were wrapped in plastic and then exposed to X-ray film at -70°C before the 
films were developed in an XP400 developer (Peromac Medical Services, South Africa). 
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2.1.9 Transformations 
Rubidium chloride transformation of E. coli DH5α  
The method used was obtained from Dr P. Stolt. For preparation of competent cells of E. 
coli DH5a, a single colony was picked from a fresh plate, inoculated in 5 ml LB and 
shaken overnight at 37°C. This pre-culture was used to inoculate 200 ml of LB and the 
culture was grown for about 4-6 h to an OD600 of 0.6. The culture was divided into 40 ml 
aliquots and then incubated on ice for 15 min before harvesting in a pre-chilled Beckman 
J2-21 rotor (1100 × g, 15 min). Cells were resuspended in one-third of the original 
volume of buffer RF1 (30 mM potassium acetate, 100 mM rubidium chloride, 10 mM 
calcium chloride, 50 mM manganese chloride, 15% glycerol v/v, pH 5.8) and left on ice 
for 30 min. To collect cells, samples were centrifuged at 3000 rpm for 15 min. Finally 
cells were resuspended in one-twelfth of the original volume of buffer RF2 (10 mM 
MOPS, 75 mM calcium chloride, 10 mM rubidium chloride, 15% glycerol v/v, pH 6.5)  
and incubated for 15 min on ice. The cell suspension was aliquoted into Eppendorf tubes 
and stored at -70°C. Competent cells were thawed on ice. DNA was mixed with 100-200 
μl cells and incubated on ice for 15 min. Cells were heat-shocked at 42°C for 90 s and 
then rapidly cooled on ice for 2 min before adding 500 μl of 2× TY medium. Cells were 
incubated at 37°C for at least 30 min to allow for phenotypic expression, and then plated 
on LA containing appropriate antibiotics. Transformants were recovered after an 
overnight incubation at 37°C. 
 
Electroporation of mycobacteria  
Electroporations were carried out as previously described (Larsen, 2000; Gordhan and 
Parish, 2001). A 100 ml culture of M. smegmatis was grown to an OD600 of between 0.9 
and 1.5 and then chilled on ice for at least 15 min before harvesting in a pre-cooled 
Beckman J2-21 rotor (1100 × g for 10 min). Cells were washed twice in ice-cold 10% 
glycerol, first in 25 ml followed by 10 ml, and finally resuspended in 1 ml of 10% 
glycerol. Two- to four-hundred μl aliquots of the electro-competent cells were mixed 
with 10 μl of salt-free DNA (ca.1 μg precipitated twice in ethanol to remove excess salts) 
and incubated on ice for 5 min. The mixture was then transferred into chilled 0.2 cm 
BIO-RAD electroporation cuvettes. Electroporation was carried out in a Gene Pulser I 
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model (BIO-RAD, Johannesburg, South Africa) or Gene Pulser Xcell™ (BIO-RAD) 
under the following conditions: voltage 2.5 kV, capacitance 25 µF and resistance 1000 Ω. 
The cells were rapidly rescued in 1 ml of LB, transferred into a sterile Eppendorf tube 
and incubated at 37°C for at least 2 h to allow for phenotypic expression. Cells were 
plated on LA containing appropriate supplements and plates were incubated at 30°C for 
at least 3 days.  
 For M. tuberculosis strains, the procedure was carried out as described for M. 
smegmatis with the following modifications. Glycine was added to the culture about 16 h 
before harvest, to a final concentration of 1.5%, and all the glycerol washes were carried 
out at room temperature. The DNA (ca. 5 μg) was UV-irradiated (100 mJ/cm2) before 
mixing with the cells. Cells were plated on Middlebrook 7H10 plates supplemented with 
0.5% glycerol, 10% v/v OADC and appropriate antibiotics. Plates were incubated at 37°C 
for at least 21 days.  
 
2.2 Cloning and characterization of the cytochrome bc1 and aa3 knockout 
 mutants of M. smegmatis and M. tuberculosis 
 
2.2.1 Construction of knockout vectors for qcrCAB, ctaC, ctaDI and ctaDII genes 
 of M. smegmatis 
PCR amplification and cloning of deletion allele substrates  
M. smegmatis homologues of genes in the cytochrome bc1-aa3 pathway were identified 
by BLAST searching (Altschul et al., 1990) of the unfinished genome sequence of strain 
mc2155 (http://www.tigr.org/ufmg/) using the corresponding M. tuberculosis genes as 
query sequences. The M. smegmatis sequences were used to design PCR primers for 
amplification of DNA segments that would be used in the construction of deletion alleles 
for the target genes. For each gene (or operon, in the case of qcrCAB), two sets of PCR 
primers were designed to amplify upstream and downstream flanking segments of DNA 
that include between 69 and 239 bp of 5’- and 3’-ends of the target gene(s). Unique 
restriction sites were engineered into the PCR primers to facilitate subsequent cloning of 
the PCR products. The primer sequences and sizes of the corresponding PCR products 
are detailed in Table 3. Amplification was carried out as described above using Expand 
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High Fidelity PCR system (Roche Biochemicals, Germany). PCR products were 
individually cloned into pGEMTeasy (Promega, Madison, USA) or pCR2.1-TOPO 
(Invitrogen, UK) and completely sequenced (Inqaba Biotec, Pretoria, South Africa) 
before further use. 
 The upstream and downstream fragments were simultaneously sub-cloned into 
p2NIL (Parish and Stoker, 2000) using the engineered restriction sites, effectively 
resulting in a deletion of most of the internal region of the gene(s) of interest. In the case 
of the 4404-bp ctaE-qcrCAB operon, ligation of the up- and downstream fragments in 
p2NIL resulted in the deletion of an internal segment of 3472 bp to produce plasmid 
p2QCR. In the case of the 1026 bp ctaC gene, an internal region of 757 bp was deleted 
resulting in p2CTAC. Similarly, plasmids p2CTADI and p2CTADII carried mutant 
alleles containing 1506 bp and 1295 bp deletions within the ctaDI (1689 bp) and ctaDII 
(1752 bp) genes, respectively. Maps of these plasmids are shown in Appendix C. 
  
Cloning of marker cassettes  
To mark the deletion alleles in each case, a Hyg resistance (HygR) gene carried on a 1758 
bp BglII cassette was inserted at the junction site of the two PCR products (upstream and 
downstream segments), creating plasmids p2QCRH, p2CTACH, p2CTADIH and 
p2CTADIIH. Further selection markers were introduced by cloning of a lacZ-sacB 
cassette from pGOAL17 (Parish and Stoker, 2000) in the unique PacI site of p2NIL, to 
produce the suicide vectors pQCRSMKO, pCTACSMKO, pCTADISMKO and 
pCTADIISMKO for knockout of the qcrCAB, ctaC, ctaDI and ctaDII genes, respectively 
(Table 2). An additional knockout vector for deletion-insertion mutagenesis of the ctaDI 
gene (pGEMCTADIKO) was constructed by excising an EcoRI-HindIII fragment bearing 
the deletion allele from plasmid p2CTADI, and then cloning into pGEM3Zf(+). A 1264 
bp BamHI cassette bearing the Km resistance (KmR) gene was then cloned into the 
junction site, followed by cloning of the lacZ-sacB cassette from pGOAL17 to produce 
plasmid pGEMCTADIKO. This plasmid was used in experiments aimed at inactivating 
the second copy of ctaDI either in the hyg-marked ctaDI+/- or ΔDR strains of M. 
smegmatis (Table 1). Prior to use in M. smegmatis, all of the suicide plasmids were tested 
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for their ability to confer Suc sensitivity (SucS) and to produce a blue color in E. coli cells 
plated on LA supplemented with sucrose and X-gal, respectively.  
 
2.2.2 Allelic replacement of the qcrCAB, ctaC, ctaDI and ctaDII genes of M. 
 smegmatis 
Delivery of knockout constructs into M. smegmatis 
The knockout constructs (Figure 2; Table 2) described above, were electroporated into M. 
smegmatis mc2155, with the exception of pGEMCTADIKO which was later 
electroporated into strains ctaDI+/- and ΔDR. An E. coli-M. smegmatis replicating shuttle 
vector, pOLYG, was also included as a control to assess transformation efficiency of the 
cells, whereas a no DNA control was used to exclude contamination in the cells. 
Electroporation was carried out as described in section 2.1.9 and cells were plated on LA 
containing Hyg, Km and X-Gal.  
 
Selection and genotypic analysis of mutants  
Blue, KmR, HygR M. smegmatis transformants (potential single crossover recombinants; 
SCOs) were picked from the electroporation plates and grown to late log phase in LB 
containing Hyg and Tween. Serial dilutions of these cultures were plated on LA 
containing Hyg, X-Gal and 5% Suc and incubated at 37°C for at least 5 days to allow a 
second crossover to occur. White, HygR, Suc-resistant (SucR) colonies (potential double 
crossover recombinants; DCOs) were isolated and patched on fresh medium containing 
Km to test for Km-sensitivity (KmS). This was used as a criterion to confirm loss of the 
intervening vector sequence. To confirm site-specific integration of the inactivated 
allele(s) in the candidate knockout mutants that displayed the expected phenotype (white, 
HygR, SucR and KmS), Southern blot analysis was carried out as described in section 
2.1.8. Genomic DNA was isolated from these clones and digested with appropriate 
restriction enzyme(s). Either the upstream or downstream PCR product used in the 
knockout construct was used as a probe. For validation, the blot was stripped of the 
bound probe and then hybridized with a different probe, or a different enzyme was used 
to digest the genomic DNA. 
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Figure 2. Knockout constructs used for inactivation of the M. smegmatis aerobic respiratory 
genes. (A) qcrCAB; (B) ctaCF; (C) ctaDI; (D) ctaDII. Shown on the maps are enzymes used for 
Southern blot analyses of the mutants. An apostrophe on the right or left of a gene name indicates 
truncation at the 3’ and 5’, respectively. 
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Table 3. Oligonucleotides used for construction of knockout vectors  
Gene(s) Oligonucleotide pairs used to construct knockout vectors 
 Oligonucl-
eotidea 
Sequence (5’-3’)b Region amplified 
M. smegmatis qcrCAB QCRF1 GGGCCGGAAGCttATGGGAACGGCTGGGAAGGT                                                                        878 bp product including 114 bp of 5’-end of qcrC 
 QCRR1 CTGCCAGACgGATCcGCAGCAGAAGCCCTGCTGACA  
 QCRF2 CGCTCACCGgGATCcCGCATGCGTCCGAGCACA  863 bp product including 104 bp of 3’-end of qcrB 
 QCRR2 GCTGTCGGgtACCTGTGCGCTGGGCGTGGC  
    
M. smegmatis ctaC CTACF1 TTCGGGACGAgGTACCGCGTCACCTCGGGTGC 1038 bp product including 130 bp of 5’-end of ctaC 
 CTACR1 TTGCCTCAGGGGgGATcCCCGTTGGCCAGCCGAGT  
 CTACF2 CAAGGCCTACATgGATCcGCGCAACGCCGG 1100 bp product including 139 bp of 3’-end of ctaC 
 CATCR2 TCACGCGCGACGAGAAGCttTACCGACGCCACG  
    
M. smegmatis ctaDI CTAD1F1 ACCTCGTCGgGTACCGAGGCAGGCAGCCCGGCG  883 bp product including 114 bp of 3’-end of ctaDI 
 CTAD1R1 ACTACCCGCACATGGTCGAGCGGATcCGGGCCGA  
 CTAD1F2 TGAACAGCGCCAgGAtcCCGCCGACCAGGAAGAA 787 bp product including 69 bp of 5’-end of ctaDI 
 CTAD1R2 AATACGACGGCTGCGCGTCCGAAgCTtCGGGCAG  
    
M. smegmatis ctaDII CTAD2F1 ACCCGGAGGaaGCTtGCTGGCTGTGTCCGGCGCT 859 bp product including 217 bp of 5’ end of ctaDII 
 CTAD2R1 AACTGCAGGCCGGGATCCGCCAACTCGGTGCGGA  
 CTAD2F2 TCACGGTCGAgGATCCGTGGGGCTACGGCAACT 844 bp product including 239 bp of 3’-end of ctaDII 
 CTAD2R2 CGCGTTTGGgGTAccTCTCCAGATCCCAACCGA  
    
M. tuberculosis ctaC TBCTACF1 GGCCATCTCGTGGAAGCttCTACCCAGGTCC 1903 bp product including 221 bp of 3’-end of ctaC 
 TBCTACR1 TCGTGGGCCACTGCGtCtAGATGTGTGGCAC  
 TBCTACF2 AGCATTGCTGCGAGCGCCAGCTcTaGAAGACCAC 1994 bp product including 111 bp of 5’-end of ctaC 
 TBCTACR2 GTACTTGGTGGTGGTACGGGTaAgCTTGGCGCCC  
a F, forward primer; R, reverse primer. 
b Restriction sites used for cloning are underlined (HindIII, BamHI KpnI) and bases changed to introduce the sites are given in lower case.
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2.2.3 Phenotypic characterization of M. smegmatis mutants 
Preparation of M. smegmatis seed stocks  
All M. smegmatis cultures used for growth and expression analyses were seeded from 
frozen stocks prepared as follows. A single colony was inoculated in 5 ml of broth 
(MADC-Tw) and grown to mid-log phase in a 25 ml Erlenmeyer flask. This culture was 
diluted in 100 ml of MADC-Tw, and grown to an OD600 of 2.0 at 37°C with shaking (350 
rpm). The culture was mixed with an equal amount of Dubos medium containing 15% v/v 
glycerol, divided into 8 ml aliquots (seed stocks) in sterile Bijou bottles, and stored at -
70°C. Each seed stock was thawed on ice and used to inoculate a pre-culture for growth 
in shaking flasks or in a bioreactor, as described below. 
 
Growth in shaking flasks  
To determine the effects of mutations in the various components of the cytochrome bc1-
aa3 pathway on growth, the M. smegmatis mutants and their parental wild type were 
grown under aerobic conditions in shaking flasks. Starter cultures (OD600 ~0.013) were 
prepared by diluting an overnight pre-culture (OD600 ~2.0) in 100 ml of MADC-Tw and 
incubating at 37°C with shaking (350 rpm). The cultures were grown in 500 ml 
Erlenmeyer conical flasks, giving a head space ratio of 1:4 to allow for adequate aeration. 
Optical density was monitored at 3 h intervals for a period of 42-60 h. 
 
Growth in a bioreactor under oxystatic conditions  
For gene expression analysis by DNA microarray, RT-PCR, and β-galactosidase assays, 
M. smegmatis strains were grown in a bioreactor under defined O2 tensions. Oxystatic 
cultures were grown in a New Brunswick Scientific (NBS) Bioflow 110 fermentor in 
batches. This system is similar to the Braun BIOSTAT B bioreactor culturing system that 
was employed previously for the batch growth of M. smegmatis under oxystatic 
conditions (Kana et al., 2001), with minor differences. The NBS system consists of a 
thermo-jacketed 2 liter vessel fitted with a baffle, two six-bladed impellers, a ring 
sparger, a water cooling coil, a sampling port, a temperature probe and a dissolved O2 
probe (Mettler Toledo), as well as a pH probe. The probes, water cooling coil and thermo 
jacket were connected to the fermentor control unit, through which all the variables (with 
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the exception of airflow rate) were adjusted and monitored. Air was supplied into the 
system by sparging compressed air through a rotometer and a 0.22 μm sterile filter. The 
rotometer allowed air supply to be manually controlled from 0 to 150 ml/min, depending 
on the desired air saturation. Vapour from the culture was allowed to escape through an 
exhaust fitted at the tip with a 0.22 μm sterile filter. Temperature was maintained at the 
set level by interplay of the thermo jacket and the circulatory water cooling system. An 
over-head motor connected to the impellers through a shaft was used to control stirring, 
with agitation speeds ranging from 50 to 1200 rpm. The fermentor control unit could be 
set to a dissolved O2 cascade mode, which linked the stirring rate to the dissolved O2 
level, hence maintaining air saturation at the required level. Experimental conditions were 
monitored through a BioCommand Plus Bioprocessing software (New Brunswick 
Scientific), which was linked to the fermentor control unit. 
For growth of reporter strains, the fermentor was autoclaved with 990 ml of 
Middlebrook 7H9 plus 2 ml glycerol. Autoclaved glucose (0.2%) and NaCl (0.085%) 
were added as the vessel cooled down, bringing the final volume to 1.0 liter. The vessel 
was allowed to equilibrate overnight, before the dissolved-O2 probe was calibrated. The 
O% air saturation level was set by sparging the medium with 100% nitrogen and the 
100% air saturation level was set by sparging with 100% compressed air. The medium 
was inoculated with 200 ml of pre-culture (OD600 ~2.0) to yield a starting culture of ca. 
107 CFU/ml. Sterile Tween 80 (0.05%) and 700 ul of an organic antifoam 204 (Sigma, 
USA) were added to the medium together with the inoculum.  
 
2.2.4 cyd expression analysis in a ΔqcrCAB::hyg mutant using a lacZ reporter 
Construction of a cyd reporter strain  
To monitor expression of the cydAB-encoded cytochrome bd oxidase in a cytochrome bc1 
mutant, plasmid pBK4 was electroporated into M. smegmatis strain ΔqcrCAB::hyg to 
obtain the reporter strain ΔqcrCAB::hyg::pBK4. This plasmid carries a cydA’::lacZ 
transcriptional fusion that expresses the lacZ gene under the control of the cyd promoter 
(Kana et al., 2001). Single crossovers were selected on media containing Km and X-Gal 
and site-specific recombination was confirmed by Southern blot analysis.  
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Oxystatic growth of the reporter strains  
The reporter strain, ΔqcrCAB::hyg::pBK4, was grown under oxystatic conditions in a 
New Brunswick Scientific Bioflow 110 fermentor as described above. For comparison of 
cyd expression in the qcrCAB mutant and its parental wild type, a reporter strain 
mc2155::pBK4 (Kana et al., 2001), carrying the same lacZ fusion at the cyd locus of wild 
type mc2155, was also grown under the same conditions as the ΔqcrCAB::hyg::pBK4 
strain. Each strain was analyzed at least twice at each of 1, 5 and 21% air saturation 
levels. For each biological replicate experiment, 200 ml of pre-culture was started from 
the same amount of seed stock3 and grown overnight to an OD600 of 2.0.This pre-culture 
was used to inoculate 1 liter of MADC-Tw containing 700 μl antifoam 204. Cultures 
were grown for 6 h and 2 ml duplicate samples were drawn at 2-h intervals, starting from 
time zero, therefore generating four samples (each in duplicate) per experiment.  
 
β-Galactosidase Assays  
Assays were performed on cell extracts as described by Ghanekar et al (1999) with a few 
modifications (Kana et al., 2001). Cells were harvested from 2 ml samples by 
centrifuging at 1500 × g for 5 min. The cell pellets were resuspended in 900 μl of ice-
cold Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM 
β-mercaptoethanol) and transferred to 2 ml screw cap Lysing Matrix B tubes containing 
beads (Southern Cross Biotechnology). Cells were lysed in a Savant BIO101 Fastprep 
cell disruptor in 2 cycles of 15 s at speed 4. Samples were cooled for 2 min on ice in 
between the pulses. The samples were transferred to Eppendorf tubes and the cell debris 
was pelleted by centrifuging at 1500 × g and the lysate was decanted into clean 
Eppendorf tubes. The assay reaction consisted of 50 to 100 μl of soluble cell extract and 
0.8 mg/ml of 2-nitrophenyl-β-D-galactopyranoside (ONPG), in a total volume of 1 ml 
(volume adjusted with Z-buffer). Samples were incubated at 37°C for 80 min, and the 
reaction was stopped by addition of 500 μl of 1 M Na2CO3 bringing the total volume to 
1.5 ml. To exclude enzyme activity in the reagents used, a negative control containing all 
the reagents but no cell extract was also assayed. Absorbance of the samples was 
                                                 
3 Preparation of seed stocks is described in section 2.2.3. 
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measured at 420 nm against Z-buffer. The units of β-galactosidase in the samples were 
calculated in the following steps: 
(i) Conc. of product (M) = A420/ЄL   where Є = 4500 for ONPG, L = 1 cm 
        for cuvettes used. 
(ii) Number of moles (n) = M × v/1000  where v = volume of sample. 
(iii) β-galactosidase units (U) = μmoles/t    where t= incubation time in min. 
 
Bradford assay  
Protein concentrations in the cell extracts were determined using a Bradford-based BIO-
RAD reagent according to the manufacturer’s instructions. Two hundred μl of the cell 
extract was made up to 800 μl with Z-buffer and 200 μl of Bio-rad reagent was mixed in. 
The samples were incubated at room temperature for approx. 10 min, and the absorbance 
was read at 595 nm against a negative control containing all the reagents but no cell 
extract. To obtain a standard curve for determination of the unknown protein quantity in 
the cell extracts, known amounts of purified BSA (Amersham) in the range of 2-14 μg 
were also assayed in duplicate as described for the cell extracts. The averaged A595 values 
for BSA were plotted against the corresponding protein quantities (μg), and the equation 
of the slope of the graph was used to calculate the amount (μg) of protein in the cell 
extracts. Expression of the cydA’::lacZ fusion was measured as specific activity (SA) of 
the enzyme β-galactosidase. SA values in each sample were calculated as follows:  
SA = amount of protein (mg)/enzyme units (mU). 
SA values of samples taken at different time points were averaged within an experiment, 
and then between experimental replicates. Unpaired t tests were performed on the data to 
determine statistical significance, using GraphPad Instat version 3.00 
(www.graphpad.com). 
 
2.2.5 Genome expression profiling of the bc1 and aa3 mutants using DNA 
 microarray 
Sources of DNA microarrays  
Two different sets of M. smegmatis DNA microarrays were used in this study. The first 
was a partial-genome amplicon array constructed, in collaboration with V. Mizrahi’s 
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group (Molecular Mycobacteriology Research Unit [MMRU], University of the 
Witwatersrand, South Africa), by Coppel and colleagues (Monash University, Australia). 
This array consists of 1822 genes constituting M. smegmatis mc2155 homologues of 1327 
M. leprae genes (Cole et al., 2001), 95 homologues of selected M. tuberculosis genes 
(Cole et al., 1998) and 4 M. smegmatis genes absent in both M. tuberculosis and M. 
leprae. Included in this selection are homologues of genes involved in respiration (Table 
4), DNA metabolism, cobalamin biosynthesis, hypoxic response, some members of the 
dormancy regulon and others. Briefly, PCR amplicons of all the above genes were 
evaluated for specificity by gel electrophoresis and then printed in triplicate on Corning 
Gaps II slides using a Genetic Microsystems Inc GMS 417 Arrayer. Slides were hydrated 
at 100°C for 5 s, cross-linked in a Stratagene UV Stratalinker 1800, baked at 80°C for 2 h 
and then boiled for 2 min before storage. More details on the array production are 
provided elsewhere (Matsoso et al., 2005) and the MIAME compliance file can be 
downloaded at http://vbc.med.monash.edu.au/~powell/M.smegmatis. The second set of 
array was a full genome microarray consisting of 6746 seventy-mer oligonucleotides 
representing 6746 ORFs from M. smegmatis mc2155. Each ORF is printed in duplicate on 
the array. This array was obtained as a grant to V. Mizrahi from the TIGR Pathogen 
Functional Genomics Resource Center (http://pfgrc.tigr.org/). 
 
RNA extraction  
M. smegmatis wild type and mutant strains were grown oxystatically at full aeration (21% 
air saturation) in a bioreactor as described in section 2.2.3. A 200 ml pre-culture was 
inoculated from a seed stock (described in section 2.2.3), grown to OD600 ~ 2.0 and then 
used to inoculate 2 liter of MADC-Tw to a starting OD600 of approx. 0.2. The culture was 
grown to an OD600 of 0.6 and then harvested. RNA extraction was performed as 
previously described (Betts et al., 2002). Briefly, cell pellets were suspended in 1 ml 
Trizol reagent (Invitrogen, UK) and transferred to 2 ml screw cap Lysing Matrix A tubes 
containing beads (Southern Cross Biotechnoloy). Cells were lysed in a Savant BIO101 
Fastprep cell disrupter for three cycles (20 s at speed 6) with cooling between pulses. Cell 
debris was separated by a 45 s centrifugation and the supernatant was transferred to 2 ml 
Phase Lock gel tubes (Eppendorf, Hamburg, Germany) containing 300 μl 
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chloroform/isoamyl alcohol (24:1). Samples were inverted rapidly for 15 s and then 
periodically for 2 min before centrifugation (10 000 × g for 5 min). Nucleic acids were 
precipitated from the top aqueous phase with 600 μl isopropanol and incubated overnight 
at 4°C. The RNA pellets were collected by centrifugation (9 000 × g for 20 min at 4°C), 
washed in 1 ml 70% ethanol and air-dried. RNA samples were resuspended in nuclease-
free water (DEPC water) and then treated with DNase I (Ambion) for 30 min at 37°C. 
RNA was further purified using RNeasy kit (Qiagen, Germany) according to the 
manufacturer’s instructions.  
 
Table 4. M. smegmatis respiratory genes present on the partial-genome amplicon array 
ID Gene Function 
ctaB ctaB aa3-type cytochrome c oxidase assembly factor 
ctaC ctaC aa3-type cytochrome c oxidase subunit II 
ctaD ctaD aa3-type cytochrome c oxidase subunit I 
ctaE ctaE aa3-type cytochrome c oxidase subunit III 
ML0876 ctaF aa3-type cytochrome c oxidase subunit IV 
qcrA qcrA Rieske iron-sulfur protein 
qcrB qcrB ubiquinol-cytochrome c reductase cytochrome b subunit 
qcrC qcrC ubiquinol-cytochrome c reductase cytochrome c subunit 
Rv1542c glbN Hb-like oxygen carrier 
Rv3145 nuoA NADH dehydrogenase chain A 
Rv3146 nuoB NADH dehydrogenase chain B 
Rv2392 cysH 3-phosphate adenylylsulfate reductase 
Rv2899c fdhD formate dehydrogenase family accessory protein 
Rv1161 narG nitrate reductase subunit 
Rv1162 narH nitrate reductase subunit 
Rv2391 nirA probable nitrite reductase 
Rv0252 nirB nitrite reductase flavoprotein 
Rv1623c cydA cytochrome bd oxidase subunit I 
Rv1622c cydB cytochrome bd oxidase subunit II 
Rv1620c cydC ABC transporter 
Rv1621c cydD ABC transporter 
 (ctaDII) ctaDII aa3-type cytochrome c oxidase chain I (second allele) 
 (ythA) ythA YthA (homolgoue of CydA) 
 
Preparation of labeled cDNA probes  
Probe preparation and hybridization were carried out using previously described methods 
(Boshoff et al., 2004). RNA from the control experiment was labelled with Cy3-dCTP 
(Amersham Pharmacia Biotech, USA) and hybridized against Cy5-dCTP-labelled subject 
RNA. The 25 µl labeling reaction contained 2 µg of RNA (control) or 4 ug of RNA 
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(subject), 60 µM random primers, 0.5 mM each of dATP, dGTP and dTTP, and 0.05 mM 
dCTP, 10 mM DTT, 1 nmol of either Cy3-dCTP or Cy5-dCTP (Amersham Pharmacia 
Biotech) and 200 units reverse transcriptase Superscript II (InvitrogenTM Life 
Technologies). The primers were annealed to the RNA by heating to 70°C for 10 min and 
snap-cooling on ice before adding the remaining reaction components. The sample was 
incubated for 10 min at 25°C followed by 90-min incubation at 42°C. To stop the 
reaction, the sample was heated to 72°C, 5 µl of a 1 M NaOH was added and the mixture 
incubated for 15 min. The pH was neutralized by addition of 5 µl of 1M HCl. To remove 
unincorporated nucleotides and Cy-dye, the Cy3- and Cy5-labelled cDNA samples to be 
compared were combined run through a microcon filter (Millipore). The sample was 
added to a microcon filter tube containing 400 μl of TE and centrifuged at 10 000 × g for 
ca. 10 min. The wash step was repeated and the sample was finally eluted in a volume of 
ca. 11 ul.   
 
Microarray hybridization  
For the partial amplicon array, slides were first boiled in 95°C deionised water for 2 min 
followed by a rinse in 95% ethanol and quick-dried by centrifugation at 36 ´ g for 5 min 
prior to hybridization. For all arrays, the slides were pre-hybridized for 1 hr at 42°C in a 
buffer containing 5´ SSC, 1% BSA and 0.1% SDS. Pre-hybridization was carried out 
under a glass coverslip in a humidified Corning hybridization chamber submerged in a 
42°C water bath. Prior to addition of labeled probes, the pre-hybridized slides were 
removed from hybridization chambers and coverslips were removed in distilled water. 
The slides were washed twice in isopropanol (2 min each) and then dried by centrifuging 
at 36 ´ g for 5 min. Labeled probes were mixed with blocking reagents (4 μg yeast tRNA, 
1.9 μg Herring sperm DNA) and made up to a total of 24 μl (for the partial-genome DNA 
microarray) or 48 μl (for the full genome DNA microarray) in hybridization buffer (5 ´ 
SSC, 25% formamide, 0.1% SDS). Samples were denatured at 98°C for 2 min, snap-
cooled on ice and applied to the array. Hybridization took place under a glass coverslip in 
a humidified slide chamber (Corning) submerged in a 42°C water bath for approximately 
16 h. Cover slips were removed in wash buffer I (1 ´ SSC, 0.05% SDS) and slides were 
washed once in buffer I and twice in buffer II (0.1 ´ SSC) for 2 min each at room 
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temperature before being dried by centrifugation (36 ´ g, 5 min). Slides were scanned 
using a GenePix 4000B instrument (Axon Instruments).  
 
Data analysis  
After capture with the GenePix 4000B scanner, the image was analyzed with GenePix 
Pro 4.1 (Axon Instruments). Although the program was allowed to automatically flag bad 
spots, a manual flagging was also performed based on visual inspection. The results were 
normalized such that the ratio of medians of all the feature pixels was equal to 1. For a 
spot to be included in the analysis, at least one of the two channels (Cy3 or Cy5) median 
intensities had to be ≥ 1000 (or a background-subtracted median intensity of at least 600). 
However, these cut-offs were decreased in the analysis of the TIGR full genome 
oligonucleotide array as the spot intensities were generally lower with this array than they 
were with the partial genome amplicon array. A gene was considered significantly 
differentially expressed if the log2 of the ratio of medians of the two channels was ≥ 1. 
Results were exported into Microsoft Excel and the log2 values of duplicate spots were 
averaged per array, before data from biological replicates was collated.  
 An independent data analysis was performed by D. Powell (Victorian 
Bioinformatics Consortium, Australia) on some of the microarrays to validate the results 
(Matsoso et al., 2005). Images obtained from the GenePix 4000B scanner were analyzed 
and quantified using Imagene 6.0 (BioDiscovery) to determine spot integrity, and further 
analyzed using Bioconductor (Dutoit and Yang, 2003) and Limma (Smyth, 2004) 
packages. Spot intensities were background corrected by subtracting the background 
median from the foreground mean. Any resulting non-positive values were replaced with 
half the minimum of all positive corrected intensities for that array. The normalization to 
remove various biases involved two parts. Firstly, each array was normalized 
independently using print-tip loess normalization (Yang et al., 2001). Secondly, 
diagnostic plots suggested a variation in scale between arrays, so the log-ratios were 
scaled in such a way that each array had the same median-absolute-deviation (MAD). 
The normalized data were then used to fit a linear model (Yang et al., 2001) for each 
gene using generalized least-squares which takes into account the correlation between 
duplicate spots (Smyth et al., 2005). The coefficient of the fitted model for each gene 
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describes the inferred difference in RNA expression between wild-type and mutant. 
Empirical Bayes was then used to calculate the moderated t-statistics and associated P-
values. The P-values were adjusted for multiple testing using false-discovery-rate (FDR), 
and a cut-off of 1% FDR was used to define a set of differentially expressed (DE) genes.  
 
2.2.6 Effects of chlorpromazine on the transcriptome of a bc1 mutant of M. 
 smegmatis  
DNA microarray  
Cultures were grown oxystatically at 21% air saturation, in a New Brunswick Scientific 
Bioflow 110 fermentor as described above, to an OD600 of 0.6 and then rapidly harvested 
into a pre-warmed flask (37°C). The culture was then divided into two 200 ml samples in 
pre-warmed 1 liter flasks. To one flask, 200 µl of chlorpromazine (CPZ, [50mg/ml stock 
in DMSO]) was added, and 200 µl DMSO was added to the other flask as a control. Both 
cultures were shaken at 350 rpm for 1 h at 37°C. Cells were harvested and frozen in 
Trizol reagent or used immediately for RNA isolation. The RNA was analyzed on the 
partial-genome amplicon DNA microarray.   
 
Semi-quantitative RT-PCR  
RNA samples were treated with DNA-free kit (Ambion) according to the manufacturer’s 
instruction, to remove contaminating DNA. Reverse transcription was carried out in 20 μl 
reactions containing 0.5 μg of total RNA, 0.3 mM gene-specific reverse primers (Table 
5), 0.8 mM each of dATP, dGTP, dCTP and dTTP, and Enhanced Avian HS reverse 
transcriptase (Sigma). The primers were annealed to the RNA by heating to 94°C for 90 
s, followed by 3 min at 65°C and then 57°C for 3 min. Samples were snap-cooled on ice 
before adding the remaining components and then incubated at 60°C for 30 min, followed 
by a 5 min heating step at 95°C. The resulting cDNA was either used immediately or 
frozen at -20°C. Five-fold serial dilutions of the cDNA were prepared and 2 μl from each 
dilution used as template for PCR. The 50 μl reaction mixture contained 4 mM MgCl2, 
0.4 mM each of dATP, dCTP, dGTP and dTTP, 0.4 μM primers, 0.5 mg/ml BSA, 10% 
DMSO, reaction buffer and 2.5 U of FastStart Taq polymerase (Roche). Samples were 
heated to 94°C for 10 min before cycling for 14 cycles of 94°C for 30 s, 65°C for 30 s, 
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72°C for 30 s, followed by 24 cycles of 94°C for 30 s, 57°C for 30 s and 72°C for 30 s. 
The PCR products were analyzed on a 3% agarose gel.  
 
Table 5. Oligonucleotides used in RT-PCR 
M. smegmatis 
gene 
H37Rv 
homologue 
Oligonucl-
eotide 
Sequence (5’-3’) Product 
length (bp) 
MSMEG5229 devR / Rv3133c 3133L GCCTGATGCTCACGTCGTTC         80 
  3133R CTTGACCACGTATCCGCTCG  
MSMEG3937 hspX / Rv2031c 2031L GACGGTGGTTACGAACTGCG 98 
  2031R TCGGCCTTGATGGTCAACAC  
MSMEG5231 acg / Rv2032 2032L ACATGGACACCCTCGGTGAG 104 
  2032R GGCGAGTTCGGAATGGTAGG  
MSMEG5230 uspL / Rv2028c 2028L GACGCACCGCTTTCGGTGAT 144 
  2028R GAGTTCGGGATACCGCTTGC  
MSMEG3957 uspM / Rv2026c 2026c1L TCGACGTCGGTGACATTCCT 106 
  2026c1R GGATAGCGTTCCTGCCAACC  
MSMEG5708 uspN / Rv2026c 2026c2L CGTCATCGACTGGGAAGGTG 108 
  2026c2R TCGACGTAGCACTTCGCCTC  
MSMEG2759 sigA / Rv2703 SigA-F1 TCTACGCCACGCAGAAGCTG 124 
  SigA-R1 GTTCGCCTCCAGCAGATGGT  
 
 
2.2.7 Complementation of the M. smegmatis ctaC knockout mutant 
In order to determine if the growth defect of the M. smegmatis ctaC mutant could be 
complemented by presence of a functional ctaC gene from M. tuberculosis, a 
complementing vector, pMVCTAC, was constructed (Figure 3B). A 2892 bp KpnI 
fragment from M. tuberculosis H37Rv was cloned into the KpnI site of plasmid 
pMV306K. This fragment carried the entire ctaCF operon (1520 bp) plus 530 bp and 842 
bp of the 5’ and 3’ flanking sequences. The resulting plasmid, pMVCTAC, was 
electroporated into M. smegmatis ctaC mutant, ΔctaC::hyg. Integration of this construct 
at the attB locus of the mutant was confirmed by PCR amplification if the resulting attL 
and attR regions. The following primer pairs were used: attBS2 (5’-
ACAGGATTTGAACCTGCGGC-3’) and attL4 (5’-AATTCTTGCAGACCCCTGGA-
3’) for attL, and attBS1 (5’-ACGTGGCGGTCCCTACCG-3’) and attL2 (5’-
CTTGGATCCTCCCGCTGCGC-3’) for attR. The primers were kindly supplied by S. 
Barichievy (MMRU). Growth of the complemented strain under aerobic conditions was 
compared to that of ΔctaC::hyg and its parental wild type under the same conditions.  
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2.2.8 Attempts to construct a cytochrome bc1-bd double mutant of M. smegmatis 
The viability of a M. smegmatis mutant lacking both known aerobic electron routes 
terminating in cytochrome aa3 and cytochrome bd oxidases, was investigated. Plasmid 
pCYDAKO used to generate a knockout mutant of cytochrome bd in M. smegmatis 
(Kana et al., 2001), was electroporated into a cytochrome bc1 mutant, ΔqcrCAB::hyg (this 
work). Selection of recombinants was carried out as described above. 
 
2.2.9 Attempts to construct a ctaC mutant of M. tuberculosis 
Cloning and delivery of the knockout substrate  
To investigate the effects of blocking the cytochrome bc1-aa3 pathway in M. tuberculosis, 
the gene encoding subunit II (ctaC) of the aa3-type cytochrome c oxidase was targeted 
for deletion. A knockout vector for the M. tuberculosis ctaC was made using the same 
strategy described for M. smegmatis genes above. Two PCR products amplified from the 
up- and downstream flanking regions of M. tuberculosis H37Rv ctaC were individually 
cloned into pGEMTeasy and sequenced. These fragments, which included 111-bp of the 
5’- and 221-bp of the 3’- ends of ctaC, respectively, were subsequently cloned into 
p2NIL (Parish and Stoker, 2000), effectively deleting an internal 760-bp region of ctaC. 
The deletion mutation was marked by insertion of a hyg gene at the deletion junction. 
The lacZ-sacB cassette was then cloned in the PacI site of p2NIL, as described above, to 
create the knockout construct, p2CTACTBKO (Table 2; Figure 3A). This plasmid was 
electroporated into M. tuberculosis H37Rv and plated on Middlebrook 7H10 
supplemented with glycerol, OADC, Km, Hyg and X-Gal. Plates were incubated for 21 
days at 37°C. 
 
Selection of recombinants  
Blue Hyg- and Km-resistant colonies were recovered and genotyped by Southern blot 
analysis to confirm that they resulted from a site-specific SCO recombination at the ctaC 
locus. The SCOs were streaked onto fresh plates containing Hyg and X-Gal and grown 
for 22 days at 37°C to allow for a second cross to occur. Serial dilutions of the white 
Hygr colonies were prepared and plated on media containing Hyg, X-Gal and 5% sucrose. 
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Figure 3. M. tuberculosis ctaC constructs. (A) Knockout construct used for attempted gene 
replacement of ctaC in M. tuberculosis H37Rv. (B) a vector used for complementation of a ctaC 
mutant in M. smegmatis. This vector carries the M. tuberculosis ctaCF operon plus flanking 
sequence. An apostrophe to the left or right of a gene name means a truncation at the 5’ or 3’ end 
of the gene, respectively. 
 
Since it was hypothesized that the mutant in this gene, if viable, would be retarded in 
growth, the plates were incubated for a total period of 54 days to increase the chances of 
isolating such a mutant. After this period plates started drying out. All white HygR, SucR 
colonies were isolated from the plates were tested for Kan-sensitivity (potential DCOs). 
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3. RESULTS 
 
Function of the cytochrome bc1-aa3 branch of the respiratory network in 
mycobacteria 
In order to gain insight into how M. tuberculosis, which is considered an obligate aerobe, 
survives the environments of variable oxygen availability during latent and active 
infections, it is necessary to investigate the functioning of the mycobacterial respiratory 
chain. The states of functionality of the different components of the respiratory chain may 
determine the mode of adaptation of the bacilli under existing conditions. In an attempt to 
dissect the roles played by the various respiratory components in growth and survival of 
mycobacteria, genes encoding such were selected for targeted gene knockout and the 
effects thereof studied. The major genetic and physiological aspects of this study were 
carried out in M. smegmatis and based on the insights gained from this work further 
investigations were subsequently performed in M. tuberculosis.  
  
3.1 Identification of the aerobic respiratory genes in the genome of M. smegmatis 
This work was initiated before the release of the complete genome sequence of M. 
smegmatis strain mc2155. Therefore to identify the complement of M. smegmatis genes 
involved in aerobic respiration, the unfinished genome sequence of M. smegmatis strain 
mc2155 (http://www.tigr.org/ufmg/) was initially analyzed by BLAST searching 
(Altschul et al., 1990) using M. tuberculosis aerobic respiratory genes as query sequences 
(Cole et al., 1998; Fleischmann et al., 2002). These included genes that encode the 
various aerobic respiratory enzyme complexes such as NADH dehydrogenase 
(nuoABCDEFGHIJKLMN; ndh; ndhA), and succinate dehydrogenases (sdhCDAB), 
menaquinol:cytochrome c oxidoreductase (cytochrome bc1 complex; qcrCAB), and the 
terminal oxidases, cytochrome aa3 (ctaD, ctaCF, ctaE) and cytochrome bd (cydAB) as 
detailed in Table 6.  
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Table 6. Genes encoding components of the aerobic respiratory chain of M. smegmatis 
Origin of query 
sequence(s)a 
Gene / 
operon 
name 
H37Rv ORF # Homologue(s) in smeg Function TIGR annotation  
M. tuberculosis nuoABCDEF
GHIJKLMN 
Rv3145-Rv3158 nuoABCDEFGHIJKLMN Type I NADH dehydrogenase  MSMEG2064-MSMEG2051 
M. tuberculosis ndh Rv1854c ndh Type II NADH dehydrogenase MSMEG3627 
M. tuberculosis ndhA Rv0392c ndhA Type II NADH dehydrogenase MSMEG3463 
M. tuberculosis sdhCDAB Rv3316-Rv3319 sdhBADC succinate dehydrogenase  MSMEG1666-MSMEG1669 
M. tuberculosis qcrCAB Rv2194-Rv2196 qcrCAB cytochrome bc1 complex  MSMEG4264-MSMEG4266 
ctaDI (two copies)c cytochrome c oxidase subunit I MSMEG1027 & MSMEG2320 M. tuberculosis ctaD Rv3043c 
ctaDII (2nd homologue)b cytochrome c oxidase subunit I MSMEG4435 
M. tuberculosis ctaC Rv2200c ctaC cytochrome c oxidase subunit II MSMEG4271 
M. tuberculosis ctaE Rv2193 ctaE cytochrome c oxidase subunit III MSMEG4263 
M. tuberculosis ctaF Rv2199c ctaF cytochrome c oxidase subunit IV MSMEG4270 
M. tuberculosis cydA Rv1623c cydA cytochrome bd oxidase, subunit I MSMEG3243 
M. tuberculosis cydB Rv1622c cydB cytochrome bd oxidase, subunit I MSMEG3240 
M. tuberculosis cydDC Rv1621c-Rv1620c cydDC ABC transporter MSMEG3241-MSMEG3240 
B. subtilis ythA None ythA (cydA homologue) cytochrome bd’ oxidase, subunit I MSMEG5584 
B. subtilis ythB None ythB (cydB homologue) cytochrome bd’ oxidase, subunit II MSMEG5585 
 
a Sequences were obtained from Tuberculist (http://genolist.pasteur.fr/TubercuList/) for M. tuberculosis and Subtilist 
(http://genolist.pasteur.fr/SubtList/). 
b M. smegmatis has two homologues of the M. tuberculosis ctaD gene.  
c M. smegmatis ctaD located on the previously reported duplicated region of the chromosome (Galamba et al., 2001; http://www.tigr.org/tigr-   
scripts/CMR2/CMRHomePage.spl
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 To identify genes that may be present in M. smegmatis but not in M. tuberculosis, 
homologues of other known aerobic genes such as those of E. coli, and B. subtilis were 
also searched for in the M. smegmatis genome sequence. Although the genome of M. 
smegmatis was found to contain a full complement of all the known M. tuberculosis 
aerobic genes, some notable differences between these two species were identified. In 
particular, M. smegmatis has more than one homologue of the ctaD gene and its genome 
sequence also contains an additional putative cytochrome bd-type terminal oxidase, 
encoded by homologues of the B. subtilis ythAB genes (Table 6).  
 
3.1.1 Occurrence of multiple ctaD homologues in M. smegmatis 
BLAST searches of the unfinished genome sequence of M. smegmatis mc2155 
(http://www.tigr.org/ufmg/) revealed presence of two distinct ctaD homologues. Of these, 
one is located within a region of the genome that has been reported to be duplicated 
(Galamba et al., 2001), and as a result, this strain carries a total of three ctaD-type genes. 
The duplicated ctaD homologue, designated in this work as ctaDI, shows 86% amino 
acid (aa) identity with M. tuberculosis ctaD and is located in the same chromosomal 
context as its M. tuberculosis counterpart (Table 5; MSMEG1027 and MSMEG2320). In 
all the Mycobacterium species for which complete genome sequences are available a 
serB2 gene is found immediately downstream of ctaD, in an apparently operonic 
arrangement. A similar arrangement is also seen in other nocardioform actinomycetes, 
such as Nocardia farcinica and C. glutamicum (though not operonic with ctaD in this 
species), but not in non-nocardioform actinomycetes such as Streptomyces coelicolor. 
The second M. smegmatis ctaD homologue, designated herein as ctaDII (Table 6; 
MSMEG4435), shows 85% identity with M. tuberculosis ctaD at the amino acid level, 
but is located in a completely different chromosomal context compared to its M. 
tuberculosis counterpart (Figure 6B). 
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Mtb CtaD       LTAEAPPLGELEAIRPYPARTGPKGSLVYKLITTTDHKMIGIMYCVACISFFFIGGLLAL 60 
Msg CtaDII     MTTHAPSAGELLARRPFPQRLGPRWTLLYKLVTTTDHKLIGMMYVVACFIFFFIGGLMAL 60 
Msg CtaDI-p    LVAEAPPIGELEARRPFPERMGPKGNLIYKLITTTDHKLIGIMYCVVCFAFFLVGGLMAL 60 
Msg CtaDI      --------------------MGPKGNLIYKLITTTDHKLIGIMYCVVCFAFFLVGGLMAL 40 
 
Mtb CtaD       LMRTELAAPGLQFLSNEQFNQLFTMHGTIMLLFYATPIVFGFANLVLPLQIGAPDVAFPR 120 
Msg CtaDII     LLRTELAVPGLQFLSNEQYNQLFTMHGTVMLLFYATPIVFGFANLVVPLQIGAPDVAFPR 120 
Msg CtaDI-p    FMRTELAMPGLQFLSNEQFNQLFTMHGTVMLLFYATPIVFGFANLVLPLQIGAPDVAFPR 120 
Msg CtaDI      FMRTELAMPGLQFLSNEQFNQLFTMHGTVMLLFYATPIVFGFANLVLPLQIGAPDVAFPR 100 
 
Mtb CtaD       LNAFSFWLFVFGATIGAAGFITPGGAADFGWTAYTPLTDAIHSPGAGGDLWIMGLIVAGL 180 
Msg CtaDII     LNALSFWLFLFGASIALGGFLAPGGPADFGWTAYTPLSNAMHSPGAGGDLWIFGLIVGGL 180 
Msg CtaDI-p    LNALSFWLFLFGALIAIAGFITPGGAADFGWTAYSPLTDAIHSPGAGGDLWIMGLAVGGL 180 
Msg CtaDI      LNALSFWLFLFGALIAIAGFITPGGAADFGWTAYSPLTDAIHSPGAGGDLWIMGLAVGGL 160 
                 
Mtb CtaD       GTILGAVNMITTVVCMRAPGMTMFRMPIFTWNIMVTSILILIAFPLLTAALFGLAADRHL 240 
Msg CtaDII     GTILGAVNMITTVVCMRAPGMIMFRMPIFTWNILVTSVIVLVAFPLLTSALFGLAADRNL 240 
Msg CtaDI-p    GTILGGVNMITTVVCMRAPGMTMFRMPIFTWNILVTSILVLIAFPILTAALFGLAADRHL 240 
Msg CtaDI      GTILGGVNMITTVVCMRAPGMTMFRMPIFTWNILVTSILVLIAFPILTAALFGLAADRHL 220 
                 
Mtb CtaD       GAHIYDAANGGVLLWQHLFWFFGHPEVYIIALPFFGIVSEIFPVFSRKPIFGYTTLVYAT 300 
Msg CtaDII     GAHVFDPANGGTMLWEHLFWFFGHPEVYIIALPFFGIVTEIFPVFSRKPVFGYTTLVYAT 300 
Msg CtaDI-p    GAHIYDPANGGVLLWQHLFWFFGHPEVYIIALPFFGIVSEIFPVFSRKPIFGYTTLIYAT 300 
Msg CtaDI      GAHIYDPANGGVLLWQHLFWFFGHPEVYIIALPFFGIVSEIFPVFSRKPIFGYTTLIYAT 280 
                 
Mtb CtaD       LSIAALSVAVWAHHMFATGAVLLPFFSFMTYLIAVPTGIKFFNWIGTMWKGQLTFETPML 360 
Msg CtaDII     ISIGALSIAVWAHHLYATGAVLLPFFSFMTFMIAVPTGIKFVNWIGTMWKGQLTFETPML 360 
Msg CtaDI-p    LAIAALSVAVWAHHMYATGAVLLPFFSFMTFLIAVPTGIKFFNWIGTMWKGQLTFETPML 360 
Msg CtaDI      LAIAALSVAVWAHHMYATGAVLLPFFSFMTFLIAVPTGIKFFNWIGTMWKGQLTFETPML 340 
                 
Mtb CtaD       FSVGFMVTFLLGGLTGVLLASPPLDFHVTDSYFVVAHFHYVLFGTIVFATFAGIYFWFPK 420 
Msg CtaDII     FSVGFLVTFLLGGLTGVILASPPLDFHVTDSYFVVAHFHYVLFGTIVFATYAGVYFWFPK 420 
Msg CtaDI-p    FSVGFLITFLLGGLSGVLLASPPLDFHVTDSYFVIAHFHYVLFGTIVFATYAGIYFWFPK 420 
Msg CtaDI      FSVGFLITFLLGGLSGVLLASPPLDFHVTDSYFVIAHFHYVLFGTIVFATYAGIYFWFPK 400 
                 
Mtb CtaD       MTGRLLDERLGKLHFWLTFIGFHTTFLVQHWLGDEGMPRRYADYLPTDGFQGLNVVSTIG 480 
Msg CtaDII     MTGRLLDDRLGKLHFWLTLIGFHTTFLVHHWLGAEGMPRRYADYLPTDGFTTLNIVSTIG 480 
Msg CtaDI-p    MTGRLLDERLGKLHFWLTFIGFHTTFLVQHWLGDEGMPRRYADYLPTDGFTTLNVISTVG 480 
Msg CtaDI      MTGRLLDERLGKLHFWLTFIGFHTTFLVQHWLGDEGMPRRYADYLPTDGFTTLNVISTVG 460 
                 
Mtb CtaD       AFILGASMFPFVWNVFKSWRYGEVVT------VDDPW-GYGNSLEWATSCPPPRHNFTEL 533 
Msg CtaDII     SFILGVSMLPFVWNVFKSWRYGEPVT------VDDPW-GYGNSLEWATSCPPPRHNFTEL 533 
Msg CtaDI-p    AFILGVSSLPFVWNVFKSWRYGEPVT------VDDPW-GYGNSLEWATSCPPPRHNFTEL 533 
Msg CtaDI      AFILGVSSCRSCGTCSRAGVTASPSRSTIRGATATPWSGPPAARRRGTTSPSCRVSGRSV 520 
                 
Mtb CtaD       PRIRSERPAFELHYPHMVERLRAEAHVGRHHDEPAMVTSS---------- 573 
Msg CtaDII     PRIRSERPAFELHYPHMIERLRAESHPGRTQGGPGAVTLPQPQARSHPVE 583 
Msg CtaDI-p    PRIRSERPAFELHYPHMVERMRAEAHVGRAHH-PELETADKSS------- 575 
Msg CtaDI      RRSSCTTRTWSSGCGPRPTWVAPTIPSSRPRTSPADAFAPTG-------- 562 
                  
 
 
Figure 4. Comparison of subunit I of cytochrome c oxidase (CtaD) from M. tuberculosis and M. 
smegmatis. The alignment was generated with ClustalW version 1.8 
(http://www.ebi.ac.uk/clustalw/). Sequences were obtained from http://genolist.pasteur.fr/ 
TubercuList for M. tuberculosis (Mtb CtaD) and http://www.tigr.org/tigr-
scripts/CMR2/CMRHomePage.spl for M. smegmatis (Msg CtaDI and Msg CtaDII). Msg CtaDI-p 
is a variant of Msg CtaDI, in which a probable frame-shift (underlined) starting at residue 469 has 
been corrected and a Leu residue 20aa (in bold) upstream of the Msg CtaDI Met start codon was 
proposed as the start site. M. smegmatis amino acid residues that differ from the M. tuberculosis 
CtaD are highlighted in yellow. Marked on the sequences are the histidine residues that putatively 
serve as ligands for CuB (blue), heme a (red) and heme a3 (green) (Niebisch and Bott, 2001).   
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Analysis of the M. smegmatis CtaD homologues reveals a possible frame-shift in ctaDI 
A comparison of the two different M. smegmatis CtaD protein sequences to each other 
and to that of M. tuberculosis CtaD, highlighting the similarities and divergence, is 
shown in Figure 4. Alignment of these sequences revealed a frame-shift in the coding 
sequence of M. smegmatis ctaDI (both identical copies; MSMEG1027 and 
MSMEG2320) caused by a probable DNA sequencing error that resulted in a missing 
nucleotide base (either a C or a T) at position 1405 of the nucleotide sequence. This 
frame-shift resulted in complete divergence of the last 94aa at the carboxyl end of M. 
smegmatis CtaDI from the M. tuberculosis CtaD (Figure 4; Msg CtaDI).  
Also apparent from these alignments is the possibility that a leucine (Leu) 20aa 
upstream of the TIGR-annotated methionine (Met) start codon in both copies of CtaDI 
(MSMEG1027 and MSMEG2320 [http://www.tigr.org/tigr-scripts/CMR2/ 
CMRHomePage.spl]) may serve as a start codon. This inference is based on the high 
homology (75% and 65%) of this 20aa region to the amino end of M. tuberculosis CtaD 
and M. smegmatis CtaDII, respectively (Figure 4). Both the possible missing 20aa N-
terminal region and the frame-shift were corrected in the CtaDI sequence, generating Msg 
CtaDI-p (Figure 4). Although start site mapping would be necessary in order to determine 
the likelihood of such a proposed sequence, Msg CtaDI-p was used as the M. smegmatis 
CtaDI sequence in further comparative analyses with other actinomycetes CtaD 
sequences (Figure 5; Table 7). 
 
The occurrence of multiple ctaD alleles is not uncommon in actinomycetes 
The presence of two different ctaD alleles in M. smegmatis prompted an interest to 
investigate this occurrence in other actinomycetes. Although distinct ctaD alleles were 
only identified in M. smegmatis and not any other sequenced mycobacterial species, 
BLAST searches on the sequenced genomes of other actinobacteria 
(http://www.tigr.org/tigr-scripts/CMR2/CMRHomePage.spl) revealed that the occurrence 
of two or more distinct ctaD alleles was not uncommon. Two species of Streptomyces 
and one of Nocardia were also found to possess two distinct ctaD homologues with 
similarity to the M. smegmatis ctaD genes (Figure 5 and Table 7).  
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Figure 5. Phylogenetic relationship of CtaD proteins from sequenced actinomycetes bearing 
multiple ctaD alleles. The tree was constructed using ClustalW (http://www.ebi.ac.uk/clustalw/). 
A similar tree was obtained with the MegAlign module of the Lasergene suite of programs 
(DNASTAR, Madison, WI). Abbreviations are as follows, Msg: M. smegmatis; Nfa: Nocardia 
farcinica; Sav: Streptomyces avermitilis; Sco: S. coelicolor. With the exception of Msg CtaDI-p 
(explained in Figure 4), the sequences were obtained from http://www.tigr.org/tigr-
scripts/CMR2/CMRHomePage.spl for Sav and Sco, and Nfa. The tree indicates a much closer 
evolutionary relationship between M. smegmatis and N. farcinica CtaDs than the Streptomyces 
CtaDs. 
 
 
 
Table 7. Sequence distances between various actinomycete CtaD polypeptides 
Percent Identitya 
  1 2 3 4 5 6 7 8   
1 *** 84 80.9 78.3 67.7 67.9 69.8 67.4 1 Msg CtaDI-p 
2 17.4 *** 75.8 75.2 64.5 65.6 66.5 65.7 2 Msg CtaDII 
3 20.7 27.2 *** 82.3 65.7 65.8 68.4 66.4 3 Nfa CtaDI 
4 24.8 30.3 19.2 *** 66.2 65.6 66.8 66.9 4 Nfa CtaDII 
5 42 45.7 42.5 43.8 *** 78 93.3 72.6 5 Sav CtaDI 
6 41.1 44.3 44 45.2 24.6 *** 77.1 74.6 6 Sav CtaDII 
7 37.7 42.4 37.6 42.7 6.3 26.2 *** 72.8 7 Sco CtaDI 
8 41.5 44.7 42.7 42.3 33.6 29 33.3 *** 8 Sco CtaDII 
D
iv
er
ge
nc
eb
 
  1 2 3 4 5 6 7 8    
 
a,b Sequence identities and divergence, respectively, as generated with MegAlign (DNASTAR) 
using a clustal method. 
Msg, M. smegmatis; Nfa, N. farcinica; Sav, S. avermitilis; Sco, S. coelicolor. 
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 Phylogenetic analysis of these various actinobacterial CtaD proteins grouped the 
M. smegmatis and N. farcinica CtaD sequences together showing that they share a much 
more recent common ancestor than the link to their Streptococcus counterparts (Figure 5). 
This is consistent with the classification of the genera Mycobacterium and Nocardia 
together as nocardioform actinomycetes (Goodfellow and Minnikin, 1977; Finnerty 1992; 
Ishikawa et al., 2004).  
 
3.1.2 Genetic composition and organization of the aerobic respiratory chain of M. 
 smegmatis  
The genome analysis revealed presence of an aerobic respiratory chain consisting of at 
least three branches, namely a cytochrome c branch terminating in an aa3-type 
cytochrome c oxidase, and two quinol branches terminating in cytochrome bd and bd’ 
oxidases, encoded by cydAB and homologues of ythAB, respectively (Figure 6). With the 
exception of the ythAB-encoded cytochrome bd’ oxidase (nomenclature based on the 
corresponding B. subtilis homologues; Table 6), which is absent in M. tuberculosis, the 
aerobic respiratory chain of M. smegmatis was found to closely resemble that of M. 
tuberculosis. This composition was later confirmed by searching the complete genome 
sequence of M. smegmatis which became available during the course of this study 
(http://www.tigr.org/tigr-scripts/CMR2/CMRHomePage.spl). 
 While the role of the alternative bd’ (ythAB) quinol oxidase has yet to be 
investigated, the cydAB-encoded bd oxidase was previously characterized in M. 
smegmatis and was shown to be highly expressed under microaerobic conditions (Kana et 
al., 2001). A cydA::aph mutant was attenuated for growth under these conditions, 
suggesting that the pathway terminating in cytochrome c oxidase may serve as the major 
route for respiration under aerobic growth conditions. Therefore the cytochrome bc1-
cytochrome aa3 pathway became the focus of investigation in this study. 
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Figure 6. Genetic composition and organization of the aerobic respiratory chain of M. smegmatis. 
(A) Proposed pathway of electron flow. Solid arrows indicate established pathways and dashed 
arrows represent putative pathways. Various enzyme complexes are denoted by boxes. The 
cytochrome bc1 complex contains a diheme cytochrome c1 (represented as c1c; encoded by qcrC), 
and together with cytochrome c oxidase this complex is proposed to form a supercomplex (fused 
boxes) as is the case in C. glutamicum (Niebisch and Bott, 2001). (B) Genomic organization of 
the genes encoding cytochrome bc1-aa3 pathway. The arrows denote the respiratory pathway 
(black) and neighbouring (grey) genes. The annotation for M. tuberculosis H37Rv is taken from 
Tuberculist (http://genolist.pasteur.fr/TubercuList/), and the annotation for M. smegmatis mc2155 
is from the TIGR Comprehensive Microbial Resource (http://www.tigr.org/tigr-
scripts/CMR2/CMRHomePage.spl). 
Succinate 
dehydrogenase 
Menaquinone 
pool 
Cytochrome 
bc1c complex 
Cytochrome 
c oxidase 
qcrCAB ctaCF, ctaD, ctaE 
NADH 
dehydrogenase 
Cytochrome 
bd oxidase 
Cytochrome 
bd’ oxidase 
ythAB 
cydAB 
Type I: nuoABCDEFGHIJKLMN 
Type II: ndh 
sdhBADC 
trpD ctaE qcrC qcrA qcrB Rv2197c mmpS3 ctaF ctaC asnB 
M. tb 
 
MSMEG4269 
trpD ctaE qcrC qcrA qcrB mmpS3 ctaF ctaC MSMEG4268 asnB 
M. sg 
adhC fecB ctaD serB2 Rv3041c Rv3040c 
M. tb  
MSMEG1025 
MSMEG1029  MSMEG2320 
M. sg  MSMEG1027 
fecB ctaDI serB2 mocR fecB ctaDI serB2 
 
menG tk
kduD MSMEG4435 
ctaDII MSMEG4436 
 67 
Genetic structure of the M. smegmatis cytochrome bc1-aa3 pathway 
The sequences of the M. smegmatis genes in the cytochrome bc1-aa3 pathway were 
obtained as described above. The pathway consists of a qcrCAB-encoded menaquinol-
cytochrome c oxidoreductase (cytochrome bc1), that transfers electrons to the terminal 
cytohrome aa3-type cytochrome c oxidase (cytochrome aa3) encoded by ctaC, ctaD (two 
distinct alleles of which have been found; section 3.1.1), ctaE and ctaF. As demonstrated 
for C. glutamicum (Niebisch and Bott, 2001) and proposed for M. tuberculosis 
(Weinstein et al., 2005), the cytochrome bc1 complex of M. smegmatis contains a diheme 
cytochrome c1 and is also proposed to form a supercomplex with cytochrome aa3. The 
genomic context of these genes (http://www.tigr.org/tigr-scripts/CMR2/ 
CMRHomePage.spl) and the organization of their encoded complexes as determined by 
their roles in electron transfer are illustrated in Figure 6.   
 
3.2 Targeted knockout of genes in the cytochrome bc1-aa3 pathway in  M. 
 smegmatis 
Based on previous studies in other organisms, it was proposed in this study that mutants 
in the components of the cytochrome bc1-aa3 pathway would provide tools to investigate 
the role of individual components of this pathway in growth and control of respiration in 
M. smegmatis. Different mechanisms have previously been proposed that describe the 
role of aerobic respiratory components in sensing and responding to oxygen. In one such 
mechanism it was proposed that when oxygen is not used as the terminal electron 
acceptor, the reduced quinones react with oxygen to form reactive oxygen species, 
sending signals to regulators of oxidative stress (Chandel et al., 2000). A M. smegmatis 
mutant lacking cytochrome bc1 would provide a tool to probe this mechanism as it is 
proposed in this work that blockage of cytochrome bc1 may result in an increase in the 
reduced quinones. Based on their study in M. tuberculosis, Voskiul et al (2003) suggested 
another mechanism in which they proposed that the terminal oxidase, cytochrome aa3 is 
itself the sensor of oxygen availability. The basis for this proposal was the observation 
that the dormancy (DosR) regulon of M. tuberculosis was induced as a result of hypoxia 
or low-dose NO treatment, suggesting a common signal transduction for both. Similar 
proposals had previously been based on studies on paralogous oxidases in yeast (Kwast et 
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al., 1999) and Rhodobacter sphaeroides (Oh and Kaplan, 2000), both of which 
demonstrated the involvement of cytochrome oxidase in oxygen-sensing and signaling 
for hypoxia-induced genes. Therefore it was proposed in the current study that 
cytochrome aa3 mutants would help to investigate whether a similar mechanism exists in 
M. smegmatis.         
 
3.2.1 Construction of a cytochrome bc1 mutant of M. smegmatis 
Initially the qcrCAB-encoded cytochrome bc1 was targeted for disruption by allelic 
exchange mutagenesis. The hypothesis was that disruption of this complex would block 
electron flow to the major terminal oxidase, cytochrome aa3, and therefore have a severe 
impact on the growth of the organism under aerobic conditions. Electroporation of 
pQCRMSKO into M. smegmatis mc2155 gave rise to 3 blue colonies (potential single 
crossovers, SCOs). The clones were analyzed by Southern blot and 2 were confirmed to 
be SCOs (Figure 7), one resulting from a recombination event upstream of qcrCAB and 
the other one from a downstream recombination event. This confirmed that in both clones 
the knockout vector had been site-specifically integrated at the qcrCAB locus of M. 
smegmatis.   
SCO 1 (downstream) was subjected to a counter-selection against the sacB gene 
to identify the product of a second recombination event in which the intervening vector 
sequence was eliminated from the merodiploid strain to produce a DCO recombinant. 
Counter selection by plating on sucrose yielded a total of 5 white, HygR, SucR, KanS 
colonies that were potential double crossovers (DCOs). Interestingly, these colonies did 
not emerge at the same time, and they generally took much longer than the usual time 
(about 3-5 days) to emerge as compared to wild type M. smegmatis. The first colony 
became visible after ±8 days, whereas the other 4 emerged after approximately 14 days 
from the date of plating. All 5 of the DCOs looked morphologically different from M. 
smegmatis wild type colonies, displaying a glossier and smoother appearance compared 
to the usual rough surface morphology of the wild type strain.  
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Figure 7. Site-specific integration of the M. smegmatis qcrCAB knockout vector, pQCRSMKO, 
in the chromosome. (A) A diagrammatic illustration of recombination at the qcrCAB locus (not 
drawn to scale). Recombination either upstream (light-green cross) or downstream (pink cross) of 
the operon results in integration of the entire vector into the chromosome, producing upstream or 
downstream SCO mutant strains, respectively. A subsequent crossover event on the opposite side 
of the operon in either SCO would result in loss of the intervening vector sequence, producing a 
DCO. Double headed arrows indicate ApaI fragments that would cross-hybridize to the 863-bp 
downstream PCR product, dnQcr (hatched box) in a Southern blot. (B) Southern blot analysis of 
ApaI-digested genomic DNA from the three SCOs obtained from electroporation of pQCRSMKO 
into M. smegmatis mc2155, hybridized to Qcr2. SCO1 (lane 1; bands 11.7 and 1.1 kb) and SCO3 
(lane 3; bands 10.2 and 6.8 kb) were confirmed to be downstream and upstream SCOs, 
respectively, based on the ApaI fragments obtained. The genotype of SCO2 (lane 2) could not be 
confirmed. The wild type band is slightly masked by leakage from the control band and is 
indicated by an arrow. 
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Genotypic analysis of the DCO mutants  
The 5 white colonies (potential DCOs) were grown up and characterized genotypically by 
Southern blot analysis. On the wild type M. smegmatis chromosome, the qcrCAB operon 
is flanked on both sides by ApaI restriction sites, enclosing the genes on a 5896 bp ApaI 
fragment. Two more ApaI sites were introduced into the mutant allele by insertion of a 
hyg cassette at the deletion site within qcrCAB (Figures 7A and 8A). Therefore digestion 
of the genomic DNA with this enzyme would be expected to yield a 5896 bp fragment 
from the wild type, and 3012 bp, 1052 bp and 57 bp fragments in the mutant, at this 
locus. ApaI-digested chromosomal DNA from the 5 candidate qcrCAB mutant (referred 
to from here on as ΔqcrCAB::hyg) clones was hybridized with the 878 bp upstream PCR 
product (upQcr) used in the construction of the knockout vector. The results confirmed 
site-specific replacement of the wild type qcrCAB allele with the mutant allele, 
ΔqcrCAB::hyg, in all the 5 clones (Figure 8B). To validate the results, the blot was 
stripped of the bound probe and then hybridized with the downstream PCR product, 
dnQcr. The results of this analysis were consistent with those of the first Southern blot 
(Figure 8C).  
 
3.2.2 Targeted knockout of cytochrome aa3 oxidase subunit I of M. smegmatis 
Based on the high degree of similarity of the mycobacterial cytochrome bc1-aa3 pathway 
to that of the closely related and better studied C. glutamicum, it was proposed that a 
knockout of the terminal oxidase, cytochrome aa3 would have a similar effect as a 
ΔqcrCAB::hyg mutant, on the growth of M. smegmatis as was the case in C. glutamicum, 
in which both ΔqcrCAB and ΔctaD mutants were growth impaired (Niebisch and Bott, 
2001; Bott and Niebisch, 2003). In an effort to generate additional tools with which to 
probe the function of this pathway, the genes encoding the major subunit of cytochrome 
aa3 (subunit I, encoded by ctaD) were also targeted for disruption. Together with the 
ctaC-encoded subunit II, the CtaD subunit is believed to form the functional core of the 
enzyme, bearing all the redox centers. Subunit I of cytochrome aa3 contains the heme a3-
CuB binuclear site where binding and reduction of oxygen occurs, whereas the unique 
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CuA of subunit II provides the primary electron entry point into the enzyme (Hansford, 
2001; Wikström, 2002). 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Allelic replacement of M. smegmatis qcrCAB with the mutant ΔqcrCAB::hyg. (A) 
Schematic representation of the wild type (top) and mutant (bottom) alleles, not drawn to scale. 
An internal deletion (3472 bp) that removed the whole of qcrA, most of the 3’ end of qcrC and 5’ 
end of qcrB (black arrows) was replaced by the inserted hyg marker (white block). Locations of 
the probes used for genotypic characterization of the mutants are shown by the black (upQcr) and 
hatched (dnQcr) boxes above the maps. Chromosomal DNA from an upstream SCO (Figure 7), 
five double crossovers (DCO) and parental wild type (mc2155) was digested with ApaI and 
hybridized with upQcr (B) or dnQcr (C).   
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Targeted knockout of ctaDI in M. smegmatis mc2155 
As described above (section 3.1), genome sequence analysis of M. smegmatis mc2155 
revealed presence of two distinct ctaD homologues, ctaDI and ctaDII, in this strain, one 
of which (ctaDI) exists on the duplicated region of the chromosome. Based on the 
percentage identity to the M. tuberculosis ctaD and on the similarity in their 
chromosomal context, M. smegmatis ctaDI was proposed to be the principal ctaD allele 
encoding subunit I of cytochrome aa3, and therefore was initially targeted for disruption. 
Specific PCR primer sets were designed to clone knockout substrates for allelic exchange 
mutagenesis of this M. smegmatis ctaD homologue. Construction of the knockout vector, 
pCTADISMKO, was carried out as described earlier. The same principle of homologous 
recombination illustrated in Figure 7A applies to all the knockout mutants constructed in 
this study. Electroporation of pCTADISMKO into M. smegmatis mc2155 yielded 1 SCO, 
which upon counter-selection against the sacB gene, gave rise to 2 DCOs. Southern blot 
analysis of these DCOs confirmed site-specific integration of the vector at the ctaDI 
locus, as well as duplication of this gene in M. smegmatis mc2155 (Figure 9A).  
 The analysis revealed the presence, in the mutant isolates, of two cross-
hybridizing bands of 4.6 and 2.6 kb in size, corresponding to the wild type (ctaDI) and 
mutant (ΔctaDI::hyg) alleles respectively (Figure 9A). Due to the duplication of ctaDI, in 
this mutant allelic exchange has occurred at only one of the two ctaDI loci, leaving the 
second locus (4.6 kb band) intact. This mutant strain, with one inactivated and one wild 
type ctaDI alleles, is referred to in this study as ctaDI+/-. In wild type M. smegmatis 
mc2155, the band intensity indicated that this band was a doublet, consistent with 
presence of two copies of the ctaDI gene in this strain (Figure 9A, last lane).  
 Although the first copy of the ctaDI gene could be readily inactivated, attempts to 
create a null ctaDI mutant of M. smegmatis by inactivation of the second copy in strain 
ctaDI+/- were not successful. An aph-marked deletion-insertion allele carried on plasmid 
pGEMCTADIKO was delivered into ctaDI+/- (carrying one DctaDI::hyg allele and one 
wild type allele; Figure 9A), yielding 20 blue colonies (potential SCOs). 
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Figure 9. Genotypic analysis of ctaDI mutants of M. smegmatis mc2155 and ΔDR. Each panel 
shows a schematic representation of the wild type and/or predicted genotypes of mutant alleles 
(not drawn to scale). The gene in which an internal deletion was made is denoted by a black 
arrow, the inserted hyg or aph marker is symbolized by a white block, and the neighboring genes 
are shown as grey arrows. The positions of the restriction enzymes used for Southern blot 
analysis (right) are indicated by vertical arrows, and the probes used are shown as hatched boxes 
above each map. (A) Knockout of one copy of ctaDI in mc2155 to produce strain ctaDI+/- 
(carrying one inactivated ctaDI allele and one wild type allele). The arrow on the right of the blot 
indicates the doublet band in mc2155. N. B. Equal amounts of digested genomic DNA were 
assayed in each lane. (B) SCOs obtained in an attempt to create a null ctaDI mutant in strain ΔDR 
using the aph-marked knockout vector, pGEMCTADIKO. The genotype of these SCOs confirms 
presence of only one copy of ctaDI in this strain, as only two instead of three (panel A) bands 
were obtained.  
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 The aph-marked plasmid pGEMCTADIKO was used instead of the other plasmid 
pCTADISMKO (hyg-marked), used for knockout of the first ctaDI copy in mc2155, to 
avoid recombination between the hyg sequence in pCTADISMKO and that at the 
DctaDI::hyg locus of strain ctaDI+/-. Sixteen of the 20 blue colonies were genotyped and 3 
were confirmed to be site-specific SCOs, 2 upstream and 1 downstream of the wild type 
ctaDI locus of strain ctaDI+/- (data not shown). The remaining clones were the unwanted 
products of futile recombination at the previously inactivated ctaDI locus (ctaDI::hyg) in 
ctaDI+/-. Both up- and downstream SCOs were subjected to sacB counter-selection on 
sucrose, but none of them yielded the desired DCOs. Candidate DCOs were found to be a 
mixture of futile recombinants and spontaneous sacB mutants as assessed by Southern 
blot analysis (data not shown). Because of the differences in the sizes of the hyg and aph 
cassettes used in the knockout vectors as well as the restriction sites available in each, 
Southern blot analysis enabled differentiation between recombinants at either site by the 
sizes of bands obtained, making it easier to distinguish desired crosses from the unwanted 
crosses. 
 
Attempts to create a null ctaDI mutant in M. smegmatis ΔDR  
To try and overcome the complication of unwanted crosses presented by the presence of 
two ctaDI loci, the M. smegmatis strain, DDR, which is a derivative of mc2155 that has 
lost the 56-kb genome duplications (D.F. Warner & V. Mizrahi, unpublished), was used 
as the host strain for ctaDI gene knockout. Since the ctaDI gene is located within the 
genome duplication, the DDR strain carries only one copy of this gene. Numerous blue 
colonies were obtained from electroporation of ΔDR with the knockout vector, 
pGEMCTADIKO, and 16 of these colonies were genotyped by Southern blot analysis. Of 
the 16 blue colonies, 8 were found to be upstream SCOs and 5 were downstream SCOs. 
The genotype of the remaining 3 could not be identified (data not shown), suggesting that 
they may have resulted from rearrangement of the integrated suicide vector. Southern blot 
analysis of the site-specific SCOs revealed the presence of only one chromosomal copy 
of the ctaDI gene (2 cross-hybridizing bands in Figure 9B, lanes 1-3), thus providing 
independent support for the conclusion that ΔDR had lost one of the 56-kb genome 
duplications present in mc2155 (3 cross-hybridizing bands in Figure 9A, lane 1).  
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One of each type of SCO was then subjected to sacB counter-selection to obtain 
DCOs. Approximately 425 blue colonies and only 4 white colonies were obtained from 
sucrose plates of the upstream SCO, and 65 blue colonies (no white colonies) from the 
downstream SCO. Southern blot analysis of these 4 colonies suggested that they were 
spontaneous sacB mutants and not DCOs. The failure to create a null ctaDI mutant of M. 
smegmatis in both ctaDI+/- and ΔDR strains suggested that the gene may be essential. 
Alternatively, this may suggest that the mutation has polar effects on the possibly 
essential serB2 gene (Sassetti et al., 2003) found immediately downstream of ctaDI. The 
serB2 gene is involved in the biosynthesis of serine. In order to explore the possibility 
that a null mutant of ctaDI could not be obtained due to polar effects on serB2 and hence 
a possible serine auxotrophy of such a mutant, sacB-based counter-selection against 
upstream SCOs from both ctaDI+/- and ΔDR strains was carried out by plating on media 
that contained a serine supplement (100 μg/ml) in addition to sucrose. However, the 
presence of the serine supplement had no effect on the outcome of the counter-selection 
step, as no DCOs were obtained from either type of SCO recombinant.  
 
Construction of a ctaDII mutant of M. smegmatis mc2155 
Although the ctaDI gene described above was proposed to be the principal allele coding 
for subunit I of cytochrome aa3, the possibility that the second homologue ctaDII may 
code for the same function or another function important for the growth of M. smegmatis 
could not be excluded based on genome analysis. Therefore in an attempt to dissect the 
role of this alternate subunit I, the ctaDII gene was also targeted for disruption. Contrary 
to the results obtained with ctaDI, a ΔctaDII::hyg mutant was readily obtained. 
Approximately 103 blue colonies were obtained from electroporation of plasmid 
pCTADIISMKO into M. smegmatis mc2155, 8 of which were genotyped and confirmed 
to be upstream (2) and downstream (6) SCOs. Counter selection against a downstream 
SCO yielded 5 candidate DCOs all of which were confirmed by Southern blot analysis to 
be ΔctaDII::hyg mutant clones (Figure 10). The mutant displayed no discernible growth 
phenotype, suggesting that the ctaDII gene is dispensable for the growth of M. 
smegmatis. 
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Figure 10.  Allelic exchange mutagenesis of ctaDII in M. smegmatis mc2155. (A) A schematic 
representation of the wild type and mutant alleles (not drawn to scale). The gene in which an 
internal deletion was made is denoted by a black arrow, the inserted hyg marker is symbolized by 
a white block, and the neighboring genes are shown as grey arrows. The positions of the 
restriction enzyme, PvuI, used for Southern blot analysis (B) are indicated by vertical arrows. The 
location of the probe, upD2 (upstream PCR product used in the construction of the knockout 
vector, pCTADIISMKO), is shown as hatched boxes above each map. N.B. The two bands (1.6 
and 1.3 kb) present in all the lanes are due to a partial digestion with PvuI. The clones were 
independently confirmed in another Southern blot using NruI (data not shown).  
 
 
3.2.3 Construction of a M. smegmatis cytochrome aa3 knockout mutant lacking 
 subunit II (CtaC) 
Given the difficulties in inactivating the ctaDI gene, an alternative strategy was used to 
disrupt the aa3-type cytochrome c oxidase of M. smegmatis, which involved knockout of 
the ctaC gene, which encodes subunit II of this enzyme. A similar experimental approach 
as was used for allelic exchange mutagenesis of the qcrCAB and ctaD genes was 
employed to construct a hyg-marked ctaC mutant using the knockout vector, 
pCTACSMKO (Table 2). Both up- and downstream SCOs were obtained from 
electroporation of the vector into M. smegmatis mc2155 (Figure 11). Sucrose selection 
from a downstream SCO yielded 10 potential DCOs, only 2 of which showed the correct 
phenotype (white, HygR, SucR and KanS). These 2 candidate clones were confirmed by 
Southern blot analysis to be ΔctaC::hyg mutants (Figure 11). 
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Figure 11. Construction of a ctaC deletion mutant of M. smegmatis. (A) A schematic 
representation of the wild type and mutant ctaC alleles, not drawn to scale. A deletion in the wild 
type gene (top; black arrow) was replaced by insertion of a hyg marker cassette (bottom; white 
block). Locations of the enzyme and probe (hatched box) used for Southern blot analysis are 
shown on the map. (B) Genotypic confirmation of mutants by Southern blot analysis.  SalI-
digested chromosomal DNA from up- and downstream single crossover recombinants (upSCO 
and dnSCO, respectively), double crossover (DCO) mutants and the parental wild type (mc2155) 
was hybridized to a 1.1 kb downstream PCR product (dnCtaC) used in the construction of the 
knockout vector.  
 
 
3.2.4  Targeted knockout of genes in the cytochrome bc1-aa3 respiratory pathway in  
 M. tuberculosis  
The above results have demonstrated that the M. smegmatis cytochrome bc1 complex and 
cytochrome c oxidase can be inactivated. Therefore, the ultimate goal was to generate 
equivalent mutants in M. tuberculosis and use these to probe the function of this pathway 
and its possible role in M. tuberculosis pathogenesis. Previous attempts to create a 
qcrCAB deletion mutant of M. tuberculosis in an independent study had failed. Although 
SCO recombinants on both sides of the locus were obtained, no DCOs were recovered 
following counter-selection against an upstream SCO (Matsoso et al., 2005). To increase 
the likelihood of identifying potentially growth-impaired mutants in this pathway, the 
ctaC-encoded subunit II of M. tuberculosis cytochrome c oxidase was targeted for allelic 
exchange mutagenesis.  
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Figure 12. Targeted knockout of cytochrome c oxidase subunit II (encoded by ctaC) in M. 
tuberculosis H37Rv. (A) A schematic representation of the wild type ctaC allele on the 
chromosome (top), and the two types of single crossovers (SCO) (bottom) resulting from 
homologous recombination of the knockout vector, pQCRTBKO, upstream or downstream of 
ctaC , respectively. Shown on the maps are locations of restriction enzymes and probe (hatched 
box) used in Southern blot analysis. (B) Genotypic characterization of SCO by Southern blot 
analysis. Chromosomal DNA from three SCOs (SCO 1-3) and wild type (H37Rv) was digested 
with SalI and SphI, and hybridized to a 1.9 kb downstream PCR product (probe) used in the 
knockout construct (vector). N.B Due to a very weak signal, the wild type band (*) was not 
visible on the scan.  
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 Following electroporation of the knockout vector, pQCRTBKO (Table 2), into M. 
tuberculosis H37Rv, approx 328 potential SCOs were obtained, and 3 of them were 
genotyped using Southern blot analysis. Two were confirmed to be upstream SCOs 
whereas the third one was a downstream SCO (Figure 12). All 3 SCOs were subjected to 
counter-selection on plates containing sucrose and Hyg, and plates were incubated at 
37°C for more than twice the normal length of time (54 vs 21 days). However, no DCOs 
were recovered; all clones obtained from upstream (25/25) and downstream SCOs 
(40/40) were KmR, suggesting that they were all spontaneous sacB mutants. 
 
3.3 Phenotypic analysis of M. smegmatis cytochrome bc1 and aa3 mutants 
3.3.1 ΔqcrCAB::hyg and ΔctaC::hyg mutants are attenuated for growth 
To ascertain whether the loss of cytochrome bc1 or aa3 complexes affected the growth of 
M. smegmatis, the bc1-aa3 pathway mutants (ΔqcrCAB::hyg and ΔctaC::hyg) and their 
parental wild type strain (mc2155) were grown as liquid cultures in MADC-Tw under 
aerobic conditions on a rotary shaker (350 rpm, 37°C). Growth was assessed by 
monitoring the optical density of the culture at 600 nm. The ΔqcrCAB::hyg (Figure 13A 
and B) and ΔctaC::hyg (Figure 13B) mutants both showed growth impairment under 
these conditions, with a more than two-fold decrease in the growth rate compared to their 
parental wild type. The growth defect was exacerbated on solid medium, with pin-prick 
colonies taking a minimum of 6 days (Figure 13D). In a separate experiment, 2 of the 5 
different isolates of ΔqcrCAB::hyg (Figure 8B) were grown independently alongside the 
wild type to ensure that the phenotype observed was consistent in both isolates (Figure 
13A). Both ΔqcrCAB::hyg isolates tracked one another closely through all stages of 
growth, demonstrating that the growth defect observed was indeed a result of the qcrCAB 
mutation, and clone 2 was selected for further experiments.  
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Figure 13. Growth of cytochrome bc1 and aa3 mutants of M. smegmatis under aerobic conditions. 
(A to C) Growth in liquid medium. Strains were grown at 37°C in shaking flasks (350 rpm) in 
MADC-Tw medium and growth was followed by monitoring the absorbance at 600 nm (OD600). 
ΔqcrCAB::hyg clones 2 (▲) and 5 (■); ΔctaC::hyg (■); ctaDI+/- (■); ctaDII::hyg (▲); wild type 
mc2155 (¨). Initially two independent ΔqcrCAB::hyg isolates were analyzed to ensure that the 
phenotype was indeed a result of the mutation (A). Subsequently growth of ΔctaC::hyg is 
compared to that of ΔqcrCAB::hyg and their parental wild type (B). The growth curves are 
representative of at least two independent experiments. (C) Growth of the single ctaD mutants 
(ctaDI+/- and ctaDII::hyg) was also compared to that of the wild type. (D) Growth of 
ΔqcrCAB::hyg on solid medium. Strains were grown oxystatically (21% air saturation) in 
MADC-Tw in a New Brunswick Scientific Bioflow 110 fermentor and aliquots were withdrawn 
and plated on LA. Plates were incubated at 37°C for 3 d (wild type) or 6-8 d (mutant).  
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In contrast, growth of the ctaDI single mutant (ctaDI+/-) and the ctaDII mutant 
(ΔctaDII::hyg) was found to be indistinguishable from that of the wild type as already 
mentioned above (Figure 13C). Nonetheless, this observation was not unexpected as both 
mutants still have a functional copy of ctaDI, implying that they were still able to 
synthesize a functional cytochrome c oxidase. 
 
3.3.2 Complementation of the M. smegmatis ctaC mutant with M. tuberculosis ctaC 
The M. smegmatis ctaC gene shows 77% identity to its M. tuberculosis homologue at the 
amino acid level, suggesting a close functional relationship between these two proteins. 
In order to investigate the feasibility of reversing the growth defect of the M. smegmatis 
cytochrome aa3 mutant, DctaC::hyg, a complementing vector carrying a functional M. 
tuberculosis ctaCF operon plus flanking sequence was electroporated into this mutant. 
Integration of the vector at the attB locus was confirmed by PCR analysis (Figure 14A). 
The resulting merodiploid strain, ΔctaC::hyg attB::ctaC, was analyzed under the same 
conditions in which the DctaC::hyg mutant strain had been shown to be attenuated in 
growth. Genetic complementation of ΔctaC::hyg partially reversed the growth phenotype 
(Figure 14B). 
 
3.3.3 Over-expression of cytochrome bd oxidase compensates for loss of the bc1 
complex 
In a previous study from this laboratory, Kana et al. (2001) showed that M. smegmatis 
possesses a cydAB-encoded cytochrome bd oxidase which is induced under microaerobic 
conditions. A reporter strain that carried a cydA’::lacZ transcriptional fusion integrated at 
the cyd locus of M. smegmatis was analyzed oxystatically over a range of oxygen 
tensions to determine the dependence of cyd expression on air saturation. This 
transcriptional fusion carries a promoter-less lacZ gene under the control of the cyd 
promoter.  cyd expression was found to increase two- to three-fold between 5% and 0.5% 
air saturation  (Kana et al., 2001). 
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Figure 14. Complementation of M. smegmatis ctaC mutant with M. tuberculosis ctaC gene 
carried on pMVCTAC. (A) Diagrammatic illustration of the integration of the vector at the attB 
locus of M. smegmatis ΔctaC::hyg mutant (left). Site-specific integration of pMVCTAC was 
confirmed by PCR amplification of the resulting attL and attR regions (right). Locations of 
primers used to amplify attL and attR are shown as black arrow heads below the map. (B) Growth 
analysis of the complemented strain, ΔctaC::hyg attB::ctaC, under aerobic conditions. Strains 
were grown at 37°C in shaking flasks (350 rpm) in MADC-Tw medium and growth was followed 
by monitoring the absorbance at 600 nm (OD600). ▲, ΔctaC::hyg attB::ctaC; ■, ΔctaC::hyg; ¨, 
wild type mc2155. 
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 Based on genome analysis, M. smegmatis contains at least three terminal oxidases 
– the aa3-type cytochrome c oxidase demonstrated in this study as the major oxidase 
under aerobic conditions, cytochrome bd oxidase previously demonstrated to be required 
for microaerobic growth (Kana et al., 2001), and the putative cytochrome bd’, whose 
function has yet to be investigated. Having established the viability, albeit severe 
attenuation, of the cytochrome bc1 and cytochrome aa3 mutants, it was imperative to 
investigate the effects, on the expression of the bd-type quinol oxidase, of the loss of 
functionality in the cytochrome bc1-aa3 pathway under various oxygen tensions.  
 To determine the effect of loss of the bc1 complex on expression of cytochrome 
bd oxidase, a similar approach as described above was adopted. A reporter strain that 
carries a cydA’::lacZ transcriptional fusion (Kana et al., 2001), site-specifically integrated 
at the cyd locus of the M. smegmatis ΔqcrCAB::hyg mutant, was constructed. The 
reporter plasmid, pBK4, used in the analysis of cyd expression in wild type mc2155 
(Kana et al., 2001) was electroporated into the ΔqcrCAB::hyg strain. The genotype of 7 
KmR transformants recovered from the electroporation was confirmed by Southern blot 
analysis (Figure 15A) and one clone was selected for further analysis.  
Levels of b-galactosidase in the recombinant strain DqcrCAB::hyg::pBK4, were 
analyzed under aerobic and microaerobic conditions (21, 5 and 1% air saturation, 
respectively) and were compared with those observed in the control strain, 
mc2155::pBK4, in which the same transcriptional fusion was integrated at the cyd locus 
of the parental wild type (Kana et al., 2001). Both strains were grown oxystatically in a 
New Brunswick Scientific Bioflow 110 fermentor as described in section 2.2.4. For each 
reporter strain, at least two independent experiments were performed at each air 
saturation level and specific activity was determined based on four time points (samples 
in duplicate at each time point) per experiment. 
Up-regulation of the cyd promoter was observed in the wild type strain under 
micoraerobic conditions (Figure 15B). This observation was consistent with previous 
results (Kana et al., 2001). Importantly, a marked increase in expression of the cyd 
operon was observed in the ΔqcrCAB::hyg mutant over the air saturation range tested (1-
21%). The difference in the level of cyd expression between the wild type and mutant 
strain was significant under all conditions tested (P < 0.0001).  
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Figure 15. Effect of cytochrome bc1 disruption on expression of the cyd operon in M. smegmatis. 
(A) Genotypic characterization of the cyd reporter strain, DqcrCAB::hyg::pBK4. Genetic 
organization of the cydA-lacZ fusion construct at the cyd locus of DqcrCAB::hyg is schematically 
illustrated to the left of the panel. The hatched arrows denote the putative cyd promoter, Pcyd, 
carried both on the reporter construct and natively on the chromosome. Southern blot analysis 
was carried out to confirm site-specificity of pBK4 integration into the chromosome (right). 
Chromosomal DNA from 7 candidate clones of DqcrCAB::hyg::pBK4 and mc2155 was digested 
with EcoRI and SphI, and then probed with a 2.6 kb PstI fragment from the cyd locus of M. 
smegmatis mc2155. (B) Expression analysis of the cyd operon in the wild type (yellow bars) and 
DqcrCAB::hyg (dark red bars) strains. The same data for wild type were plotted on a different 
scale (to the right of the panel). Specific activity was assessed at 21, 5 and 1% air saturation. All 
assays were performed in duplicate and the data shown represent the averages and SD of at least 
two independent experiments. Unpaired t tests were performed on the data to determine statistical 
significance (p<0.0001).  
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However, comparison of cyd expression levels in the mutant strain under 
conditions of varying O2 availability revealed no induction under microaerobic conditions 
above the basal expression level observed under full aeration. These results confirm that 
the loss of cytochrome bc1 resulted in constitutive over-production of the bd-type oxidase, 
and suggest that electron flow from the menaquinone pool is re-routed through the quinol 
oxidase pathway of the aerobic respiratory chain in this mutant. 
 
3.3.4  Attempts to construct a cytochrome bc1/ cyotochrome bd double mutant of  
M. smegmatis 
Based on the compensatory over-expression of the cytochrome bd oxidase observed in 
mutants lacking the bc1 complex (ΔqcrCAB::hyg; Figure 15) and the severe growth defect 
exhibited by this mutant, it was proposed that a mutant in which both the cytochrome bc1-
aa3 and bd  branches of the respiratory chain were blocked would be non-viable. To test 
this hypothesis, attempts were made to create such a double mutant. The cytochrome bc1 
mutant, ΔqcrCAB::hyg, was electroporated with the knockout vector, pCYDAKO, 
previously used to create a cytochrome bd mutant of M. smegmatis (Kana et al., 2001), 
and 2 SCOs were obtained. Both SCOs were confirmed to be site-specific by Southern 
blot analysis (data not shown), and were both passaged through sucrose selection. Despite 
incubating the plates for an extended period of time (20 days), no white SucR colonies 
were obtained from either SCO but only several blue colonies, suggesting that the double 
mutant was not viable. If this is true, it implies that the other putative cytochrome bd 
oxidase (encoded by ythAB homologues), if at all functional, may not be able to sustain 
aerobic growth of M. smegmatis on its own. 
 
3.3.5 Genome expression profiling of the cytochrome bc1 (ΔqcrCAB::hyg) and 
 cytochrome aa3 (ΔctaC::hyg) mutants  
To gain insight into the consequences of blockage of the cytochrome bc1-aa3 aerobic 
respiratory pathway in M. smegmatis, comparative expression profiling of the mutant 
strains was performed by DNA microarray analysis. A partial-genome microarray 
containing the M. smegmatis homologues of all M. leprae genes and a selection of other 
genes, including the homologues of M. tuberculosis genes not found in M. leprae as well 
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as genes which have no homologues in either M. tuberculosis or M. leprae. The subset of 
respiratory pathway genes included on this array is listed in Table 4. During the course of 
this study, a full genome oligonucleotide array became available from the Pathogen 
Functional Genome Resource Center (PFGRC) at TIGR (http://pfgrc.tigr.org/). The same 
samples as used with the partial-genome amplicon array were therefore analyzed using 
the whole-genome oligo array. The results obtained with both types of array are presented 
below. Data analysis of the three replicate arrays (partial amplicon arrays) on 
ΔqcrCAB::hyg mutant was carried out as described in Section 2.2.5, and subsequently 
confirmed by an independent analysis, which was performed by Dr. D. Powell, Victorian 
Bioinformatics Consortium, Australia, as described in Section 2.2.5. The results 
summarized in all of the tables except for Tables 8, D1 and D2 (which were produced on 
the basis of Dr. D. Powell’s analysis) were analyzed and produced by the investigator as 
described in Section 2.2.5. 
 
Differential gene expression profiling of the ΔqcrCAB::hyg mutant of M. smegmatis 
using a partial-genome amplicon microarray  
Cultures of the mutant and wild type strains were grown oxystatically at full aeration 
(21% air saturation) to an OD600 of 0.6 and RNA was extracted. For each experiment, 
Cy5-labeled cDNA of the mutant was hybridized against Cy3-labeled cDNA from the 
wild type. The data from the biological replicates were analyzed, and the analysis was 
subsequently validated by Dr D. Powell. Importantly, both analysis methods produced a 
comparable list of differentially expressed (DE) genes. According to Powell’s analysis, a 
total of 78 genes were found to be DE in the ΔqcrCAB::hyg mutant, 42 of which were up-
regulated and 36 down-regulated. The top ranked genes with expression fold change 
greater than or equal to 1.8 are listed in Table 8. The complete lists of up-regulated 
(Table D1) and down-regulated (Table D2) genes are provided in Appendix D. 
 The majority of the up-regulated genes (52%) are involved in intermediary 
metabolism and respiration. Importantly, the presence of cydA in this group of DE genes 
was independently validated by the marked induction of cyd expression in the 
ΔqcrCAB::hyg mutant strain, as had been deduced using the cydA’::lacZ reporter assay 
(Figure 15). Other up-regulated genes included uspL and the M. smegmatis homolog of 
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MSMEG3205 (Rv1592c), which were previously shown to be induced in response to 
hypoxia in M. tuberculosis (uspL and Rv1592c; Sherman et al., 2001; Boshoff et al., 
2004; Park et al., 2003) and in M. smegmatis (uspL; O’Toole et al; 2003a). The marked 
up-regulation of mihF in the ΔqcrCAB::hyg mutant was also notable as this gene is up-
regulated in M. smegmatis just prior to stationary phase and may be involved in the 
expression of genes required for stationary phase survival (Pedulla and Hatfull, 1998). 
Because of the stringency of the statistical analysis applied to generate the list of DE 
genes shown in Tables 8, D1 and D2, some of the genes that were found to be 
significantly DE by my analysis were excluded on statistical grounds (data not shown). 
Among these excluded genes were ML2440 (senX3), which was significantly up-
regulated in 2 of the 3 biological replicates. Since the analysis method (Powell’s) used to 
generate the above-mentioned Tables calculated significance based on the number of 
replicate spots, inclusion of the third biological replicate rendered the differential 
expression of this gene insignificant. Similarly, some members of the DosR regulon such 
as dosR, hspX and acg were also DE on the partial-genome amplicon array based on my 
analysis, but failed to meet statistical requirements for inclusion on this list.  
 In contrast, many of the down-regulated genes (Tables 8 and D2) are involved in 
information pathways (transcription and DNA repair) and in cell wall and cell processes. 
The most highly down-regulated gene was lytB (MSMEG5208). This gene is involved in 
the non-mevalonate pathway for the biosynthesis of terpenoids (Rohdich et al., 2002) and 
its down-regulation may thus affect the biosynthesis of menaquinone in the 
ΔqcrCAB::hyg mutant. The principal sigma (σ) factor-encoding gene, sigA (Gomez et al., 
1998), was also markedly down-regulated in the ΔqcrCAB::hyg mutant, which is 
significant in light of the down-regulation of sigA that occurs in M. tuberculosis during 
anaerobiosis (Kendall et al., 2004; Boshoff et al., 2005). 
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Table 8. Genes differentially expressed in aerobically grown ΔqcrCAB::hyg mutant of M. smegmatis (as analyzed by D. Powell) 
IDa Gene TIGR annotationb Functionc Md 
P 
value Classe 
Upregulated genes      
ribA ribA2 MSMEG3082 GTP cyclohydrolase II, riboflavin biosynthesis  -2.301 0.0020 7 
ML2274  MSMEG3498 Probable conserved secreted protein -1.914 0.0072 3 
mihF mihF MSMEG3063 Putative integration host factor -1.764 0.0003 2 
glgC glgC MSMEG5067 glucose-1-phosphate adenyl-transferase -1.753 0.0072 7 
ML1835  MSMEG6527 CHP -1.556 0.0030 10 
ML0510  MSMEG3035 probable oxidoreductase -1.444 0.0004 10 
ML0886  MSMEG4257 possible glycosyl transferase -1.430 0.0024 7 
ML1312  MSMEG4598 CHP -1.229 0.0001 10 
argD-g argD MSMEG2446 probable acetylornithine aminotransferase -1.027 0.0033 7 
gabD-q gabD MSMEG2554 probable aldehyde dehydrogenase  -1.005 0.0052 7 
Rv3134c uspL MSMEG5230 Universal stress protein -0.990 0.0098 10 
Rv1623c cydA MSMEG3243 Cytochrome bd oxidase subunit I -0.931 0.0069 7 
ML1926  MSMEG0828 putative tuberculin-related protein -0.915 0.0058 3 
Rv1592c  MSMEG3205 CHP -0.878 0.0016 10 
ML1783  MSMEG4344 Possible transcriptional regulatory protein -0.849 0.0080 9 
Downregulated genes      
lytB2 lytB MSMEG5208 probable LytB-related protein, LytB2 3.316 0.0002 3 
xseA xseA MSMEG5210 exo-deoxyribonuclease VII, large subunit 2.737 0.0003 2 
ML2088-a  MSMEG4807 putative cytochrome P450 2.039 0.0004 7 
ctpC-a  MSMEG5384 cadmium-translocating P-type ATPase 1.789 0.0081 3 
rpoT sigA MSMEG2759 RNA polymerase sigma factor, SigA 1.513 0.0000 2 
rplE rplE MSMEG1464 ribosomal protein L5 1.198 0.0002 2 
ML2661-e fadD7 MSMEG3702 Fatty acid CoA ligase, FadD7 1.197 0.0051 1 
Fpg fpg MSMEG2417 formamidopyrimidine-DNA glycosylase 0.961 0.0078 7 
ML1750   MSMEG2202 CHP 0.922 0.0098 10 
a Gene identifier as defined in the MIAME compliance file (http://vbc.med.monash.edu.au/~powell/M.smegamtis).  
b TIGR annotation (http://www.tigr.org/tigr-scripts/CMR2/CMRHomePage.spl). 
c Function as per Tuberculist and Leproma (http:genolist.pasteur.fr).  d M, log base 2 of the fold ratio 
e Functional class as per Tuberculist: 1, Lipid metabolism; 2, Information pathways; 3, Cell wall & cell processes; 6, PE/PPE; 7, Intermediary metabolism & respiration; 9, 
Regulatory proteins; 10, Conserved hypothetical protein (CHP).
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Differential gene expression profiling of the ΔqcrCAB::hyg mutant using a whole-genome 
oligo array of M. smegmatis 
To obtain a broader reflection of the adaptations of M. smegmatis in response to blockage 
of cytochrome bc1 complex, the same RNA samples used for the amplicon array were 
then analyzed using the whole-genome oligo array from TIGR, using the same method of 
labeling, hybridization and slide preparation as was used for the amplicon array, with 
only one modification. Whereas the amplicon array slides were boiled for 2 min prior to 
pre-hybridization (section 2.2.5), this step was skipped with the TIGR array slides as it 
was found to cause streaking of the spots. However, a significant number of spots were 
found to be missing or bad on the TIGR array and there was relatively lower spot 
intensity as well as higher background hybridization on these slides than on the amplicon 
arrays, rendering a lot of spots unusable. Two of the three biological replicates of the 
ΔqcrCAB::hyg mutant vs wild type were analyzed on the whole-genome array. The list of 
DE genes was in agreement with the results obtained from the amplicon array, with 
several more genes found to be DE on the whole-genome TIGR array. A list of the top 29 
genes up-regulated in the mutant in both biological replicates is shown in Table 9. Of 
these 29 genes, 11 have previously been shown to be induced by hypoxia in M. 
tuberculosis (nadA, acg, hspX, uspL, MSMEG5215 [Rv1738]4, MSMEG3958 [Rv3127], 
MSMEG5228 [Rv3129], tgs1 [Rv3130c] (Sherman et al., 2001 and Park et al., 2003); 
MSMEG0364 [Rv0241c], MSMEG3847 [Rv1628c] (Sherman et al., 2001, 
supplementary data); and glgE [Rv1327c], (Park et al., 2003, supplementary data)). 
Seven of these hypoxically induced genes require the transcription factor DosR for 
induction (acg, hspX, uspL, Rv1738, Rv3127, Rv3130c (Park et al., 2003; Kendall et al., 
2004); and Rv3129 (Park et al., 2003; Voskuil et al., 2004)). The eighth gene, dosT, 
encodes an alternative sensor kinase that can autophosphorylate in response to hypoxia 
and subsequently activate the cognate regulator dosR in M. tuberculosis (Roberts et al., 
2004). DosR-dependent hypoxia-induction of some of these genes – acg, hspX, uspL - 
and four others, dosR, dosS, uspM and uspN, has also been reported in M. smegmatis 
(hspX, uspL, (Mayuri et al., 2002 and O’Toole et al., 2003a); dosR, dosS (Mayuri et al., 
                                                 
4 Where gene names are not known, the MSMEG numbers and their corresponding Rv homologues are 
given for cross-referencing. 
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2002); acg, uspM, and uspN (O’Toole et al., 2003a)). Also substantiated on these arrays 
is the up-regulation of cydA in the ΔqcrCAB::hyg mutant, once again demonstrating the 
constitutive expression of this gene as observed in the reporter analysis and on the partial-
genome amplicon microarray. Due to missing spots on all the TIGR arrays used, the up-
regulation of senX3 and mihF observed on the amplicon arrays could not be confirmed. 
 
Table 9. Genes induced in aerobically grown ΔqcrCAB::hyg mutant of M. smegmatis as 
analyzed on the whole-genome microarray (TIGR) 
Name Gene Description (as per TIGR) LRa SDb 
Closest 
Rv #c 
BLASTd 
E-value 
ORFA06621  conserved hypothetical protein 6.44 0.74 Rv3127 [3e-87] 
ORFA02305  alcohol dehydrogenase II 4.68 0.16 Rv1808 [0.036] 
ORFA06592 hspX heat shock protein, Hsp20 family 4.26 0.13 Rv2031c [2e-46] 
ORFA02970  STAS domain protein 3.22 0.07 Rv0516c [4e-07] 
ORFA10188  hypothetical protein 3.11 0.08 Rv1638 [0.52] 
ORFA08628 dosT GAF domain protein 3.03 0.06 Rv2027c [1e-162] 
ORFA08635 uspL universal stress protein family domain protein 2.93 0.06 Rv2028c [1e-48] 
ORFA08106 glgE probable glucanase GlgE 2.81 0.19 Rv1327c [0.0] 
ORFA02989  conserved hypothetical protein 2.76 0.12 Rv1111c [0.040] 
ORFA11060   hypothetical protein 2.63 0.11 Rv2228c [0.55] 
ORFA05331 treY glycosyl hydrolase, family 13 2.54 0.27 Rv1563c [1e-128] 
ORFA10672  hypothetical protein 2.50 0.04 Rv0683 [2.4 
ORFA08629 tgs1 triacyl glycerol synthase 2.32 0.06 Rv3130c [1e-127] 
ORFA08613  conserved hypothetical protein 2.30 0.00 Rv1738 [8e-04] 
ORFA10419  conserved hypothetical protein 2.28 0.05 Rv1210 [0.86] 
ORFA05419 cydA Cytochrome BD-I oxidase subunit I 2.20 0.03 Rv1623c [0.0] 
ORFA00097 cfp10 10 kDa culture filtrate antigen Lhp (CFP10) 2.18 0.38 Rv3874 [5e-21] 
ORFA08382 glgC glucose-1-phosphate adenylyltransferase 2.17 0.04 Rv1213 [0.0] 
ORFA04061  4-aminobutyrate aminotransferase 2.16 0.05 Rv3329 [6e-52] 
ORFA01654 trcR response regulator DrrA 2.14 0.02 Rv1033c [9e-41] 
ORFA05358 nadA quinolinate synthetase complex, A subunit 1.93 0.05 Rv1594 [1e-172] 
ORFA00098 esat6 early secretory antigen target 1.72 0.13 Rv3876 [2e-29] 
ORFA08113  
4-hydroxyphenylpyruvate dioxygenase C 
terminal 1.48 0.05 Rv1322 [7e-60] 
ORFA00617  MaoC domain protein 1.44 0.01 Rv0241c [1e-112] 
ORFA09559  metallo-beta-lactamase superfamily domain  1.37 0.07 Rv0786c [3e-55] 
ORFA08638 acg conserved hypothetical protein 1.33 0.04 Rv2032 [2e-95] 
ORFA05950 bfrA Bacterioferritin 1.15 0.01 Rv1876 [3e-78] 
ORFA08631  probable aminotransferase 1.15 0.00 Rv3129 [5e-30] 
ORFA00682  hypothetical protein 1.09 0.05 Rv1628c [0.87] 
a LR, log base 2 of the fold ratio 
b SD, standard deviation 
c,d BLAST search results for the M. tuberculosis H37Rv homologues of the M. smegmatis genes on the TIGR array was 
kindly provided by Prof. N. Stoker (Royal Veterinary College, London, UK). 
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Table 10. Genes induced in aerobically grown ΔctaC::hyg mutant of M. smegmatis 
(partial-genome array) 
IDa Gene  Function as per Leproma & TubercuList LRb SDc 
Induced genes     
ml0886 * pimA alpha-mannosyl transferase 2.82 0.11 
ML2440* senX3 two-component sensor histidine kinase 2.81 0.28 
ml1312*  CHP 2.33 0.52 
ML0778  CHP 1.73 0.96 
mihF* mihF putative host integration factor 1.66 0.48 
Rv1592c*  CHP 1.64 0.16 
ftsW ftsW putative cell division protein 1.61 0.19 
ml0893*  probable integral membrane protein 1.56 0.37 
ribA ribA probable riboflavin biosynthesis protein 1.55 0.81 
Rv1623c* cydA cytochrome bd oxidase subunit I 1.48 0.44 
polA-a polA DNA polymerase 1.46 0.27 
ml1103-b  probable oxidoreductase 1.45 0.47 
ML1030  CHP 1.28 0.36 
ML2010*  CHP 1.26 0.10 
thrC  probable threonine synthase 1.25 0.10 
ml2137  CHP 1.24 0.10 
ML2568  possible transcriptional regulatory protein (TetR family) 1.23 0.10 
ML1165  CHP 1.23 0.26 
yrbE1-b  conserved hypothetical integral membrane protein 1.21 0.36 
ml0596-a* csd probable cysteine desulfurase 1.19 0.28 
ML1391*  CHP 1.19 0.09 
Rv1622c cydB cytochrome bd oxidase subunit II 1.14 0.33 
ml0759 fbiA probable F420 biosynthesis protein 1.13 0.13 
ml1835  CHP 1.11 0.13 
PPE-b* PPE68 PPE family domain 1.11 0.10 
ml1714  CHP 1.10 0.07 
ML0271  possible conserved transmembrane protein 1.07 0.18 
pstA1 pstA1 phosphate-transport integral membrane ABC transporter 1.01 0.32 
ml2631-c  CHP 1.00 0.14 
ML0158  34 kDa antigen 0.97 0.06 
menD menD bifunctional menaquinone biosynthesis protein 0.94 0.13 
Rv3134c* uspL universal stress protein 0.93 0.16 
glnA2-e glnA2 probable glutamine synthetase 0.91 0.21 
Rv2028c* uspL universal stress protein 0.89 0.04 
rhlE-a rhlE probable ATP-dependent RNA helicase 0.82 0.14 
Repressed genes     
rnpA* rnpA ribonuclease P protein -4.50 1.12 
rplE  ribosomal protein L5 -1.63 0.78 
gabD-k gabD probable aldehyde dehydrogenase -1.42 0.18 
argD-a argD probable acetylornithine aminotransferase -1.16 0.33 
ML2609  CHP -1.08 0.08 
ML1115 lprB possible lipoprotein -1.05 0.14 
rpsC rpsC ribosomal protein S3 -1.02 0.12 
* DE in all three biological replicates, whereas the rest of the genes are DE in at least two of the three replicates  
 a Gene identifier as defined in the MIAME compliance file (http://vbc.med.monash.edu.au/~powell/M.smegamtis).  
b LR, log base 2 of the fold ratio.  c SD, standard deviation 
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Transcriptome analysis of the cytochrome aa3 mutant using the amplicon array 
Comparative expression profiling of aerobically grown ΔctaC::hyg mutant and its 
parental wild type was carried out using the partial-genome amplicon array. As was 
observed for the ΔqcrCAB::hyg mutant, this analysis also revealed a significant up-
regulation of the cydAB genes in the ΔctaC::hyg mutant strain, demonstrating that 
blockage of the cytochrome bc1-aa3 pathway at either complex generates a common 
signal that results in up-regulation of cydAB. This induction was accompanied by an even 
more profound up-regulation of senX3 (ML2440) in all the three biological replicates 
(Table 10). In general, a comparable list of DE genes was obtained for both the 
ΔqcrCAB::hyg and ΔctaC::hyg mutants, with a few exceptions. Among the common DE 
genes in the two mutant strains was mihF, which was previously shown to be required for 
stationary phase survival and viability of M. smegmatis (Pedulla et al., 1998). Also 
observed in both mutants (Tables 10, and D1 [Appendix D]) was an induction of PPE2, a 
dosR-dependent gene previously reported to be induced in standing cultures of M. 
tuberculosis (Kendall et al., 2004). Interestingly the most highly down-regulated gene in 
the ΔqcrCAB::hyg mutant, lytB2, was not DE in the DctaC::hyg mutant. As mentioned 
earlier, this gene is involved in the synthesis of menaquinone, and its down-regulation in 
the ΔqcrCAB::hyg mutant but not ΔctaC::hyg mutant may highlight the different effects, 
on the quinone pool, of electron backup at different points along the cytochrome bc1-aa3 
pathway.  
 
3.3.6 Effects of chlorpromazine on the transcriptomes of the bc1 and aa3 mutants 
Analysis by DNA microarray  
The phenothiazine, chlorpromazine (CPZ), has previously been shown to act on the 
respiratory chain of M. tuberculosis (Boshoff et al., 2004; Weinstein et al., 2005), by 
inhibiting the activity of the ndh- and ndhA-encoded type II NADH dehydrogenases 
(Weinstein et al., 2005). To investigate the effects of altering the redox state of the 
menaquinone pool on gene expression in the bc1-aa3 pathway mutants, the DqcrCAB::hyg 
and DctaC::hyg mutants were treated for 1 h with 50 μg/ml of CPZ before harvesting for 
RNA extraction. This concentration of drug was chosen based on the observation that the 
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growth of M. smegmatis is inhibited by CPZ in a dose-dependent manner, with a 
minimum inhibitory concentration (MIC) of 9.23 μg/ml, whereas four-fold this 
concentration (35.5 μg/ml) completely inhibited growth  over 48 h (H. Rubin and E. D. 
Weinstein et al, unpublished). Therefore, it was proposed in this study that treating M. 
smegmatis with a higher dose (50 μg/ml) of the drug for a shorter period of time (1 h) 
would be enough to disrupt the flow of electrons from NADH into the menaquinone pool, 
without killing the organism. The effects of this treatment on gene expression in the 
mutant strain were analyzed by comparative gene expression profiling of the CPZ-treated 
culture against an untreated control using the partial-genome amplicon array. Cy5-labeled 
cDNA from the CPZ-treated mutant strain was co-hybridized with Cy3-labeled cDNA 
from the untreated mutant control. Among the genes whose expression was significantly 
up-regulated by CPZ in the ΔqcrCAB::hyg mutant were cydA, cydB and senX3, 
suggesting that the signal leading to up-regulation of these genes, all three of which were 
already up-regulated in the untreated mutant strain, was intensified by CPZ treatment 
(Table 11 and Appendix D, Table D3).  
 Interestingly, three M. smegmatis homologs of M. tuberculosis genes previously 
shown to be part of the DosR regulon (uspL, acg, dosS) and two others shown to be 
DosR-regulated in M. smegmatis (uspM and uspN; Table 12), as well as other M. 
smegmatis homologues of M. tuberculosis hypoxia-induced genes (groEL, gltA2) were 
down-regulated in response to CPZ. These data support the hypothesis that blockage of 
electron flow upstream of the menaquinone pool affected the signal that led to the modest 
over-expression of these genes observed in the untreated bc1 mutant. Another gene whose 
expression was negatively affected in the ΔqcrCAB::hyg mutant by CPZ treatment was 
mihF. In addition to the genes mentioned above, a large number of genes encoding 
ribosomal proteins and others involved at various levels of gene expression (such as 
rpoA, tsf, infA;) are also down-regulated in response to CPZ, suggesting that growth  and 
hence metabolic activity of the organism is significantly reduced (Tables 12 and 13).   
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Table 11. Genes up-regulated in response to CPZ in the ΔqcrCAB::hyg mutant (partial-
genome array) 
ID Gene Function (as per Leproma & TubercuList) LR SD 
ML0778*  CHP 4.49 0.70 
gabD-q aldA 
probable aldehyde dehydrogenase (NAD-
dependent) 4.44 0.51 
ML1030*  CHP 3.53 0.68 
metH* metH methionine synthase 3.19 1.07 
xseB xseB probable exodeoxyribonuclease VII, large subunit  3.16 0.74 
aroE aroE probable shikimate 5-dehydrogenase 3.04 0.51 
ml0798*  CHP 2.71 0.64 
pbpB pbpB probable penicillin-binding membrane protein 2.67 1.27 
tpi-a tpi probable triosephosphate isomerase 2.60 0.11 
nrdF* nrdF ribonucleoside-diphosphate reductase beta chain 2.58 0.29 
ML0956  putative integral membrane protein 2.53 0.43 
ribA* ribA2 probable riboflavin biosynthesis protein 2.47 0.29 
glnA2-a* glnA2 probable glutamine synthetase 2.44 0.24 
fdxA* fdxA probable ferredoxin 2.44 0.12 
Rv1623c* cydA cytochrome bd oxidase subunit I 2.33 0.64 
htpX htpX probable protease transmembrane protein 2.24 0.41 
metS* metS methionine synthase 2.17 0.32 
clpB clpB probable endopeptidase ATP-binding protein 2.09 0.16 
ml1312*  CHP 2.05 0.43 
ML1254  CHP 2.04 0.20 
ML2691  CHP 2.04 0.13 
menG* menG demethylmenaquinone methyl transferase 2.00 0.61 
ml1328-b paf probable proteasome associated factor 1.98 0.21 
ML0904*  CHP 1.93 0.46 
ml0594  CHP 1.89 0.18 
hisB hisB 
probable imidazole glycerol-phosphate 
dehydrogenase 1.88 0.19 
pgsA-b* pgsA probable diacylglycerol phosphatidyl transferase 1.87 0.43 
fabG4* fabG4 probable oxoacyl-(acyl carrier protein) reductase 1.85 0.15 
ml2661-d fadD7 probable fatty acid CoA ligase 1.85 0.05 
ML0335*  CHP 1.77 0.50 
ML2440 senX3 two-component sensor histidine kinase 1.73 0.27 
ml0818*  CHP 1.71 0.59 
ml2435  CHP 1.70 0.20 
ML0079  probable phosphoglycerate mutase 1.70 0.15 
ml2550-b  CHP 1.68 0.26 
Rv1592c*  CHP 1.67 0.33 
ML0322* ispF methyl erythritol cyclodiphospahte synthase 1.67 0.47 
ml0886  possible glycosyl transferase 1.66 0.20 
thrB* thrB probable homoserine kinase 1.65 0.25 
ml2272 pimB Mannosyltransferase 1.64 0.32 
ML1367  putative initiation inhibitor 1.62 0.15 
glbO* glbO possible globin (oxygen-binding protein) 1.60 0.37 
leuC-a leuC 
conserved integral membrane protein (Leu & Ala 
rich) 1.59 0.37 
argD-g* argD probable acetylornithine aminotransferase 1.59 0.22 
modD modD possibly involved in molybdate uptake 1.57 0.13 
lsr2 lsr2 probable iron-regulated protein 1.55 0.23 
Rv1622c* cydB cytochrome bd oxidase subunit II 1.53 0.55 
ml0510*  CHP 1.52 0.15 
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ID Gene Function (as per Leproma & TubercuList) LR SD 
trxB-b trxB probable thioredoxin 1.52 0.06 
ML1446  CHP 1.51 0.33 
thrC* thrC probable threonine synthase 1.50 0.17 
ml2088-f* cyp140 probable cytochrome p450 140 1.48 0.10 
mraY-b* mruX UDP-N-acetylmuramoyl pentylpeptide transferase 1.47 0.39 
ribH ribH riboflavin synthase, beta subunit 1.47 0.17 
ml2409* ccsA possible cytochrome c-type biogenesis protein 1.46 0.33 
Rv2578c  CHP 1.46 0.10 
ML2111*  CHP 1.46 0.33 
Rv3841 bfrB Bacterioferritin 1.45 0.07 
uspA uspA sugar ABC transporter 1.43 0.15 
ML0174 mprA mycobacterial persistence regulator 1.39 0.42 
tyrS tyrS tyrosyl-tRNA synthase 1.33 0.48 
ml0606*  CHP 1.33 0.25 
ML2531* cfp7 low molecular weight portein antigen 7 1.33 0.14 
ML0031  probable secreted proline rich protein 1.31 0.42 
ml1332* tatC probable Sec-independent protein translocase 1.31 0.36 
ml0759 fbiA probable F420 biosynthesis protein 1.29 0.12 
ML1077  CHP 1.28 0.08 
dnaJ dnaJ probable chaperone protein 1.26 0.25 
ml1946  CHP 1.24 0.18 
polA-a polA DNA polymerase I 1.24 0.15 
ribC ribC riboflavin synthase, alpha subunit 1.23 0.17 
bccA-a* bccA biotincarboxy carrier protein & carboxyl transferase 1.23 0.30 
rplN rplN 50S ribosomal protein L14 1.22 0.08 
ML1560*  CHP 1.22 0.25 
ml2489  possible conserved secreted protein 1.22 0.24 
moaB moaB molybdopterin biosynthesis protein 1.22 0.18 
ml1089 sugC sugar-transport ATP-binding membrane protein 1.21 0.18 
ilvG-a ilvG-a probable acetolactate synthase 1.18 0.02 
ml0596-b csd probable cysteine desulfurase 1.18 0.09 
ml0115  CHP 1.17 0.08 
ftsX ftsX putative cell division protein 1.17 0.10 
ML0049 esxA/esat6 probable 6 kDa early secreted antigenic target 1.17 0.02 
ml2491-a  CHP 1.16 0.27 
ml2305  probable anion transporter ATPase 1.14 0.21 
uvrB uvrB probable excinuclease ABC, subunit B 1.09 0.11 
Rv0233 nrdB ribonucleoside-diphosphate reductase  1.06 0.04 
mce1A-a mce1A virulence factor 1.05 0.17 
glcB glcB probable malate synthase 1.04 0.05 
sucD sucD probable succinyl-CoA synthetase 1.03 0.08 
ML1526  probable conserved membrane protein  1.02 0.15 
ML0376  possible membrane protein 1.01 0.13 
* DE in all three biological replicates, whereas the rest of the genes are DE in at least two of the three replicates  
 a Gene identifier as defined in the MIAME compliance file (http://vbc.med.monash.edu.au/~powell/M.smegamtis).  
b LR, log base 2 of the fold ratio 
c SD, standard deviation 
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Table 12. Genes down-regulated in response to CPZ in the ΔqcrCAB::hyg mutant 
(partial-genome array) 
ID Gene Function (as per Leproma & TubercuList) LR SD 
rplX rplX 50S ribosomal protein L24 -3.53 0.19 
rpmC rpmC 50S ribosomal protein L29 -3.46 0.17 
rpsQ* rpsQ ribosomal protein S17 -3.19 0.68 
cysS cysS cysteinyl-tRNA synthetase -3.17 1.82 
rplP* rplP ribosomal protein L16 -3.14 0.15 
sdhB sdhB succinate dehydrogenase -3.07 0.18 
argD-a* argD probable ornithine transferase -2.87 0.24 
rpsC* rpsC ribosomal protein S3 -2.84 0.16 
infA* infA probable translation initiation factor -2.78 0.23 
uvrA-a*  excinuclease ABC, subunit A -2.69 0.33 
yrbE1-b*  CHP -2.66 0.20 
mntH-a* mntH divalent cation-transport integral membrane protein -2.66 0.17 
Rv2028c uspL universal stress protein -2.60 0.51 
ml0703*  CHP -2.55 0.97 
rplC* rplC ribosomal protein L3 -2.54 0.18 
accD4-c* accD4 propionyl-CoA carboxylase beta chain -2.41 0.28 
rplS* rplS ribosomal protein L19 -2.36 1.09 
ml2687*  probable conserved transmembrane protein -2.34 0.34 
ml0593*  CHP -2.34 0.22 
rplE rplE 50S ribosomal protein L5 -2.34 0.22 
rhlE-b* rhlE probable ATP-dependent RNA helicase -2.33 0.36 
Rv3134c uspL universal stress protein -2.33 0.27 
rpsI* rpsI ribosomal protein S9 -2.32 0.13 
lpd-a* lpd Lipoprotein -2.24 0.48 
ml0691-b* dacB probable D-alanylalanine carboxypeptidase -2.21 0.17 
ML0068*  CHP -2.20 0.15 
ml0734*  probable conserved transmembrane protein -2.20 0.37 
ML2640  CHP -2.14 0.04 
ML1439*  CHP -2.13 0.58 
ML1115* lprB possible lipoprotein -2.13 0.52 
ML0386*  CHP -2.13 0.15 
ml1544-a*  probable conserved membrane protein -2.12 0.12 
pdc-a* pdc probable pyruvate decarboxylase -2.11 0.34 
ml1714*  CHP -2.10 0.05 
aroG aroG deoxy arabino heptulosonate phosphate synthase -2.10 0.45 
lipG lipG probable lipase -2.06 0.04 
rpsL* rpsL ribosomal protein S12 -2.06 0.20 
rplR* rplR ribosomal protein L18 -2.06 0.42 
Rv2032 acg putative nitroreductase -2.04 0.42 
Rv2191* polC DNA polymerase III, alpha subunit -2.01 0.11 
rpsN* rpsN ribosomal protein S14 -1.97 0.40 
mihF* mihF putative mycobacterial integration host factor -1.97 0.84 
uspE uspE universal stress protein -1.88 0.23 
PPE-b* PPE PPE family protein -1.83 0.33 
ML2487* pyrE probable orotate phosphoribosyl transferase -1.80 0.49 
ml2639-f*  probable aldehyde dehydrogenase -1.73 0.25 
leuB-c leuB probable isopropyl malate dehydrogenase -1.73 0.26 
ml2661-e fadD7 probable fatty acid CoA ligase -1.69 0.42 
fadD2-i* fadD2 fatty acid CoA synthetase -1.69 0.29 
Rv2392* cysH probable phosphoadenylsulfate reductase -1.67 0.45 
rpsE* rpsE ribosomal protein S5 -1.66 0.40 
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ml2699*  putative secreted protein -1.66 0.30 
ML2297* ephE possible epoxide hydrolase -1.65 0.18 
rpoA* rpoA DNA-directed RNA polymerase -1.64 0.20 
glnA2-e glnA2 glutamine synthetase -1.63 0.72 
pstC2* pstC2 phosphate-transport integral membrane ABC transporter -1.62 0.21 
ml1306*  CHP -1.55 0.23 
ml1835*  CHP -1.53 0.24 
ml1720*  CHP -1.51 0.12 
groEL-c* groEL heat shock protein -1.50 0.33 
ansA ansA possible aspartate aminotransferase -1.49 0.49 
tsf* tsf probable elongation factor -1.48 0.27 
eftB eftB  electron transfer flavoprotein,  beta subunit -1.47 0.38 
ML2274*  probable consrved secreted protein -1.46 0.18 
cobT* cobT dimethyl-benzimidazole transferase -1.43 0.15 
gabD-l gabD succinate-semialdehyde dehydrogenase -1.40 0.15 
mscL* mscL large-conductance ion mechanosensitive channel -1.37 0.12 
ksgA* ksgA dimethyl adenosine transferase -1.36 0.20 
atpH* atpH ATP synthase -1.35 0.35 
phoH-a* phoH probable phosphofructokinase -1.34 0.18 
ml1706*  CHP -1.33 0.32 
ctpC-a* ctpC cadmium-transporting P-type ATPase -1.32 0.26 
sucC* sucC succinyl hydroxy cyclohexadiene carboxylase synthase -1.31 0.12 
ddlA* ddlA D-alanylalanine synthetase -1.29 0.14 
ML0321 ispD methylerythritol phosphate cytidyltransferase -1.26 0.32 
ftsH ftsH membrane-bound protease -1.26 0.09 
ml0093* glfT bifunctional UDP-galactofuranosyl transferase -1.26 0.22 
accD4-b* accD4 propionyl-CoA carboxylase beta chain -1.26 0.34 
ml1538-b mycP5 serine protease -1.25 0.07 
ml2156  CHP -1.24 0.24 
glnA2-b glnA2 glutamine synthetase -1.24 0.16 
mtf1 mtf1  -1.23 0.27 
atpB* atpB ATP synthase -1.22 0.21 
ruvB ruvB probable Holliday junction helicase -1.22 0.03 
murC* murC probable UDP-N-acetylmuramate-alanine ligase -1.20 0.18 
rnpA rnpA ribonuclease P protein -1.17 0.04 
ML1138  possible integral membrane protein -1.17 0.07 
ml2400*  probable conserved transmembrane protein -1.17 0.16 
gltA2-a* gltA2 probable citrate synthase  -1.16 0.10 
ml0430*  probable conserved integral membrane protein -1.14 0.23 
Rv3132c dosS two-component sensor histidine kinase -1.13 0.16 
ML2549*  CHP -1.12 0.13 
sodA-a sodA superoxide dismutase -1.09 0.14 
ml0893  probable integral membrane protein -1.09 0.13 
gabD-k* gabD aldehyde dehydrogenase -1.07 0.25 
valS valS valyl-tRNA synthase -1.04 0.16 
gabD-p gabD succinate-semialdehyde dehydrogenase -0.99 0.14 
ml2692  Glucocycloaldolase -0.99 0.15 
ML2647 msrA protein-methionine-S-oxide reductase -0.96 0.03 
purH purH probable bifunctional purine biosynthesis protein -0.92 0.03 
fadA-b fadA probable beta ketoacyl CoA thiolase -0.91 0.06 
* DE in all three biological replicates, whereas the rest of the genes are DE in at least two of the three replicates 
 a Gene identifier as defined in the MIAME compliance file (http://vbc.med.monash.edu.au/~powell/M.smegamtis).  
b LR, log base 2 of the fold ratio 
c SD, standard deviation 
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Table 13. Genes down-regulated in response to CPZ in the ΔqcrCAB::hyg mutant (TIGR 
arrays) 
Name on 
array Gene Description (TIGR) LRa SDb 
Closest 
Rv #c E-valued 
ORFA02397 rpmC Ribosomal protein L29 -6.46 2.37 Rv0709 [1e-33] 
ORFA02387 rplD Ribosomal protein L4/L1 family -5.62 1.63 Rv0702 [1e-103] 
ORFA10253*  alcohol dehydrogenase II -5.47 1.43 Rv0405 [0.75] 
ORFA02442 rplF probable ribosomal protein -5.44 2.03 Rv0719 [2e-88] 
ORFA08638 acg Conserved hypothetical protein -5.36 1.29 Rv2032 [2e-95] 
ORFA11432*  hypothetical protein -5.19 1.66 Rv2426c  [2e-54] 
ORFA08631*  Conserved hypothetical protein -5.13 2.55 Rv3129  [5e-30] 
ORFA02531 rpsK probable ribosomal protein S11 -5.07 1.65 Rv3459c  [3e-64] 
ORFA02437 rplE Ribosomal protein L5 -5.02 0.76 Rv0716 [1e-81] 
ORFA11325* rpsF Ribosomal protein S6 -5.02 0.78 Rv0053 [3e-47] 
ORFA02389 rplW Ribosomal protein L23 -4.99 1.10 Rv0703 [6e-34] 
ORFA02396* rplP Ribosomal protein L16 -4.90 0.72 Rv0708 [3e-74] 
ORFA02391* rpsS Ribosomal protein S19 -4.82 1.10 Rv0705   [3e-51] 
ORFA09487 cysA3 thiosulfate sulfurtransferase -4.81 0.35 Rv3117   [1e-147] 
ORFA02317 rpsG Ribosomal protein S7 -4.74 0.40 Rv0683 [9e-84] 
ORFA02443 rplR Ribosomal protein L18 -4.65 0.55 Rv0720 [3e-40] 
ORFA02254* rplJ |ribosomal protein L10 -4.64 1.08 Rv0651 [3e-69] 
ORFA11322 rpsR1 Ribosomal protein S18 -4.63 0.87 Rv0055 [2e-40] 
ORFA07122 glnA1 Glutamine synthetase, type I -4.53 1.31 Rv2220   [0.0] 
ORFA02435 rplX Ribosomal protein L24 -4.50 0.51 Rv0715  [8e-51] 
ORFA02591 rplM Ribosomal protein L13 -4.32 0.16 Rv3443c  [3e-70] 
ORFA02255 rplL Ribosomal protein L7/L12 -4.31 1.24 Rv0652 [1e-32] 
ORFA02316* rpsL Ribosomal protein S12 -4.31 0.14 Rv0682 [4e-66] 
ORFA02320* fusA1 translation elongation factor EF-G (fusA) -4.29 0.17 Rv0684  [5e-93] 
ORFA10100* cspA probable cold shock protein  -4.29 0.60 Rv3648c  [4e-34] 
ORFA11402* rpsO Ribosomal protein S15 -4.24 0.30 Rv2785c [1e-32] 
ORFA06348 rplT Ribosomal protein L20 -4.24 0.28 Rv1643  [5e-64] 
ORFA02323* tuf translation elongation factor Tu -4.19 0.26 Rv0685  [0.0] 
ORFA08635* uspL universal stress protein  -4.18 2.52 Rv2028c [1e-48] 
ORFA02796 amiB probable amidase -4.13 0.62 Rv3306c  [4e-80] 
ORFA02592 rpsI Ribosomal protein S9 -4.13 0.44 Rv3442c [4e-58] 
ORFA08560* mpt70 Osteoblast specific factor 2-related protein -4.11 1.17 Rv2875 [1e-29] 
ORFA08144  vrlB protein -4.05 2.52 Rv1304 [3e-15] 
ORFA02214* rpmG2 Ribosomal protein L33 -3.90 0.85 Rv0634 [3e-27] 
ORFA07185 kasA beta-ketoacyl-ACP synthase -3.87 1.04 Rv2245  [1e-38] 
ORFA02799  Conserved hypothetical protein -3.81 0.10 Rv2839c [0.15] 
ORFA11093* glpK glycerol kinase -3.75 0.42 Rv3696c  [0.0] 
ORFA02566*  aldehyde dehydrogenase family protein -3.73 0.35 Rv0458  [0.0] 
ORFA04190 rpsB Ribosomal protein S2 -3.71 0.42 Rv2890c [1e-133] 
ORFA08937 rplY 
ribosomal 5S rRNA E-loop binding protein 
Ctc/L25/TL5 -3.68 2.09 Rv1015c [4e-68] 
ORFA07184 acpM acyl carrier protein -3.65 0.49 Rv2244   [2e-30] 
ORFA00098* esat6 early secretory antigen target -3.62 0.38 Rv3875  [2e-29] 
ORFA07656 rplU Ribosomal protein L21 -3.54 0.55 Rv2442c  [1e-45] 
ORFA01727 adhC oxidoreductase, zinc-binding -3.49 0.47 Rv3045 [1e-134] 
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ORFA10505* fbpA esterase, putative, antigen 85-A -3.45 0.98 Rv3804c [1e-122] 
ORFA06347 rpmI Ribosomal protein L35 -3.42 0.79 Rv1642 [3e-27] 
ORFA06619 uspM universal stress protein -3.31 0.87 Rv2026c [6e-97] 
ORFA01603 pknE mspA-Gen -3.28 1.37 Rv1743  [0.007] 
ORFA03933 ilvC ketol-acid reductoisomerase -3.26 0.65 Rv3001c [1e-156] 
ORFA11096* glpD2 glycerol-3-phosphate dehydrogenase -3.25 0.77 Rv3302c  [1e-173] 
ORFA03010 accD5 Propionyl-CoA carboxylase, beta subunit -3.23 0.04 Rv3280 [0.0] 
ORFA01465 groEL 60 kd chaperonin , fragment -3.19 0.43 Rv0440 [0.0] 
ORFA11091*  glycerol uptake facilitator protein -3.18 1.45 Rv3299c [0.066] 
ORFA11401* rpmJ hypothetical protein -3.13 0.30 Rv3461c   [9e-18] 
ORFA02258 rpoB DNA polymerase (rpoB) -3.13 2.92 Rv0667 [0.0] 
ORFA01360  hypothetical protein -3.11 0.87 Rv1699   [0.074] 
ORFA00097* lhp 10 kDa culture filtrate antigen Lhp (CFP10) -3.09 0.35 Rv3874 [5e-21] 
ORFA02572  B12-dependent glycerol dehydrogenase  -3.06 1.00 Rv3825c [0.018] 
ORFA02804  allantoin permease family protein -3.03 0.77 Rv0936 [0.23] 
ORFA08143* atpE ATP synthase c chain -3.01 0.09 Rv1305 [1e-19] 
ORFA09090* sucC carbamoyl-phosphate synthase, large subunit -2.84 1.02 Rv0951 [0.0] 
ORFA04224 frr ribosome recycling factor -2.79 0.40 Rv2882c  [1e-86] 
ORFA02800  YER057c/YjgF/UK114 family protein -2.78 0.51 Rv2704  [4e-10] 
ORFA04425 gpsI polyribonucleotide nucleotidyltransferase  -2.70 0.40 Rv2783c [0.0] 
ORFA09410 uspN universal stress protein  -2.69 1.45 Rv2026c  [4e-29] 
ORFA06349 infC translation initiation factor IF-3 -2.69 0.35 Rv1641 [4e-88] 
ORFA06414 rpsA rpsA -2.63 1.18 Rv1630  [0.0] 
ORFA07077* ctaC cytochrome c oxidase, subunit II, putative -2.47 0.85 Rv2200c  [1e-147] 
ORFA06997 wag31 cell division protein DivIVA -2.45 0.00 Rv2145c [1e-103] 
ORFA02224* rpl1 Ribosomal protein L1 -2.44 0.73 Rv0641 [1e-110] 
ORFA02634 groES chaperonin, 10 kDa -2.42 0.50 Rv3418c  [2e-52] 
ORFA01395 sodC superoxide dismutase (sodC), Cu-Zn family -2.39 0.44 Rv0432  [9e-84] 
ORFA07655 rpmA Ribosomal protein L27 -2.34 0.40 Rv2441c [5e-38] 
ORFA02529* infA translation initiation factor IF-1 -2.34 0.89 Rv3462c [7e-38] 
ORFA10554* sodA superoxide dismutase (mn) -2.31 0.57 Rv3846 [1e-102] 
ORFA07065* ctaE Cytochrome c oxidase subunit III -2.22 0.85 Rv2193 [1e-103] 
ORFA10746  hypothetical protein -2.21 0.04 Rv2943 [0.074] 
ORFA10741  anti-anti-sigma factor, putative -2.19 1.22 Rv0516c [0.009] 
ORFA09321 gltA2 citrate synthase I -2.19 1.01 Rv0896  [0.0] 
ORFA02698  hypothetical protein -2.03 0.71 Rv2944 [1.1] 
ORFA02223* rplK Ribosomal protein L11 -2.02 0.83 Rv0640  [3e-54] 
ORFA09975*  Conserved hypothetical protein -1.99 0.07 Rv2451  [0.095] 
ORFA05827  probable secreted protein [imported] -1.87 0.29 Rv0559c [2e-21] 
ORFA00657 nrp peptide synthetase -1.71 0.52 Rv0101 [0.0] 
ORFA09778  Conserved hypothetical protein -1.66 0.03 Rv0236c   [0.080] 
ORFA10514 pirG hypothetical protein -1.60 0.49 Rv3810 [1e-53] 
ORFA00915 cspA cold shock protein -1.60 0.48 Rv3648c [3e-25] 
ORFA05828  probable secreted protein [imported] -1.59 0.46 Rv0455c [1e-32] 
ORFA08112 fadA4 acetyl-CoA acetyltransferase -1.44 0.39 Rv1323   [0.0] 
ORFA03892 fixB electron transfer flavoprotein, alpha subunit -1.43 0.68 Rv3028c [1e-135] 
ORFA08162* rpmE Ribosomal protein L31 -1.39 1.14 Rv1298   [5e-31] 
ORFA05511 cysA1 Polyamine ABC transporter -1.33 0.22 Rv2397c [8e-57] 
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ORFA06045 apa hypothetical protein -1.03 0.04 Rv1860 [5e-58] 
* DE in all three biological replicates, whereas the rest of the genes are DE in at least two of the three replicates  
a LR, log base 2 of the fold ratio 
b SD, standard deviation 
c,d BLAST search results for the M. tuberculosis H37Rv homologues of the M. smegmatis genes on the TIGR array was 
kindly provided by Prof. N. Stoker (Royal Veterinary College, London, UK).  
 
 
Analysis of effects of CPZ on the bc1 mutant using RT-PCR  
In order to verify the microarray results, semi-quantitative RT-PCR was performed on a 
selection of the genes that were found to be DE in the DqcrCAB::hyg mutant as a result of 
CPZ treatment. These comprised 6 members of the M. smegmatis DosR regulon  (dosR, 
uspL, uspM, uspN, acg and hspX; O’Toole et al., 2003), and sigA as a control (Table 5). 
To exclude DNA contamination in RNA samples, control samples containing all the 
reaction components except reverse transcriptase were included in the reverse 
transcription step, and subsequently PCR amplified using sigA primers. Absence of PCR 
product on gel electrophoresis was an indication for lack of DNA contamination. 
Although poor or no amplification was obtained for some of the genes due to technical 
problems (data not shown), the results obtained for those genes for which amplification 
was obtained were in agreement with the microarray observation that some members of 
the DosR regulon were down-regulated in response to CPZ (Figure 16). There was 
visibly less amplified product of these genes (uspM, uspL, hspX, dosR), except for acg 
whose expression did not seem different, in the CPZ-treated samples than in the untreated 
samples. In contrast, no change in the amount of amplicon derived from the control sigA 
gene was observed between the two samples, confirming that the different effects 
observed with the above-mentioned genes were not a result of unequal amounts of 
starting total RNA or cDNA in the RT or PCR reactions, respectively. 
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Figure 16. Expression analysis, as assessed by semi-quantitative RT-PCR, of sentinel genes 
differentially expressed in response to CPZ in a ΔqcrCAB::hyg mutant of M. smegmatis. 1 μg of 
RNA from CPZ-treated and untreated cultures of DqcrCAB::hyg was reverse-transcribed and the 
undiluted cDNA (A to D) or five-fold serial dilutions of the cDNA (E to H) were used in PCR to 
amplify portions of sigA (A and E), dosR (B and F), uspM (C), acg (D), hspX (G) and uspL (H), 
using primers described in Table 2.4. (A to D) PCR product of undiluted cDNA from untreated 
(lane 1) or treated (lane 2), and DNA molecular marker V (lane 3). (E to H) Lanes 1 to 5 contain 
PCR products of serial dilutions of DNA from untreated culture, lanes 6 to 10 are from treated 
culture, DNA molecular marker V is in lane 11 (E and H) or lane 12 (F and G), and no DNA 
control in lane 11 (F and G). [N.B lanes 8 and 11 in panel F are swapped]. Arrows indicate the 
expected bands. Bands below those of interest are primer dimers.  
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4. DISCUSSION 
 
Genomic organization of the cytochrome bc1-aa3 pathway in M. smegmatis 
BLAST searches of the genome sequence of M. smegmatis mc2155 (pre- and post- 
sequence completion) revealed the genetic composition and organization of the 
components of this branch of the aerobic respiratory chain, and also allowed for 
comparison with their counterparts in other bacterial species. As has been proposed for 
M. tuberculosis (Kana et al., 2001; Weinstein et al., 2005), the pathway consists of a 
qcrCAB-encoded cytochrome bc1 complex, which transfers electrons to the terminal 
oxidase, cytochrome aa3, that ultimately reduces O2 to water.  
 
Cytochrome bc1 complex  
The chromosomal arrangement of genes (qcrCAB) encoding cytochrome bc1 complex is 
conserved in actinomycetes such as Streptomyces, Mycobacterium, Nocardia, 
Corynebacterium (http://www.tigr.org/tigr-scripts/CMR2/) and Rhodococcus (Sone et al., 
2003), which is consistent with the close evolutionary relationship between these genera 
(Ishikawa et al., 2004). Components of the qcrCAB operon, which is preceded by a ctaE 
(encoding subunit III of the aa3-type cytochrome c oxidase) in all these genera, specify 
the cytochrome c, Rieske iron-sulfur protein and cytochrome b subunits of the 
menaquinol:cytochrome c oxidoreductase (cytochrome bc1 complex), respectively. As 
has previously been shown through sequence alignments, the primary structures of these 
components are highly homologous within the actinomycetes, with some peculiar 
features apparently unique to these organisms (Bott and Niebisch, 2003; Sone et al., 
2003). The most important of these features are the presence of two heme-binding motifs 
in the cytochrome c1 (QcrC) subunit of this complex, and the apparent absence of a gene 
encoding a separate cytochrome c in the genomes of these organisms. These features 
suggest that the cytochrome c1 performs the function of a separate cytochrome c in 
electron transfer to the terminal aa3-type cytchrome c oxidase.  
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Cytochrome c oxidase 
The mycobacterial genes encoding the aa3-type cytochrome c oxidase are located at non-
contiguous positions on the chromosome, with the exception of ctaCF (encoding subunits 
II and IV, respectively) which form an operon. These two genes are separated by two 
genes downstream from the ctaE-qcrCAB operon, while ctaD (for subunit I) is located at 
a totally different position on the chromosome. Whereas the genomic context of all these 
genes is conserved within mycobacteria, the arrangement differs between the 
actinomycete genera mentioned above. However, the high sequence similarity of these 
genes across the genera indicates that they are functionally equivalent, consistent with the 
relatedness of the organisms (Niebisch and Bott, 2001; Niebisch and Bott, 2003).   
 
The apparent essentiality of the M. smegmatis ctaDI gene 
Several attempts to obtain a null ctaDI mutant of M. smegmatis failed, suggesting a 
possible essentiality of this gene, which encodes subunit I of aa3-type cytochrome c 
oxidase. However, the ability to knock out the gene encoding subunit II (ctaC) of this 
oxidase suggested that the inability to inactivate ctaDI may have been due to a polar 
effect on the downstream serB2 gene, which appears to be operonic with ctaDI, rather 
than due to the essentiality of ctaDI. In M. tuberculosis and M. bovis BCG serB2, and not 
serB, was shown to encode an essential phosphoserine phosphatase as determined by 
high-density mutagenesis using a transposon site hybridization (TraSH) method (Sassetti 
et al., 2003). Like M. tuberculosis and M. bovis BCG, M. smegmatis also possesses both 
serB and serB2 genes, so by analogy, serB2 is probably also essential in this organism.  
 The failure to recover a null ctaDI mutant using serine supplementation could be 
due to any one of a number of possible reasons. (i) If the null ctaDI mutant was a serine 
auxotroph, either the concentration of serine supplement used (100 μg/ml) may not have 
been sufficient or its uptake by M. smegmatis failed to meet the serine demand of this 
organism. In M. tuberculosis, it was demonstrated that a high concentration of exogenous 
L-arginine was required to restore the growth rate of an argF mutant (defective in 
arginine biosynthesis) to an optimum level, suggesting that this organism had a high 
arginine demand (Gordhan et al., 2002). (ii) The enzyme encoded by serB2 
(phosphoserine phosphatase) is not only required for serine biosynthesis, but also for 
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glycine and cysteine biosynthesis (Sassetti et al., 2003). Therefore it is possible that loss 
of serB2 function could confer pleiotropic effects (multiple amino acid auxotrophy) that 
are not simply reversible by serine supplementation.  
 The occurrence of two serB genes and the location of one (designated herein as 
serB2 by analogy to the mycobacterial counterparts), downstream of ctaD in the closely 
related actinobacterium C. glutamicum, suggested that these genes may have similar roles 
as in mycobacteria. However, the serB2 gene of C. glutamicum, unlike its mycobacterial 
counterpart, does not form an operon with ctaD, but is located 200 bp downstream of 
ctaD (http://www.tigr.org/tigr-scripts/CMR2/ CMRHomePage.spl). This suggests that the 
C. glutamicum serB2 may have its own promoter, and would explain the viability of a 
deletion mutant of this organism in ctaD (Niebisch and Bott, 2001).  
 
Are there isoenzymes of aa3-type cytochrome c oxidase in M. smegmatis? 
The occurrence of two distinct ctaD genes in the genome of M. smegmatis as revealed by 
the genome sequence and confirmed by targeted mutagenesis raises a question about the 
possible existence of isoenzymes of aa3-type cytochrome c oxidase in this organism. 
Although distinct ctaD alleles could only be identified in the genome of M. smegmatis 
and not any other sequenced mycobacterial species, two distinct ctaD homologues were 
identified in the genomes of three other actinobacteria, N. farcinica, S. coelicolor and S. 
avermitilis (http://www.tigr.org/tigr-scripts/CMR2/). Similarly, two ctaD alleles (with 
90% identity) have previously been reported for Paracoccus denitrificans (Raitio et al., 
1990; van der Oost et al., 1991), suggesting that a multiplicity of ctaD genes is 
reasonably common occurrence in bacterial genomes. Subunit I (CtaD) is the only 
component of aa3-type cytochrome c oxidase that is apparently encoded by more than 
one allele in these species, suggesting that either one of the encoded CtaDI or CtaDII 
subunit can combine with the other subunits to form functional isoforms of aa3-type 
cytochrome c oxidase5. Consistent with this, ctaDI and ctaDII were separately expressed 
to complement a double mutant (ΔctaDI/ctaDII) in P. denitrificans, demonstrating that 
they were isoforms of subunit I of cytochrome c oxidase (de Gier, et al., 1994). However, 
                                                 
5 Note that the genes designated as ctaDI and ctaDII in M. smegmatis are not necessarily the 
functional counterparts of the genes given this nomenclature in P. denitrificans 
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ctaDI could only be expressed if maintained on a plasmid, suggesting that there was a 
gene dosage or repressor titration effect (Baker et al., 1998) whereas ctaDII was shown to 
encode the primary subunit I of the enzyme (Baker et al., 1998; Otten et al., 2001a). 
Whether the M. smegmatis ctaDI and ctaDII encode isoforms of subunit I, as is the case 
in P. denitrificans, remains to be investigated.  
 In this study, ctaDI is proposed to be the principal ctaD allele of M. smegmatis 
under aerobic conditions for the following reasons. (i) ctaDI displays the highest 
homology to its M. tuberculosis counterpart than exhibited by ctaDII. (ii) ctaDI but not 
ctaDII exists in the same chromosomal context as ctaD genes of other mycobacteria. (iii) 
If CtaDII was a component of the principal aa3-type cytochrome c oxidase, which should 
include CtaC (subunit II, encoded by only one gene), the loss of either ctaC or ctaDII 
would be expected to confer the same phenotype. However, the ΔctaDII::hyg mutant 
showed no growth phenotype when cultured under the same conditions under which the 
DctaC::hyg mutant was impaired for growth. (iv) The expression of ctaDII under aerobic 
conditions was not affected by disruption of the cytochrome bc1 complex 
(ΔqcrCAB::hyg) or cytochrome c oxidase (ΔctaC::hyg). Taken together, these data 
suggest that ctaDI encodes the principal subunit I of aa3-type cytochrome c oxidase in M. 
smegmatis. 
 
Growth attenuation of the cytochrome bc1 (ΔqcrCAB::hyg) and aa3-type cytochrome 
c oxidase (ΔctaC::hyg) mutants of M. smegmatis 
In an earlier study from this laboratory, a cydAB-encoded cytochrome bd-type quinol 
oxidase of M. smegmatis was demonstrated to be required for growth under microaerobic 
conditions (Kana et al., 2001). Although severely growth impaired at and below 1% air 
saturation, a cydA::aph mutant of M. smegmatis showed no discernible phenotype when 
grown under high aeration (Kana et al., 2001),  suggesting that the cytochrome bc1-aa3 
branch was the main route of electron flow under aerobic conditions in this organism. 
The results presented here support this hypothesis as both the ΔqcrCAB::hyg and 
ΔctaC::hyg mutants were severely attenuated for growth under these conditions. A more 
than two-fold decrease in the growth rate of the two mutants compared to their parental 
wild type was observed during the logarithmic growth in liquid medium, demonstrating 
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the importance of this branch of the respiratory chain for the aerobic growth of M. 
smegmatis. The delayed emergence of mutant colonies on solid medium was indicative of 
a longer lag phase in these strains compared to the wild type, which was also reflected in 
the growth curves. A similar observation has been reported for C. glutamicum, in which 
ΔqcrCAB and ΔctaC mutants were severely defective in growth in glucose minimal 
medium (Niebisch and Bott, 2001; Bott and Niebisch, 2003). In P. denitrificans, an 
analogous growth defect was also reported in which mutants lacking cytochrome bc1 
displayed lower maximum cell numbers compared to the wild type (Otten et al., 2001b). 
However, the viability of the cytochrome bc1-aa3 pathway mutants in these organisms 
suggested that the loss of functionality in this pathway could be compensated by re-
routing of the electron flow through alternate pathways. 
 
Over-expression of cytochrome bd oxidase compensates for loss of the bc1 complex 
or aa3-type cytochrome c oxidase 
Disruption of the M. smegmatis cytochrome bc1-aa3 pathway at the level of the bc1 
complex (in a ΔqcrCAB::hyg mutant) or the aa3-type cytochrome c oxidase (in a 
ΔctaC::hyg mutant) resulted in a marked up-regulation of the cydAB-encoded cytochrome 
bd oxidase as determined by lacZ reporter assays and/or DNA microarray analysis. These 
results indicated that in both mutants, electron flow to the major terminal oxidase, 
cytochrome aa3 was re-routed to the bioenergetically less-efficient cytochome bd-type 
quinol oxidase. An analogous observation was made in P. denitrificans where expression 
of the qox promoter, controlling expression of the quinol oxidase cytochrome ba3, 
increased up to 11-fold in strains lacking cytochrome bc1 complex or cytochrome aa3 
oxidase (Otten et al., 2001a). To corroborate this result in P. denitrificans, aerobically 
grown cytochrome ba3-deficient mutants were unable to respire when treated with 
myxothiazol (Otten et al., 2001a), a specific inhibitor of the bc1 complex, demonstrating 
that aerobic respiration could not proceed when both pathways were blocked. 
Nonetheless, the severe growth defect of the M. smegmatis cytochrome bc1 and aa3 
mutants suggested that the compensatory effect of the cytochrome bd oxidase was not 
energetically sufficient to sustain growth to levels comparable to the wild type.  
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 The pathways terminating in aa3-type cytochrome c oxidase and cytochrome bd 
oxidase differ greatly in their bioenergetic efficiency. Although both oxidases couple 
electron transfer to the generation of an electrochemical proton gradient, which may then 
be used for the synthesis of ATP, the coupling efficiency of aa3-type cytochrome c 
oxidase is higher than that of the bd oxidase and therefore resulting in a higher ATP yield 
(Garcia-Horsman et al., 1994; Bott and Niebisch, 2003; Belevich et al., 2005). 
 
Cytochrome bd’ oxidase (YthAB) is not differentially expressed in the mutants 
The genome of M. smegmatis contains a pair of genes, designated herein as ythAB, which 
are homologous to cydAB, and may thus encode an alternate cytochrome bd-type quinol 
oxidase. Based on microarray analyses of the M. smegmatis ΔqcrCAB::hyg and 
ΔctaC::hyg mutants, the ythAB genes were not differentially expressed in either mutant, 
suggesting that these genes are not required for aerobic growth of M. smegmatis. 
However, the presence of a signal from these genes in both wild type and mutant strains 
on the array provided the first evidence that these genes are expressed, at least at the 
RNA level, in M. smegmatis. The failure to recover a double mutant of M. smegmatis in 
which the pathways terminating in both aa3-type cytochrome c oxidase and the cydAB-
encoded quinol oxidase are disrupted suggested that YthAB is unable to substitute 
functionally for the cydAB-encoded oxidase. Therefore, there currently is no experimental 
evidence to suggest that an alternate, bd-type oxidase is indeed expressed in M. 
smegmatis. Interestingly, M. smegmatis is the only sequenced mycobacterial species 
carrying ythAB homologues. In B. subtilis, the ythAB genes have been proposed to be 
required for sporulation (Winstedt and Wachenfeldt, 2000; Schau et al., 2004). Although 
both M. smegmatis and B. subtilis are soil bacteria, there is no documented knowledge of 
spore formation in M. smegmatis. Therefore, the role of ythAB in respiration and/or some 
other cellular function in M. smegmatis remains unknown.  
 
Induction of hypoxia-responsive genes in the cytochrome bc1-aa3 pathway mutants 
of M. smegmatis 
Disruption of the cytochrome bc1-aa3 pathway resulted in up-regulation of several 
hypoxia-responsive genes including cydA, cydB, hspX, uspL, uspM, acg, dosT, 
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MSMEG5227 (Rv3130c), MSMEG5228 (Rv3129), MSMEG3958 (Rv3127), 
MSMEG5215 (Rv1738)6. Based on previous studies, these genes can be classified into 
two independent, but mutually non-exclusive groups (Boshoff et al., 2004). The cydAB 
genes are sentinel members of one group, and the implication of their constitutive 
induction in the mutants has been discussed above. The remaining genes belong to the 
second group, which includes several DosR-regulated genes of M. smegmatis (hspX, 
uspL, uspM, acg; O’Toole et al., 2003) and M. smegmatis homologues of the M. 
tuberculosis DosR-regulated genes, dosT, MSMEG5227 (Rv3130c), MSMEG5228 
(Rv3129), MSMEG3958 (Rv3127) and MSMEG5215 (Rv1738). However, it is 
important to note that the induction of these genes was more significant in the 
ΔqcrCAB::hyg mutant than in the ΔctaC::hyg mutant. Although the M. smegmatis DosR 
regulon has only been partially characterized (Mayuri et al., 2002; O’Toole et al., 2003) 
and therefore, the full complement of DosR-regulated genes is unknown, up-regulation of 
the above genes suggests that there is an overlap in the type of signal(s) and/or signal 
transduction system(s) resulting from either disruption of the cytochrome bc1-aa3 
pathway or O2 starvation (hypoxia). This finding is consistent with previous studies in 
which components of the respiratory system were proposed to be involved in the 
signaling of the DosR system of M. tuberculosis (Voskuil et al., 2003; Boshoff et al., 
2004).   
 
Proposed changes in the redox states of electron carriers in the cytochrome bc1-aa3 
pathway mutants 
The proposed changes in the redox states of the NADH/NAD+ and 
menaquinol/menaquinone (MKH2/MK) pools resulting from disruption of the 
cytochrome bc1-aa3 pathway are summarized schematically in Figure 17. Under aerobic 
conditions, NADH in the wild type M. smegmatis is proposed to be rapidly re-oxidized to 
NAD+ by the NADH dehydrogenase as has been demonstrated in Streptomyces coelicolor 
(Brekasis and Paget, 2003; Green and Paget, 2004), resulting in a low NADH/NAD+ ratio 
(Figure 17A). Concomitant with this proposal, Vilchèze et al (2005) recently 
                                                 
6 The M. tuberculosis H37Rv counterparts of the M. smegmatis genes are given in brackets for the purposes 
of cross-referencing.  
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demonstrated that the NADH/NAD+ ratio in wild type M. smegmatis was approximately 
0.7. An arbitrary representation of an approximately 1:1 ratio of the MKH2/MK pool has 
been shown only for the purpose of illustrating the relative changes proposed to occur in 
response to disruption of the pathway, and it does not represent the actual ratio as such 
has not been measured in M. smegmatis. 
Disruption of the cytochrome bc1-aa3 pathway at either the level of the bc1 
complex or cytochrome aa3 is proposed to increase the reduced state of both the 
NAD+/NADH and MKH2/MK pools (Figure 17B). When the pathway is blocked 
upstream of the MK(H2) pool by treatment with, chlorpromazine (CPZ), which has 
previously been demonstrated to inhibit the type II NADH dehydrogenase (NDH-II) of 
M. tuberculosis (Boshoff et al., 2004; and Weinstein et al., 2005), the NADH/NAD+ ratio 
is proposed to increase further (Figure 17C). CPZ The ratio is estimated based on the 
previous report that ndh (NDH-II) mutants of M. smegmatis had a higher NADH/NAD+ 
ratio than the wild type [≥1.0 in ndh mutant strains vs. 0.7 in wild type; Vilchèze et al., 
2005)]. 
 
Effects of chlorpromazine on the transcriptome of the cytochrome bc1 mutant 
Inhibition of NDH-II disrupts the flow of electrons from NADH into the MKH2/MK 
pool. It was therefore predicted that such a perturbation would affect the responsiveness 
of some of the genes that were differentially regulated in the ΔqcrCAB::hyg mutant of M. 
smegmatis. Inhibition of NDH-II by CPZ treatment was found to have opposing effects 
on the genes that were differentially expressed in the untreated mutant, with some being 
down-regulated and others up-regulated (Figure 17B and C). Among the up-regulated 
genes were senX3 and cydAB which were constitutively up-regulated in the untreated 
mutant strain, and were further up-regulated by CPZ treatment. These results are in 
accordance with those previously reported for M. tuberculosis, in which the expression of 
cytochrome bd oxidase was up-regulated in the wild type M. tuberculosis treated with 
CPZ and other phenothiazines (Boshoff et al., 2004). The implications of these findings 
for the regulation of the cydAB genes are discussed in the next section. Other genes 
whose induction in the mutant was further elevated by CPZ include ribA2 and fbiA, the 
function of which will be discussed below. 
 110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cytochrome 
c  
oxidase 
Cytochrome 
bc1 
 complex 
NDH-II 
½O2 H2O NADH NAD
+ 
MK 
MKH2 
O2 
O2 
(A) Wild type  
(C). CPZ-treatment of bc1-aa3 pathway mutants  
Cytochrome 
c  
oxidase 
Cytochrome 
bc1 
 complex 
NDH-II 
O2 NADH NAD+ 
MK 
MKH2 
O2 
O2 
CPZ 
Up-regulated: 
cydA, senX3, 
ribA2, fbiA 
Down-regulated group 1: 
hspX, uspL, uspM, MSMEG5227, 
MSMEG5215, MSMEG3958, dosT, 
acg, MSMEG5228 
 
Down-regulated group 2: 
 mihF, esat6, cfp10, PPE68 
ΔqcrCAB::hyg ΔctaC::hyg 
Up-regulated group 1: 
cydA, senX3 
Up-regulated group 2: 
hspX, uspL, uspM, MSMEG5227, 
MSMEG5215, MSMEG3958, dosT, 
acg, MSMEG5228 
Up-regulated group 3: 
ribA2, fbiA, mihF, esat6, 
cfp10, PPE68 
(B) bc1-aa3 pathway mutants 
Cytochrome 
c  
oxidase 
Cytochrome 
bc1 
 complex 
NDH-II 
O2 NADH NAD+ 
MK 
MKH2 
O2 
O2 
ΔqcrCAB::hyg ΔctaC::hyg 
 111 
Figure 17. Aerobic respiration through the cytochrome bc1-aa3 pathway in M. smegmatis, and 
effects of its disruption on the redox states of the cofactors NAD(H) and MK(H2), and on gene 
expression. For the sake of simplicity, the type I NADH dehydrogenase, succinate dehydrogenase 
and the pathway terminating in cytochrome bd oxidase have not been shown. The NADH (●) / 
NAD+ (●) and MKH2 (▲) / MK (▲) ratios are not representative of the actual ratios as these were 
not measured, but are used to illustrate the differences proposed to occur in response to 
disturbance of electron flow. (A) In the wild type, the NADH/NAD+ ratio is approximately 0.7 
(Vilchèze et al., 2005). Electrons are passed from NADH into the MKH2/MK pool from where 
they are passed, via the cytochrome bc1 complex, to cytochrome aa3 oxidase, which reduces O2 to 
H2O. (B) Disruption of the pathway at level of either the cytochrome bc1 complex (ΔqcrCAB::hyg 
mutant) or cytochrome aa3 oxidase (ΔctaC::hyg mutant) blocks electron flow to O2, resulting in 
an increase in the reduced forms of the cofactors NADH and MKH2, and up-regulation of the 
three groups (boxes) of genes. (C) Treatment of the mutants with CPZ is proposed to have 
opposing effects on the cofactors as well as on the differentially expressed genes (boxes). The 
NADH/NAD+ ratio is further increased while the MKH2/MK ratio is proposed to drop.  
 
 
Among the genes down-regulated in response to CPZ treatment were genes that 
are known to be DosR-regulated in M. smegmatis and which appear to be expressed at 
slightly elevated levels in the untreated mutant strain (Figure 17B, group 2 and Figure 
17C, group 1). This reversed expression resulting from blockage of electrons into the 
MKH2/MK pool as opposed to disruption of electron flow out of the MKH2/MK pool 
indicated that the genes were responding to a change in the redox state of the respiratory 
chain, or to the secondary effects of such a change. These data suggest a cofactor whose 
redox state changes, in the ΔqcrCAB::hyg mutant, in response to blockage of electrons 
into the MK(H2) pool. Whereas the NADH/NAD+ ratio of the mutant is expected to 
increase further in the presence of CPZ, the MKH2/MK ratio is proposed to decrease 
relative to the untreated mutant (Figure 17B and C). Based on this, it is tempting to 
speculate that the DosR-DosS/DosT system senses a change in the redox state of the 
MKH2/MK pool or indirect effects thereof. However, Boshoff et al (2004) did not find 
any correlation between induction of the DosR regulon and changes in the MKH2/MK 
ration in M. tuberculosis, suggesting that the redox state of other electron carriers such as 
cytochromes, flavoproteins and iron-sulfur proteins may be sensed instead. Such 
possibilities remain to be investigated. Other genes whose expression was reversed by 
disruption of electron flow into the MKH2/MK pool include mihF, esat6, cfp10 and 
PPE68, the implications of which are discussed below.  
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 The overall effect of CPZ on the ΔqcrCAB::hyg mutant was indicative of a 
reduction in the metabolic activity of this organism, with more than 30% of the down-
regulated genes encoding ribosomal proteins, as well as a number of genes involved in 
gene expression (transcription and translation). The reduced metabolic activity may be 
indicative of a reduced availability of energy to support the metabolic activities of the 
cell, which is also demonstrated by the accompanying down-regulation of some of the 
genes that encode F0F1 ATP synthase (atpH, atpB, atpE). 
 
The regulation of cytochrome bd oxidase in M. smegmatis 
A possible role for SenX3-RegX3 in the regulation of cytochrome bd oxidase 
Although the cyd genes encoding cytochrome bd oxidase have been shown to be up-
regulated in response to O2 depletion in mycobacteria (Kana et al., 2001; Boshoff et al., 
2004; Voskuil et al., 2004), these genes do not form part of the dormancy (DosR) 
regulon, whose induction has been proposed to be mediated by changes in the redox state 
of the cell (Boshoff et al., 2004). The constitutive up-regulation of cytochrome bd 
oxidase in the ΔqcrCAB::hyg and ΔctaC::hyg mutants confirmed that this oxidase does 
respond to change(s) in the electron flux through the respiratory chain, but in a manner 
that is independent of DosR. The concomitant induction of senX3 alongside cydAB in 
aerated cultures of both the ΔqcrCAB::hyg and ΔctaC::hyg mutants of M. smegmatis 
(Figure 17B, group 1) was interesting in light of the fact that cydB was previously 
reported to be up-regulated in a senX3-regX3 mutant of M. tuberculosis grown to late 
exponential phase under aerobic conditions, which suggested that this gene may be part 
of the SenX3-RegX3 regulon (Parish et al., 2003). The co-induction of the senX3 and cyd 
genes in the ΔqcrCAB::hyg and ΔctaC::hyg mutants (this work) would suggest that this 
two-component regulatory system activates expression of the cyd genes in response to a 
change in the electron flux through the respiratory chain, such as that caused by blockage 
of electron flow through the cytochrome bc1-aa3 pathway.  
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The proposed signal for SenX3-RegX3 
The nature of the signal sensed by SenX3 is not yet known. Blockage of electron flow 
through the cytochrome bc1-aa3 pathway is proposed to cause an increase in the NADH 
and MKH2 cofactors relative to their oxidized forms as discussed above (Figure 17B). 
Therefore, the possibility that both senX3 and cydAB were up-regulated in response to the 
redox state(s) of either one or both of these cofactors is discussed in this section. A 
number of transcriptional regulators of cydAB gene expression that sense the redox states 
of the above cofactors have been described in other bacteria. In E. coli, the ArcB-ArcA 
system has been demonstrated to activate expression of the cytochrome bd oxidase in 
response to an increase in the reduced quinol form (Georgellis et al., 2001a; Alexeeva et 
al., 2003; Malpica et al., 2004). Interestingly, the senX3-regX3 genes in mycobacteria 
have been shown to exhibit the highest homology to those encoding the ArcB-ArcA 
system in E. coli, suggesting that SenX3-RegX3 may similarly respond to the oxidative 
stress generated through respiration (Rickman et al., 2004). Another example of a redox 
sensor that regulates cyd gene expression is the Rex repressor found in S. coelicolor, 
which modulates expression of cytochrome bd oxidase in response to an increase in the 
NADH/NAD+ ratio (Brekasis and Paget, 2003). Although no rex homologues have been 
found in the genomes of mycobacteria (Brekasis and Paget, 2003), the possibility of 
existence of a regulator that responds to the redox state of the NADH/NAD+ pool cannot 
be excluded. 
  The results obtained with the expression analysis of CPZ-treated ΔqcrCAB::hyg 
and ΔctaC::hyg mutants of M. smegmatis in this study are more in favor of the proposal 
that SenX3 senses the redox state of the NADH/NAD+ pool than that of the MKH2/MK 
pool. The constitutive up-regulation of cyd genes in the above mutants under highly 
aerobic conditions, suggests that the signal to which these genes (and probably senX3-
regX3) respond – a change in the redox state of electron carriers and/or a change in the 
transmembrane potential in the respiratory chain – is sustained, but can be modulated by 
CPZ-mediated disruption of electron flow into the MKH2/MK pool. The observed 
increase in the magnitude of induction of both senX3 and cydAB in the ΔqcrCAB::hyg 
and ΔctaC::hyg mutants in response to CPZ treatment suggested that the signal to which 
these genes responded was amplified by CPZ treatment. The increased signal is 
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consistent with the proposed increase in the NADH/NAD+ ratio (Figure 17B and C). In 
contrast, CPZ treatment would prevent further reduction of the MKH2/MK pool, and may 
therefore result in a decreased MKH2/MK ratio in the CPZ treated mutant compared to 
the untreated mutant, which is proposed to have an opposing effect to what was observed 
of the senX3 and cydAB expression. Nonetheless, the possibility that these genes may 
respond to a change in the redox states of cofactors other than these two cannot be 
excluded.    
 
Other adaptations to re-routing the electron flux through cytochrome bd oxidase 
A significant number of genes up-regulated in both the ΔqcrCAB::hyg and ΔctaC::hyg 
mutants are involved in intermediary metabolism and respiration, including genes such as 
ribA2 and fbiA. The up-regulation of genes of this type suggests that the mutants adapt by 
switching on or increasing the availability of alternative electron carriers. ribA2 is the 
most highly up-regulated gene in the ΔqcrCAB::hyg mutant and is also highly up-
regulated in the ΔctaC::hyg mutant. This gene encodes an important bifunctional enzyme 
of the riboflavin biosynthesis pathway, GTP cyclohydrolase II/3,4-dihydroxy-2-
butanone-4-phosphate synthase. The ribA2 gene has been shown to be essential in the 
pathogenic actinomycete Rhodococcus equi (Ashour et al., 2003) and suggested to be 
essential in M. tuberculosis (Sassetti et al., 2003). Riboflavin is a precursor of the flavin 
coenzymes FMN (flavin mononucleotide) and FAD (flavin adenine dinucleotide), which 
form important components in some of the electron transport chain enzymes, including 
most if not all of the dehydrogenases that transfer reducing equivalents to the MKH2/MK 
pool. The deazaflavin cofactor F420 encoded for by fbiA has been proposed to be 
involved in low-redox potential electron transfer reactions associated with anaerobiosis in 
M. tuberculosis (Boshoff and Barry, 2005). It is proposed that M. smegmatis may switch 
to such electron transfer reactions as a result of blockage of its aerobic respiratory 
pathways. Similar to cydAB and senX3, the magnitude of the expression of ribA2 and fbiA 
further increased in response to CPZ treatment (Figure 17B and C), suggesting that there 
was an increase in the demand for flavin-containing enzymes under the conditions tested.  
 The marked up-regulation of mihF in these mutants is also notable as this gene 
has been reported to be up-regulated in M. smegmatis and M. bovis BCG prior to 
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stationary phase (Pedulla and Hatfull, 1998). mihF has been shown to be essential in M. 
smegmatis (Pedulla and Hatfull, 1998) and is inferred as essential in M. tuberculosis 
(Sassetti et al., 2003). Since intracellular MihF protein levels peaked just prior to entry 
into stationary phase and then dropped in both M. smegmatis and M. bovis BCG, it was 
proposed that this protein may be involved in the regulation of genes required for 
stationary phase survival, as had been suggested for the E. coli orthologue (Pedulla and 
Hatfull, 1998). The up-regulation of this gene in the DqcrCAB::hyg and DctaC::hyg 
mutants suggests that blockage of the bc1-aa3 respiratory pathway generates a cellular 
environment that resembles in at least some respects, that occurring during entry into the 
stationary phase. 
 Also of note is the up-regulation of esat6 and cfp10 in both the ΔqcrCAB::hyg and 
ΔctaC::hyg mutants. These genes are found within the RD1 region of M. tuberculosis, the 
loss of which has been shown to mimic the attenuation observed in M. bovis BCG (Lewis 
et al., 2003). These genes encode secreted proteins, which are strongly immunogenic 
(Lewis et al., 2003; Brodin et al., 2005; Fortune et al., 2005; Renshaw et al., 2005). The 
proteins form a tight complex (Brodin et al., 2005; Fortune et al., 2005; Renshaw et al., 
2005) whose specific binding to the host cell surface is proposed to signal modulation of 
the host cell behavior to the pathogen’s advantage (Renshaw et al., 2005). A region 
syntenous with the RD1 region of M. tuberculosis was recently reported in M. smegmatis 
and has been implicated in regulation of DNA transfer in this organism (Flint et al., 
2004). Complementation of the conjugation suppression phenotype of M. smegmatis RD1 
mutants with the M. tuberculosis RD1 suggested that the RD1 regions of both organisms 
are functionally equivalent (Flint et al., 2004). The M. smegmatis homologue of PPE68 
(Rv3873) was also up-regulated in both bc1-aa3 pathway mutants. This gene is located 
immediately upstream of cfp10 within the RD1 loci of both M. tuberculosis and M. 
smegmatis, and it has been proposed to be involved in the export of ESAT-6 and CFP-10 
proteins (Brondin et al., 2004). Interestingly, the up-regulation of PPE68, esat6 and 
cfp10 was reversed by CPZ in both ΔqcrCAB::hyg and ΔctaC::hyg mutants. The 
molecular and physiological link between expression of these genes and perturbation of 
the respiratory chain in M. smegmatis is presently unclear, but may be associated with 
ATP synthesis, since export of ESAT-6 and CFP-10 has been proposed to involve an 
 116 
ATPase encoded within the RD1 locus by Rv3870, Rv3871 and Rv3877, in an ATP 
hydrolysis dependent process (Brodin et al., 2004).  
 
Evidence for reduced metabolic activity in the cytochrome bc1-aa3 pathway mutants  
A significant number of up-regulated genes in both the ΔqcrCAB::hyg and ΔctaC::hyg 
mutants encoded hypothetical proteins, making it difficult to interpret the full extent of 
the adaptive changes that occur in response to re-routing of electron flux through the 
menaquinol oxidase. Nevertheless, most of the genes whose expression was down-
regulated in both mutants are involved in information pathways (transcription and DNA 
repair) and cell wall and cell processes, suggesting that inactivation the cytochrome bc1-
aa3 pathway is associated with an overall metabolic shift-down. This is consistent with a 
lower availability of energy due to a switch to the bioenergetically less-efficient 
cytochrome bd oxidase. 
 
Differences in the transcriptomes of the cytochrome bc1 and aa3 mutants 
Although the transcriptomes of these two mutants were highly comparable, there were 
some notable differences. For example, the lytB2 gene is down-regulated in the 
ΔqcrCAB::hyg mutant but not ΔctaC::hyg mutant. lytB2 is involved in the nonmevalonate 
pathway for the biosynthesis of terpenoids, and hence, in the biosynthesis of 
menaquinone (Rohdich et al., 2002). Similarly, the most highly down-regulated gene, 
rnpA (which encodes a ribonuclease P protein) in the ΔctaC::hyg mutant is not 
differentially regulated in the ΔqcrCAB::hyg mutant. Another notable difference, which 
would, however, require validation by RT-PCR, is that seen in the expression of the 
DosR-regulated genes in these two mutants, where the expression appeared to be higher 
in the ΔqcrCAB::hyg than in the ΔctaC::hyg mutant One possible explanation for this 
difference is that in the cytochrome aa3 mutant, electron flow can be reversed through the 
bc1 complex, as has been shown for P. denitrificans (van der Oost et al., 1995).  
 
What can be learnt about mycobacterial respiration from this study? 
This study has provided the first experimental evidence for the presence and functionality 
of the mycobacterial aerobic respiratory pathway that transports electrons from the 
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MKH2/MK pool to aa3-type cytochrome c oxidase via the cytochrome bc1 complex 
(Figure 3.3; results section). The branch terminating in the aa3-type cytochrome c oxidase 
is the major aerobic respiratory pathway in mycobacteria and its disruption leads to 
severe growth attenuation that is accompanied by a marked constitutive up-regulation of 
cytochrome bd oxidase. Characterization of mutants in this pathway allowed for 
speculation about the possible signals that may lead to the expression of the branch 
terminating in the alternate, bd-type oxidase.  
 Expression profiling of the bc1-aa3 pathway mutants suggested that there might be 
an overlap in the signals and/or regulatory networks that govern adaptation of M. 
smegmatis to re-routing of electron flow through the cytochrome bd oxidase and hypoxia. 
The primary or secondary signal(s) for all of these responses appear to derive from 
changes in the redox status of the cell resulting from use of alternative respiratory 
pathways. However, the full extent and significance of this overlap can only be 
established once the complete hypoxia responses of this organism have been defined. A 
significant number of differentially regulated genes in the mutants encode proteins of 
unknown functions (hypotheticals) therefore obscuring what may be important 
adaptations that would probably improve our understanding of the metabolism of this 
organism.  
 Although caution has to be exercised in extrapolating findings from the fast-
growing non-pathogenic M. smegmatis to the slow-growing pathogen, M. tuberculosis, it 
is tempting to speculate that the respiratory chain of M. tuberculosis plays a very 
important role in modulating the metabolic activities of this organism in response to 
changing environmental conditions. Based on the high degree of sequence similarity and 
the relatedness in the adaptive responses reported for M. smegmatis in this work to those 
reported previously for M. tuberculosis, the respiratory chains of both organisms are 
proposed to be equivalent in function. As observed in M. smegmatis, disruption of 
electron flow through the cytochrome bc1-aa3 branch of M. tuberculosis using inhibitors 
of cytochrome c oxidase resulted in up-regulation of cytochrome bd oxidase (Boshoff et 
al., 2004). This demonstrates that in both organisms, the latter oxidase compensates for 
the loss of functionality of the main aerobic branch. The failure to recover allelic 
exchange mutants in the cytochrome bc1-aa3 pathway of M. tuberculosis H37Rv suggests 
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that they were severely impaired for growth or nonviable under the conditions tested. In 
support of this conclusion, the transposon mutations in the genes encoding the bc1 
complex (qcrCAB) and the aa3-type cytochrome c oxidase (ctaC, ctaD, ctaE) were under-
represented in high-density mutagenized libraries of M. tuberculosis, as determined by 
transposon site hybridization (Sassetti et al., 2003). This apparent essentiality of the 
cytochrome bc1-aa3 pathway in M. tuberculosis may be due to an inability of its 
respiratory network to adapt in a manner analogous to that of M. smegmatis. However, 
cyd gene expression in M. tuberculosis has been shown to be highly responsive to 
interference with the machinery that maintains the proton motive force, as evidenced by 
its up-regulation by inhibitors of aa3-type cytochrome c oxidase and chemicals that affect 
its maturation (Boshoff et al., 2004), during adaptation to hypoxia (Boshoff et al., 2004; 
Voskuil et al., 2004), by growth on palmitate (Boshoff et al., 2004), and by 
protonophores (Boshoff et al., 2004). 
 
The role of the respiratory chain in the pathogenesis of M. tuberculosis  
The respiratory chain of M. tuberculosis has been proposed to play an important role in 
the pathogenesis of this organism (Boshoff et al., 2005). The picture that has emerged 
from differential gene expression analysis of bc1-aa3 pathway mutants of M. smegmatis 
supports this view. The induction of homologues of genes previously shown to be 
involved in M. tuberculosis virulence in response to disruption of the respiratory chain of 
M. smegmatis suggests that the respiratory chain may play a central role in guiding and 
maintaining survival of M. tuberculosis in the host. While the general response is 
indicative of a metabolic shift-down, part of which may be aimed at conserving energy, 
up-regulation of the genes implicated in virulence such as ESAT-6, CFP-10, PPE68, 
SenX3, and Rv3130c, suggests that M. tuberculosis may rely on changes in its respiratory 
chain components to detect its environment. For instance, Rv3130c (tgs1), encoding a 
triacylglycerol synthase with the highest activity in M. tuberculosis exposed to hypoxia 
or NO (Schnappinger et al., 2003; Daniel et al., 2004), was shown to be one of the first 
genes induced during phagosome formation. M. tuberculosis stores triacylglycerols as a 
source of fatty acids, which may later be used for energy production during persistence 
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(Daniel et al., 2004; Boshoff et al., 2005). ESAT-6 and CFP-10 have been proposed to be 
required for M. tuberculosis escape from the phagosome (Fortune et al., 2005).  
 
Future studies 
The present study has confirmed the presence of the cytochrome bc1-aa3 branch of the 
aerobic respiratory chain in M. smegmatis and demonstrated its importance for the 
growth of this organism. While the genetic methods employed assisted in unraveling to a 
large extent the genetic components of this pathway and the effects on gene expression of 
disrupting such, the biochemical aspect of these effects are not yet fully understood. 
Studies aimed at analyzing the concentrations of the different components of the 
respiratory chain, such as proteins, quinones and cofactors, can help to determine the 
physiological relevance of each component. Spectral analysis of membrane fractions for 
cytochrome composition would help to determine, for instance, whether the assembly of 
cytochrome bc1 requires presence of a functional cytochrome c oxidase as been reported 
to be the case for C. glutamicum (Niebisch and Bott, 2003). The concentrations of 
quinones and cofactors such as NAD(H) would answer the questions of whether or not 
their redox states serve as signals for induction of the DosR-DosS/DosT and SenX3-
RegX3 two-component regulatory systems. Finally, further studies will be required in 
order to elucidate the functions of the ctaDII and ythAB genes in the respiratory chain of 
M. smegmatis.  
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5. APPENDICES 
APPENDIX A: Abbreviations 
 
aa  amino acid 
ADC  albumin dextrose catalase 
Amp  ampicillin 
aph  aminoglycoside phosphotransferase gene (Km-resistance) 
ATP  adenosine triphosphate 
BCG  bacille Calmette-Guerin 
bla  β-lactamase gene (Ap-resistance) 
bp  base pair 
BSA  bovine serum albumin 
CbdO  cytochrome bd oxidase 
CcO  cytochrome c oxidase 
CFU  colony forming units 
CHCl3/IAA choloroform/isoamyl alcohol 
CHP  conserved hypothetical protein 
CPZ  chlorpromazine 
CTP  cytosine triphosphate 
cyt  cytochrome 
DCO  double cross over 
DE  differentially expressed 
DMSO  dimethylsulphoxide 
DNA  deoxyribonucleic acid 
dNTPs  deoxyribonuceotide triphosphates 
DOTS  directly observed therapy, short-course 
DTT  dithiothreitol 
EDTA  ethylenediaminetetraacetic acid 
Fe-S  iron-sulphur 
HIV  human immunodeficiency virus 
Hyg  hygromycin 
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hyg  Hyg-resistance gene 
IPTG  isopropyl-β-D-galactopyranoside 
kb  kilobase(s) 
Km  kanamycin 
KO  knockout 
LA  (see Appendix C) 
lacZ  β-galactosidase gene 
MADC-Tw (see Appendix C) 
MDR  multidrug resistance 
MMRU Molecular Mycobacteriology Research Unit  
NaOAc sodium acetate 
NO  nitric oxide 
NRP  nonreplicating persistence 
O2  oxygen 
OADC  oleic albumin dextrose catalase 
OD  optical density 
OD600  optical density at wavelength 600 nm 
ONPG  2-nitrophenyl-β-galactopyranoside 
ORF  open reading frame 
r  resistant 
RNA  ribonucleic acid 
RNase  ribonuclease 
RNIs  reactive nitrogen intermediate 
ROI  reactive oxygen intermediate 
sacB  B. subtilis levansucrase 
SCO  single cross over 
SDS  sodium dodecyl laurel sulphate 
TB  tuberculosis 
Tween  polyoxyethylene sorbitan monooleate 
X-Gal  5-bromo-4-chloro-3-indolyl-β-D-thiogalactopyranoside 
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APPENDIX B: Media and solutions 
 
Media 
Luria Bertani broth (LB) 
1% tryptone, 0.5% yeast extract, 0.5% sodium chloride. 
 
Luria Bertani agar plates (LA) 
1% tryptone, 0.5% yeast extract, 0.5% sodium chloride, 1.5% agar. 
 
2 × TY broth 
1.6% tryptone, 1% yeast extract, 0.5% sodium chloride. 
 
Middlebrook-Tween broth (MADC-Tw) for M. smegmatis 
0.47% Middlebrook 7H9, 0.2% glycerol, 0.085% sodium chloride, 0.2% glucose, 0.05% 
Tween 80. [Sodium chloride and glucose were autoclaved separately, Tween was filter 
sterilized separately as a 20% stock, and the components were added to the autoclaved 
Middlebrook 7H9 plus glycerol]. 
 
Middlebrook-Tween broth (MADC-Tw) for M. tuberculosis 
0.47% Middlebrook 7H9, 0.2% glycerol, 10% Middlebrook ADC, 0.05% Tween. [sterile 
Middlebrook ADC and Tween were added to the autoclaved Middlebrook 7H9 plus 
glycerol after cooling to approx. 60°C]. 
 
Middlebrook 7H10 agar plates 
1.8% Middlebrook 7H10, 0.5% glycerol, 10% Middlebrook OADC. [Sterile OADC was 
added to the autoclaved media after cooling to approx. 60°C]. 
 
Solutions 
Antiobiotic stocks 
Ampicillin: 35 mg/ml in 50% ethanol. 
Kanamycin: 50 mg/ml in water. 
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Hygromycin B: 50 mg/ml in phosphate buffered saline (as supplied by Roche). 
 
50 × Denhardt’s reagent 
1% Ficoll (Type 400), 1% polyvinylpyrrolidone, 1% BSA. Filter sterilized. 
20 × SSC  
17.53% NaCl, 8.82% sodium citrate; adjust pH to 7.0 with HCl. 
DEPC-water  
0.1% diethylpyrocarbonate (DEPC) in double distilled water; incubated overnight in 
fume hood and then autoclaved. 
RNA loading buffer 
50% glycerol, 1 mM sodium EDTA, 0.4% bromophenol blue; in DEPC-water. 
Calculation for PCR primer-pair annealing temperature, T° 
T° = [(Tm1 + Tm2)/2] -6 
where Tm = 2(A+T) + 4(G+C)  
Tm1 = forward primer and Tm2 = reverse primer. 
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APPENDIX C: Plasmid Maps 
 
Vectors commercially available and those obtained from other research groups: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                    
 
 
 
 
 
 
 
 
 
 
pGEMTEasy (3017 bps) 
SpeI 
EcoRI 
NotI 
PstI 
SalI 
AccI 
NdeI 
SacI 
MluI 
ScaI 
RsaI 
XmnI NaeI 
ApaI 
AatI 
SphI 
StyI 
NcoI 
NotI 
EcoRI 
lacZ' bla 
f1 ori 
'lacZ 
pCR2.1-TOPO* (3908 bp) 
EcoRV 
NotI 
XbaI BglII 
HindIII 
Asp718 
BamHI 
'lacZα aph bla lacZα' 
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pGOAL17 
8855 bp 
PacI 
PacI 
sacB 
85lacZ 
bla 
pIJ963 
4403 bp 
BglII 
BamHI 
BglII 
hyg 
bla 
p2NIL 
4753 bp 
SalI 
BamHI 
KpnI 
NotI 
PacI 
EcoRI 
MluI 
XhoI 
PstI 
ScaI 
HindIII 
aph 
pGEM3Zfp 
3199 bp 
EcoRI 
SacI 
Asp718 
SmaI 
BamHI 
XbaI 
SalI 
PstI 
SphI 
HindIII 
lacZα 
bla 
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pOLYG 
5315 bp 
HindIII 
EcoRV 
PstI 
BamHI 
oriM 
hyg BclI 
XbaI 
SpeI 
pMV306K 
3993 bp 
NheI 
SpeI 
NotI KpnI 
XbaI 
EcoRV 
NcoI 
EcoRI 
HindIII 
BclI 
aph 
Erep 
MCS 
attP 
int 
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Intermediate plasmids constructed in this study: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For construction of M. smegmatis qcrCAB knockout vector 
 
p2QCR 
6133 bp 
SalI 
BamHI 
NotI 
PacI 
EcoRI 
MluI 
PstI 
ScaI 
HindIII 
qcrC''B 
aph 
XhoI 
p2QCRH 
7871 bp 
BclI 
BamHI 
PacI 
MluI 
XhoI 
ScaI 
HindIII 
qcrC' 
hyg 
'qcrB aph 
pTOPOQ1 
4786 bp 
EcoRV 
XbaI 
BglII 
ScaI 
HindIII 
BamHI 
BamHI 
HindIII 
'lacZα 
aph 
bla 
lacZα' 
qcrC' 
pGEMQ2 
4031 bp 
EcoRI 
Asp718 
BamHI 
XbaI 
SalI 
PstI 
HindIII 
ScaI 
'lacZα 
'qcrB 
lacZα 
bla 
 128 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For construction of M. smegmatis ctaC knockout vector 
 
 
 
pTEASYC1 
4055 bp 
SpeI 
MluI 
ScaI 
SphI 
BamHI 
BglII 
Asp718 
lacZ' 
ba 
f1 ori 
'lacZ 
ctaC' 
pCTACH 
8272 bp 
PacI 
MluI 
XhoI 
HindIII 
NspV 
aph 
ctaF 
'ctaC 
hyg 
ctaC' 
BamHI 
BglII 
SphI 
p2CTAC 
6514 bp 
NotI 
PacI 
EcoRI 
MluI 
XhoI 
HindIII 
BclI 
NspV 
BamHI 
BglII 
SalI 
aph 
ctaF 
ctaC' 
pTEASYC2 
4117 bp 
SpeI 
PstI 
SalI 
SphI 
HindIII 
Asp718 
BamHI 
lacZ' 
bla f1 ori 
'lacZ 
ctaF 
'ctaC 
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For construction of M. smegmatis ctaDI  knockout vector 
 
 
p2CTADIH 
7789 bp 
PacI 
MluI 
ScaI 
HindIII 
NspV 
SphI 
BamHI 
aph 
ctaD1' 
hyg 
'ctaD1 
p2CTAD1 
6031 bp 
PacI 
EcoRI 
MluI 
ScaI 
HindIII 
NspV 
BamHI 
aph 
'ctaD1' 
pTEASYDI-1 
3900 bp 
SpeI 
PstI 
MluI 
SphI 
Asp718 
BamHI 
lacZ' 
bla 
f1 ori 
'lacZ 
'ctaDI 
pTEASYDI-2 
3804 bp 
SpeI 
SalI 
MluI 
SphI 
HindIII 
Asp718 
BamHI 
lacZ' 
bla 
f1 ori 
'lacZ 
ctaDI' 
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For construction of M. smegmatis ctaDII  knockout vector 
 
 
 
p2CTADII 
6087 bp 
NotI PacI 
EcoRI 
MluI 
XhoI 
HindIII 
BamHI 
NspV 
aph 
'ctaDI' 
p2CTADIIH 
7845 bp 
PacI 
MluI 
XhoI 
HindIII 
BclI 
BamHI 
NspV 
aph 
ctaDII' 
hyg 
'ctaDII 
pGEMDII-1 
4001 bp 
EcoRI 
BamHI 
SphI 
PstI 
SalI 
HindIII 
''lacZα ctaDII' 
lacZα' 
bla 
pTEASYD2-2 
3861 bp 
PstI 
MluI 
Asp718 
BamHI 
lacZ' 
bla 
f1 ori 
'lacZ 
'ctaDII 
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For construction of M. tuberculosis ctaC knockout vector 
 
 
 
p2TBCTAC 
8567 bp 
PacI 
EcoRI 
XhoI 
HindIII 
BglII 
SphI 
aph 
ctaF 
ctaC’ 
SalI 
HindIII 
XbaI 
NspV 
NotI 
p2TBCTACH 
10333 bp 
PacI 
XhoI 
NspV 
BglII 
aph 
ctaF 
'ctaC 
hyg 
ctaC' 
pTEASYTBC1 
4920 bp 
ScaI 
SphI 
HindIII 
Asp718
SmaI 
XbaI 
bla 
f1 ori 
'lacZ 
ctaF 
‘ctaC 
pTEASYTBC2 
5010 bp 
SalI 
XbaI 
BglII 
SmaI 
HindIII 
lacZ' 
bla 
f1 ori 
'lacZ 
ctaC' 
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APPENDIX D: DNA microarray supplementary information 
 
Table D1. M. smegmatis ΔqcrCAB::hyg genes induced during growth at 21% oxygen as 
analyzed on the partial-genome amplicon array (Table from produced from Dr D. 
Powell’s analyses) 
ID Gene TIGR name Function (as per Leproma & Tuberculist) M P value Class 
ribA ribA2 MSMEG3082 Probable riboflavin biosynthesis protein -2.301 0.0020 7 
ML2274  MSMEG3498 Probable conserved secreted protein -1.914 0.0072 3 
mihF mihF MSMEG3063 Putative integration host factor -1.764 0.0003 2 
glgC glgC MSMEG5067 glucose-1-phosphate adenyl-transferase -1.753 0.0072 7 
ML1835  MSMEG6527 CHP -1.556 0.0030 10 
ML0510  MSMEG3035 CHP -1.444 0.0004 10 
ML0886  MSMEG4257 possible glycosyl transferase -1.430 0.0024 7 
ML1312  MSMEG4598 CHP -1.229 0.0001 10 
argD-g argD MSMEG2446 probable acetylornithine aminotransferase -1.027 0.0033 7 
gabD-q gabD MSMEG2554 probable aldehyde dehydrogenase  -1.005 0.0052 7 
Rv3134c uspL MSMEG5230 Universal stress protein -0.990 0.0098 10 
Rv1623c cydA MSMEG3243 Cytochrome bd oxidase subunit I -0.931 0.0069 7 
ML1926  MSMEG0828 putative tuberculin-related protein -0.915 0.0058 3 
Rv1592c  MSMEG3205 CHP -0.878 0.0016 10 
ML1783  MSMEG4344 possible transcriptional regulatory protein -0.849 0.0080 9 
PPE-b PPE MSMEG0063 PPE family domain -0.807 0.0003 6 
ML0663  MSMEG2085 CHP -0.804 0.0016 10 
argD-e argD MSMEG2971 probable acetylornithine aminotransferase -0.767 0.0030 7 
atpH atpH MSMEG4925 ATP synthase delta chain -0.741 0.0024 7 
ML0990  MSMEG2732 CHP -0.701 0.0066 10 
glpD-a glpD MSMEG6721 glycerol-3-phosphate dehydrogenase -0.683 0.0017 7 
menD menD MSMEG1225 bifunctional menaquinone biosynthesis protein -0.677 0.0072 7 
Rv3841 bfrB MSMEG6385 bacterioferritin -0.660 0.0062 7 
bccA-c  MSMEG1807 biotin carboxy carrier protein & transferase -0.641 0.0017 1 
purM purM MSMEG5766 phosphoribosylformylglycinamidine cyclo-ligase -0.635 0.0082 7 
fas fas MSMEG0552 fatty acid synthase -0.633 0.0015   
lpqF lpqF MSMEG6050 probable conserved lipoprotein -0.617 0.0062 3 
ML0759 fbiA MSMEG1829 probable F420 biosynthesis protein -0.611 0.0015 7 
gabD-y gabD MSMEG1497 succinate-semialdehyde dehydrogenase -0.600 0.0075 7 
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ID Gene TIGR name Function (as per Leproma & Tuberculist) M P value Class 
glnA2-f glnA2 MSMEG2596 probable glutamine synthetase -0.593 0.0026 7 
ML1094  MSMEG1104 short chain type dehydrogenase/ reductase -0.590 0.0024 7 
ML0596-a csd MSMEG4531 probable cysteine desulfurase -0.576 0.0020 7 
ML2203  MSMEG3807 CHP -0.552 0.0020 10 
ML2289  none CHP -0.537 0.0020 10 
sdhC sdhC MSMEG1669 succinate dehydrogenase -0.528 0.0082 7 
lysX lysX MSMEG6531 lysyl-tRNA synthetase -0.501 0.0070 2 
phoT phoT MSMEG2124 phosphate transport ATP-binding protein -0.496 0.0066 3 
ML2053 adhA MSMEG0251 probable alcohol dehydrogenase -0.477 0.0041 7 
uvrD2 uvrD2 MSMEG1956 ATP-dependent DNA helicase -0.476 0.0051 2 
gabD-e gabD MSMEG6662 aldehyde dehydrogenase family protein -0.469 0.0062 7 
folK folK MSMEG6064 hydroxymethyldihydropteridine phosphokinase -0.443 0.0071 7 
miaA miaA MSMEG6675 
tRNA delta(2)-isopentenylpyrophosphate 
transferase -0.383 0.0100 7 
a M, log base 2 of the fold ratio 
b Functional class as per Tuberculist: 1, Lipid metabolism; 2, Information pathways; 3, Cell wall 
& cell processes; 6, PE/PPE; 7, Intermediary metabolism & respiration; 9, Regulatory proteins; 
10, Conserved hypotheticals 
 
Table D2. M. smegmatis ΔqcrCAB::hyg genes repressed during growth at 21% oxygen as 
analyzed on the partial-genome amplicon array (Table from produced from Dr D. 
Powell’s analyses) 
ID Gene TIGR name Function M P value Class 
lytB2 lytB MSMEG5208 probable LytB-related protein, LytB2 3.316 0.0002 3 
xseA xseA MSMEG5210 exo-deoxyribonuclease VII, large subunit 2.737 0.0003 2 
ML2088-a  MSMEG4807 putative cytochrome P450 2.039 0.0004 7 
ctpC-a  MSMEG5384 cadmium-translocating P-type ATPase 1.789 0.0081 3 
rpoT sigA MSMEG2759 RNA polymerase sigma factor, SigA 1.513 0.0000 2 
rplE rplE MSMEG1464 ribosomal protein L5 1.198 0.0002 2 
ML2661-e fadD7 MSMEG3702 Fatty acid CoA ligase, FadD7 1.197 0.0051 1 
fpg fpg MSMEG2417 formamidopyrimidine-DNA glycosylase 0.961 0.0078 7 
ML1750  MSMEG2202 CHP 0.922 0.0098 10 
uvrB uvrB MSMEG3820 excinuclease ABC, B subunit 0.843 0.0057 2 
Rv1009 rpfB MSMEG5419 probable resuscitation-promoting factor B, RpfB 0.835 0.0027 3 
uspE uspB MSMEG4462 probable sugar ABC transporter 0.810 0.0024 3 
ML0115  MSMEG6327 CHP 0.807 0.0051 10 
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ID Gene TIGR name Function M P value Class 
ML2661-h fadD7 MSMEG4041 Fatty acid CoA ligase, FadD7 0.805 0.0002 1 
Rv2393  MSMEG4522 CHP 0.771 0.0041 10 
ML2491-c  MSMEG4370 CHP 0.760 0.0033 10 
ML0815  MSMEG1939 transcriptional regulator, TetR family domain 0.725 0.0002 9 
rpsL rpsL MSMEG1393 ribosomal protein S12 0.724 0.0066 2 
ML0691-b dacB MSMEG1659 probable D-alanyl-alanine carboxypeptidase 0.720 0.0005 3 
ML0729  MSMEG1810 CHP 0.674 0.0039 10 
ML0093 glfT MSMEG5323 bifunctional UDP-galactofuranosyl transferase 0.668 0.0085 3 
gatA-b gatA MSMEG1078 glutamyl-tRNA (GLN) amidotransferase  0.668 0.0024 2 
atpD-c atpD MSMEG4939 probable ATP synthase Beta chain 0.660 0.0009 7 
trpS trpS MSMEG1655 tryptophanyl-tRNA synthetase 0.655 0.0020 2 
mce1A-a mce1A MSMEG6500 host cell invasion 0.650 0.0026 0 
ML2549  MSMEG0428 CHP 0.628 0.0029 10 
ML2620-b mmpL3 MSMEG4733 conserved transmembrane transport protein 0.624 0.0024 3 
pdc-a pdc MSMEG4455 probable pyruvate decarboxylase 0.590 0.0027 7 
ML1115 lprB MSMEG1390 possible lipoprotein 0.581 0.0031 3 
ML0174 mprA MSMEG5468 DNA-binding response regulator (persistence) 0.580 0.0016 9 
umaA2-a umaA MSMEG1199 possible mycolic acid synthase 0.476 0.0041 1 
ML1698  MSMEG5185 conserved membrane protein 0.464 0.0033 3 
ML2140  MSMEG5666 transcriptional regulator, marR family 0.460 0.0070 9 
ML2377 mmpS4 MSMEG0373 conserved membrane protein 0.455 0.0073 3 
ML0243-b pks16 MSMEG5415 putative polyketide synthase 0.440 0.0081 1 
ung ung MSMEG3668 probable uracil-DNA glycosylase 0.422 0.0079 2 
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Table D3. Genes up-regulated in response to CPZ in the ΔqcrCAB::hyg mutant (TIGR 
full genome oligonucleotide array 
Closest H37Rv Hit 
(BLAST)a Name on 
array Gene  Description (TIGR) LR STDEV Rv # E-value 
ORFA09082  
transcriptional regulator, TetR family 
domain  7.05 0.17 Rv0302 [1e-06] 
ORFA04432 ald alanine dehydrogenase 5.60 1.03 Rv2780 [1e-156] 
ORFA10783  hypothetical protein 4.79 0.22 Rv3300c [2.1] 
ORFA03112*  S30AE family protein 4.63 0.42 Rv3241c [3e-89] 
ORFA10805  seq ID no 1F, putative 4.62 2.35 Rv0203 [6e-08] 
ORFA06467  
FxsA cytoplasmic membrane protein 
family 4.20 0.87 Rv2053c [1e-05] 
ORFA09393  hypothetical protein 3.97 2.45 Rv0538 [0.11] 
ORFA02973  conserved hypothetical protein 3.95 1.13 Rv2719c  [0.077] 
ORFA00682*  hypothetical protein 3.78 0.48 Rv1628c [0.87] 
ORFA04487  Helix-turn-helix domain protein 3.62 1.17 Rv2745c [1e-34] 
ORFA08694  conserved hypothetical protein| 3.51 1.72 Rv1072  [3e-82] 
ORFA06043  integral membrane protein [imported] 3.46 1.94 Rv1861 [4e-07] 
ORFA02952  conserved hypothetical protein 3.22 1.66 Rv2181 [0.004] 
ORFA11060  hypothetical protein 3.21 2.24 Rv2228c  [0.55] 
ORFA10188* uvrA hypothetical protein 3.19 0.89 Rv1638  [0.52] 
ORFA04589* sigB mysB sigma factor 3.15 1.06 Rv2710 [1e-166] 
ORFA05950* bfrA bacterioferritin 3.14 0.89 Rv1876  [3e-78] 
ORFA05222  
transcriptional regulator, ArsR family 
domain  3.07 0.80 Rv1460 [6e-88] 
ORFA05225  
Uncharacterized protein family 
(UPF0051)  3.07 1.88 Rv1462 [1e-177] 
ORFA00963*  STAS domain protein 2.98 0.40 Rv0516c [2e-22] 
ORFA05224  Pps1 sans inteine 2.97 0.43 Rv1461 [1e-129] 
ORFA02971  hypothetical protein 2.92 0.57 Rv2391 [0.37] 
ORFA02906*  desA3 2.89 2.72 Rv3229c [1e-94] 
ORFA08326  conserved hypothetical protein 2.87 0.35 Rv1249c [2e-76] 
ORFA02904*  oxidoreductase 2.86 2.54 Rv3230c  [2e-41] 
ORFA02957 usfY conserved hypothetical protein 2.68 0.38 Rv3288c  [7e-19] 
ORFA01713*  
Flavin-binding monooxygenase-like 
subfamily 2.62 1.10 Rv3049c [0.0] 
ORFA02972  putative membrane protein 2.58 0.11 Rv2566 [4.8] 
ORFA00111  putative transposase 2.39 0.68 Rv2839c [0.036] 
ORFA09026* pepD heat shock protein HtrA, putative 2.28 0.71 Rv0983  [1e-129] 
ORFA03236  CsbD-like family 2.24 0.43 Rv2176 [3.7] 
ORFA06545*  COG0464:ATPases of the AAA+ class 2.15 1.30 Rv2115c [0.0] 
ORFA08264  
Heavy-metal-associated domain, 
putative 2.15 1.58 Rv1856c [0.70] 
ORFA05227  MW07 2.13 1.50 Rv1463 [1e-121] 
ORFA00897  transposase, putative 2.02 0.53 Rv0755 [0.001] 
ORFA10770  hypothetical protein 1.95 1.12 No_Hit No_Hit 
ORFA00617*  MaoC domain protein 1.92 0.20 Rv0241c [1e-112] 
ORFA03205 rhlE rhlE 1.86 0.98 Rv3211 [1e-177] 
ORFA06532*  
Protein of unknown function (DUF797) 
family 1.80 0.35 Rv2111c [3e-14] 
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Closest H37Rv Hit 
(BLAST)a Name on 
array Gene  Description (TIGR) LR STDEV Rv # E-value 
ORFA03454* fadE23 fadE23 1.67 0.50 Rv3140 [1e-168] 
ORFA07028*  SEQ ID NO 45F 1.64 0.71 Rv2169c  [2e-44] 
ORFA04061*  4-aminobutyrate aminotransferase 1.59 0.63 Rv3329  [6e-52] 
ORFA08327* sucA 
2-oxoglutarate dehydrogenase E1 
component 1.56 0.67 Rv1248c [0.0] 
ORFA03313  hypothetical protein 1.50 0.07 Rv2284  [0.088] 
ORFA06530* prcB proteasome beta subunit 1.46 0.15 Rv2110c  [1e-112] 
ORFA05419* cydA appC 1.36 0.46 Rv1623c [0.0] 
ORFA01621  conserved hypothetical protein 1.26 0.43 Rv0483  [0.39] 
ORFA07027  
conserved hypothetical protein 
TIGR00242 1.25 0.04 Rv2166c [2e-70] 
ORFA10275 furA furA 1.24 0.00 Rv1909c [3e-45] 
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